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Abstract 
 
In this thesis the development of several new gold-catalysed reactions are described. Two new 
strategies have been employed to access pyrroles by the cycloisomerisation of alkynyl 
aziridines, and the formation of α,β-unsaturated imides by the oxidation of ynamides has been 
developed. 
A rare gold-mediated vinylidene rearrangement of brominated or silylated alkynes has been 
used to prepare brominated or silylated 2,4-substituted pyrroles regioselectively. The practical 
applicability of this process was limited by instability of products under the reaction 
conditions. 
Cationic gold catalysis was used in a novel synthesis of 2,4- and 2,5-substituted pyrroles from 
alkynyl aziridines. The role of counterion in these processes was studied and shown to be 
important in determining reaction outcomes. A Ph3PAuCl/AgOTs catalyst system, allows 2,5-
substituted pyrroles to be regioselectively synthesised in an atom-economical manner in near 
quantitative yield. From the same aryl-substituted starting materials the 2,4-substituted 
pyrrole isomer were accessed preferentially when a Ph3PAuCl/AgOTf catalytic system was 
employed. A reaction mechanism accounting for the reaction outcome was proposed on the 
basis of 13C- and deuterium-labelling studies. 
A new gold-catalysed synthesis of α,β-unsaturated imides was developed using a ynamide 
oxidation approach. Gold carbenoid intermediates can be formed regioselectively by action of 
a mild external oxidising agent, and were subsequently used in 1,2-insertion reactions. 
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Chapter 1:  Introduction 
2 
1.1  Gold: A widely used metal 
 
Gold has been used for millennia by mankind. It has long been employed as currency and in 
jewellery manufacturing and decoration thanks to its famous malleability and resistance to 
tarnish. It has been associated to numerous industrial processes where its properties to resist 
oxidation from air or moisture were also very useful. More importantly, gold’s excellent 
chemical resistance and conductivity has made this metal a key component in electronics. 
Aerospatiale, among other high technology companies, has used gold for the preparation of 
highly efficient and reliable heat shields, semiconductors, connecting wires, switches and 
relay contacts indispensable in the 21st century. Dentistry and medicine1,2 have also employed 
gold: Its non-allergenic, non-toxic characteristics were particularly prized for use in fillings or 
bridges for example, and gold-based anticancer,3 antimicrobial4 or antiarthritis5 complexes 
have already successfully been developed. 
But despite those numerous applications in a variety of fields, gold has been considered of 
low interest in organic chemistry for a long period of time. When other transition metals were 
already used in catalysis, gold was still commonly considered chemically inert and too 
expensive. In fact, rhodium and platinum, commonly used in catalysts, were for example 
100% and 30% more expensive than gold in the beginning of August 2010 (Au: 1182 US$ per 
ounce, Rh: 2175, Pt: 1590).6 
The huge increase in the development of homogeneous gold catalysed processes in the past 
decade has proved that chemists have finally realised the fantastic possibilities offered by the 
use of gold complexes in organic chemistry. The renunciation of mercury catalysis, due to the 
high toxicity of mercuric salts, has certainly helped to drive the interest of chemists on to its 
neighbour of the periodic table. 
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1.2  Gold homogeneous catalysis: Origin of reactivity 
 
1.2.1  Relativistic effects 
 
With the development of new processes using homogeneous gold catalysis, where all the 
reactive species of the reaction are in the same phase, a better understanding of the reactivity 
modes of gold complexes has emerged. Furthermore, relativistic effects have helped 
rationalize the observed reactivity of gold complexes.7 Those effects account for the 
contraction of the s and p-orbitals of elements of the sixth period (mainly Ir, Pt, Au, Hg and 
Tl) and are more significant for gold than any other metal (Figure 1). The electrons of those 
orbitals are therefore closer to the nucleus and have greater ionization energies. A result of 
this is the expansion of the 5d and 4f-orbitals which are more shielded from the core. 
 
 
Figure 1: Calculated relativistic contraction of the 6s orbital (the relativistic and non-relativistic radii 
were dertermined computationally)8 
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One direct consequence of these relativistic effects is the reduction of the M-L (Metal-Ligand) 
bond length in gold complexes in comparison with its neighbours in the periodic table (Pt and 
Hg).9 In other terms the Au-L bonds are strengthened. The electronegativity of the ligand is 
important and the relating effect will be, for example, more pronounced for a phosphine 
ligand than a bound chloride (Figure 2).10 
 
 
Figure 2: Structure of [AuCl(PPh3)]. α = 179.6°, a = 2.235 Å, b = 2.279 Å 
 
Furthermore, as illustrated in Figure 2, gold (I) LAuX compounds have a pronounced 
preference to form two coordinate linear complexes.11 Frequently one of the ligands is 
abstracted in order to obtain reactive species of the type LAu+, bearing an empty coordination 
site. To that respect silver salts are often used in an in situ ligand metathesis step prior to 
catalysis to replace chlorine by a weakly coordinated counterion (Scheme 1). 
 
 
Scheme 1: Metathesis reaction between Ph3PAuCl and AgOTf 
 
Another consequence of the relativistic studies results is the Lewis acid character of gold (I) 
complexes. The large and diffuse d-orbitals of the gold atom renders it more susceptible to get 
involved in orbital rather than charge interactions.12 Therefore, gold catalysts predominantly 
activate “soft” nucleophilic π-systems such as alkynes, alkenes and allenes. This very specific 
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affinity of gold compounds generally allows the use of a wide variety of functional groups, a 
quality particularly appreciated for transformations involving complex functionalized 
molecules and illustrated later in this chapter. 
 
1.2.2  π-System activation 
 
According to the Dewar-Chatt-Duncanson model (DCD),13 upon complexation a π-system 
(alkyne or alkene) acts as a ligand to a transition metal complex and donates electron density 
through σ-bonding from its π-orbital to an empty metal d-orbital (Scheme 2). Back-donation 
occurs from a filled d-orbital of the metal into the empty π* antibonding orbital of the ligand 
to create a π-interaction. Two more π and δ interactions are also involved in the interaction 
between the metal and an alkyne ligand, the δ interaction contributing only very weakly to the 
bonding because of poor overlap (dashed interactions represented in Scheme 2). 
 
 
Scheme 2: Qualitative orbital diagram representing interactions between alkyne ligand and gold 
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Gold complexes follow this DCD mode of interaction and the resulting activated C-C 
multiple bond in alkynes and also alkenes are lengthened and the geometry of the carbon 
atoms can be considered changed from trigonal planar (alkene) and linear (alkyne) to bent as 
spectroscopic data and isolated complexes confirm (Scheme 3).14 
 
Scheme 3: Impact of the association of a gold complex on the geometry of cyclododecyne14 
 
Nevertheless, a reluctance of the metal center to back-donate electrons to the π-system has 
been suggested by calculations.15 Only approximately 25% of the interaction with the 
acetylene ligand model ([Au+(C2H2)]) would be due to back-donation from the metal while 
the filled π-orbital of the C-C multiple bond would contribute to 64% of the bonding. Those 
results suggest the alkyne is impoverished in electron density and its carbons atoms are 
rendered more electrophilic. As a consequence, those gold-activated π-systems are suitable 
intermediates for attack by various nucleophiles. 
 
1.2.3  Nucleophilic addition 
 
Despite calculations having shown ethylene binds more strongly than acetylene to a LAu+ 
fragment,15 experimental results confer a preference of gold complexes to catalyse 
transformation of alkynes versus allenes and alkenes. This “alkynophilicity” is considered to 
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be driven by kinetics and reflects discrimination by the incoming nucleophile more than a 
better activation of the C-C triple bond versus other π-systems. Indeed as alkynes bear lower 
“highest occupied molecular orbital” (HOMO) and “lower unoccupied molecular orbital” 
(LUMO) than alkenes, it can be generally expected that LAu-alkyne complex should have a 
lower LUMO preferred for the addition of a nucleophile than the corresponding LAu-alkene 
one.16 
Subsequently to the anti approach of a nucleophile, to the activated π -system, slippage of the 
metallic η2 complex along the axis of the π-system-Au bond occurs (Scheme 4).17 
Redistribution of electron density leads to the formation of trans-η1-complex A with new C-
Au and C-Nu bonds. 
 
 
Scheme 4: Redistribution of electron density upon nucleophilic attack on alkyne or alkene 
 
At that stage the η1-intermediate can undergo different transformations depending on the 
functionalities present in the substrate or in the reaction mixture. 
The catalytic cycle can end with the regeneration of the catalyst through protodeauration or 
trapping by another appropriate electrophile like N-iodosuccinimide (NIS).18 This process is 
completely stereospecific and deuteriated experiments from vinyl gold species 3 have proved 
the electrophile is positioned exactly where the gold was (Scheme 5).19  
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Scheme 5: Example of stereoselective deuterodeauration 
On the other hand when the η1-intermediate A is a vinylgold species, arising from an activated 
alkyne, more possibilities than regeneration of the catalyst are offered. This intermediate can 
be involved in further reactions or rearrangement due to the presence of the double bond. 
The next sections of this chapter will introduce the main modes of reactivity possible with 
gold activated alkynes. It will concentrate on heterocycle formation and the synthetic potential 
offered by functional group migration during gold catalysed processes. 
 
1.3  Selected recent examples of alkyne activation 
 
Among C-C π systems, alkynes have been the most widely studied in gold catalysis. The use 
of alkynes allows more complex molecules to be obtained than when simple alkenes are 
employed, and alkynes are also more readily available than the similarly reactive allenes. 
 
Many methods were recently developed in this area using heteroatom nucleophiles, mainly 
oxygen or nitrogen. Hydroamination, which describes the addition of a primary or secondary 
amine across an alkyne, was for example used in an efficient gold (I)-catalysed tandem 
reaction to access various tetracyclic heterocycles like 7 (Scheme 6).20 These important 
precursors of benzo[c]phenanthridine alkaloids, a promising class of antitumor agents,21 were 
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obtained from a 6-endo gold-mediated cyclisation followed by condensation under mild 
conditions. 
Another remarkable transformation in a one pot cascade manner this time was created to 
prepare highly functionalised pyrrolo[1,2-a]quinolin-1(2H)-ones (Scheme 6).22 It was 
suggested that hydroamination was followed by a gold-catalysed hydroarylation of the 
starting arylamide 8 to give product 11 in good yield and good regioselectivity. The use of a 
combination of gold and silver salts was necessary to obtain total conversion of the starting 
material, and dramatic reduction of the yield was observed when lower temperatures were 
employed. 
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Scheme 6: Selected examples of gold-catalysed hydroamination of alkynes in cascade reactions 
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New advances in hydroalkoxylation reactions also led to the development of efficient 
methodologies (Scheme 7). Valuable spiroketals could be prepared in an expedient 
intramolecular hydroalkoxylation of functionalised monopropargylic triols.23 The gold 
catalysed reaction is though to go through the formation of a cyclic alkoxyallene 13 which 
next underwent cyclisation into the spiroketal in excellent yield. 
This type of transformation was also employed in the preparation of 3-(2H)-furanones, 
naturally occurring and biologically active moieties. The γ-hydroxyalkynone precursor 15 was 
engaged in a Michael addition of the hydroxyl group across the gold-activated triple bond. 
The proposed epoxide intermediate 17 would then cyclise to form heterocycle 18 in very good 
yield. 
HO
OH
OTBDPS
OH
P
(2 mol%)
O O
OTBDPS
94 %
THF, MS 4Å
0 C
tBu
AuCl
tBu
AgOTf (2 mol%)
O
H
[Au]
OH
OTBDPS
12
13
14
O
OH
O
OAgOTf (5 mol%)
(p-CF3C6H4)3PAuCl (5 mol%)
toluene, rt
91 %
O
O[Au]
H
O
[Au]
O
15
16 17
18
-[Au]
 
Scheme 7: Selected recent examples of gold catalysed hydroalkoxylation and hydration of alkynes 
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Substituted piperidines were expediently synthesised in a cationic gold (I) catalysed reaction 
of mixed N,O-acetals (Scheme 8).24 2,6-di-tert-butyl pyridine was employed as an additive to 
avoid in situ hydration of the enolether. The product of the reaction could eventually further 
react under acidic conditions to give the corresponding ketone. 
In the case of allylic tertiary amine 23, a five-exo nucleophilic addition occurred under gold 
activation conditions and rearrangement of the intermediate 24 delivered the corresponding 
cyanoindole 25 in excellent yield.25 
Reactions using nitrones could also be performed.26 It was proposed that after addition of the 
nucleophile on the activated C-C triple bond, intermediate 27 rearranged to give 1,3-dipole 
28. Subsequent [3+2] cycloaddition between the alkene moiety and the dipole would then 
form the final seven-membered ring. Application of the same type of reactivity with other 
kinds of N-oxides will be developed and discussed in more details in chapter 5. 
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Scheme 8: Selected recent examples of gold-catalysed reactions between alkynes and nucleophiles 
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Reactions involving sp2-hybridised heteroatom nucleophiles were also employed in novel 
methodologies (Scheme 9). For example highly substituted tricyclic furo[3,4-d][1,2]oxazines 
were accessed in high yield and diastereoselectivity.27 This gold (I)-catalysed reaction 
proceeded through cyclisation of α,β-unsaturated ketone 30 to form intermediate 32 which 
was immediately trapped with a nitrone in a 1,3-dipolar [3+3] cycloaddition. 
Amide derivatives also proved to be suitable reagent for these transformations. The already 
known simple formation of alkylidene oxazoline28 35 from propargyl carboxamide 34 
recently attracted much attention again.29 Indeed after running the reaction using one 
equivalent of gold catalyst in the presence of triethylamine, isolation and characterisation of 
the key vinyl gold intermediate 37 was possible. As expected the organogold compound could 
easily be transformed into the corresponding alkylidene oxazoline under acidic conditions. 
14 
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Scheme 9: Selected examples of gold-catalysed reaction involving sp2-hybridised heteroatom nucleophiles 
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Heteroaryl functionalities like indoles were employed as carbon nucleophiles to form 
heterocyclic compounds. A recent reaction of alkynylindole 38 illustrated this in a 
diastereoselective 6-exo-dig cyclisation (Scheme 10).30 The bridged tricyclic indoline product 
40 was obtained in high yields with total retention of chirality at the secondary propargyl 
alcohol when the indole nitrogen bore an electron-withdrawing group. Furans were also used 
in a similar fashion to access polyheterocyclic compounds. Ynamide 41 endured a 6-exo 
cyclisation followed by a nucleophilic attack from the second furan moiety.31 Protodeauration 
and aromatisation process by elimination of the furyl enol ether bridge delivering the final 
product 45. 
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Scheme 10: Selected examples of gold-catalysed reaction of heteroaryls with alkynes 
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Recently, novel reactions concerning different types of enynes and the trapping of their 
organogold intermediates upon activation were developed to form heterocycles (Scheme 11). 
Tricyclic structure 48 was obtained employing 1,5-enynes in a 6-endo-dig intramolecular 
phenoxycyclisation.32 High yields were reported under smooth reaction conditions using 
commercially available Ph3PAuNTf2. The importance of the geometry of the starting alkene 
was also highlighted as E-olefin gave trans product 50 and the Z-olefin furnished the cis 
isomer 48 only. 
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Scheme 11: Example of a 6-endo-dig intramolecular phenoxycyclisation 
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1.4  Functional group migration with alkyne activation 
 
The examples presented in the previous section have illustrated the broad range of 
transformations possible in gold-catalysed processes to access heterocycles from alkynes. A 
large number of these reactions can also include migrations, such as 1,2-alkyl and aryl shifts, 
ring expansion or pinacol-type rearrangement among others, to achieve powerful new 
transformations. 
 
1.4.1  1,2- and 1,3-ester migration of propargylic carboxylates 
 
As mentioned previously, sp2-hybridised nucleophiles have been used in gold-catalysed 
transformations. Among this class of compounds propargylic carboxylates C have represented 
a special case as two divergent initial transformations have been proposed (Scheme 12). A 
1,2-ester migration would take place through a 5-exo nucleophilic attack to form species E. 
This carbenoid form can also be described as a metal-stabilised carbocation F by mesomeric 
resonance. 
A 1,3-rearrangement forming H would be the result of a 6-endo attack pathway to access 
intermediate G. 
The type of cyclisation in the initial step was shown to be dependent on the nature of the 
substrate, with terminal or electron-withdrawing substituted alkynes favouring the formation 
of the carbenoid species F, mesomeric form of E. On the other hand internal alkynes would 
react preferentially to give allene intermediate H. 
18 
 
Scheme 12: Evolution of gold-activated propargyl acetates 
 
This latter case was for example described in a cascade gold(I)-catalysed synthesis of 2,5-
dihydrofurans from readily available butynediol monobenzoates (Scheme 13).33 Activation of 
the triple bond by the gold complex was proposed to promote the nucleophilic attack of the 
benzoate moiety to form 52 through a 1,3-migration of the ester. Subsequent activation of the 
allene by the catalyst allowed nucleophilic attack of the alcohol causing formation of the 
vinyl-gold species 53. Protonation finally ended the reaction and the final product was 
released. A good yield of 2,5-dihydrofuran 54 was obtained and excellent retention of the 
stereochemical information from the starting material was observed. 
19 
 
Scheme 13: Gold-catalysed 2,5-dihydrofuran formation involving a 1,3-benzoate migration 
 
However it was found that some analogues were unable to undergo the same π-acid-induced 
rearrangement. tert-Butyl carbonate 55 led to the formation of isolable 1,3-dioxolan-2-one 
5634 and carbamate 57 gave oxazolidinone 5935 by elimination of isobutene and subsequent 
protonation from intermediate 58 (Scheme 14). 
 
 
Scheme 14: Gold-catalysed formation of 1,3-dioxolan-2-ones or oxazolidinones 
20 
The carbenoid pathway, involving a gold-catalysed 1,2-acyloxy migration, was also used in 
recent transformations (Scheme 15). Notably, the first reported trapping of a rearranged 
propargylic ester with a 1,3-dipole was performed under mild conditions to access bicyclic 
structures.36 The cycloaddition of carbenoid species 62 with chiral azomethine imine 61 led to 
high yields of product 65 in good distereomeric ratios at 0 °C. The diastereoselectivity 
observed was rationalised by minimisation of unfavourable steric interactions in the ring 
closing transition state and led to the preferred cis product. 
 
 
Scheme 15: Example of gold-catalysed 1,2-migration of propargylic esters 
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1.4.2  1,2-migration onto a gold carbenoid 
 
Formation of carbenoid intermediates has been evoked in gold-catalysed processes and the 
use of such species in reactions was described in the previous section. 
One way to take advantage of such very reactive functionality is to incorporate, in the 
molecular structure, a moiety capable of migrating to an adjacent gold carbenoid center thus 
providing a means to terminate the reaction (Scheme 16). Hydrogen, aryls and alkyls have all 
been shown to be suitable substituents for 1,2-shifts and their migrating aptitude to gold 
carbenoids generally followed the order H > aryl > alkyl, as is observed for free carbenes.37 
 
 
Scheme 16: 1,2-migration step to a gold carbenoid center 
 
Due to the fact that 1,2-hydrogen shift is usually favoured, 1,2-alkyl and aryl migration are 
only found in gold-catalysed reactions where no hydrogen could compete. 
 
An example of this preference for a 1,2-hydrogen versus 1,2-alkyl shift was particularly well 
illustrated in a gold(I)-catalysed synthesis of diene 68 (Scheme 17).38 In the case of iso-
propyl-substituted alkyne 66, the carbenoid intermediate 67 from diazo decomposition was 
shown to rearrange solely into diene 68 through a 1,2-hydrogen shift. In the absence of a 
22 
hydrogen, when tert-butyl-substituted alkyne 69 was submitted to the same reaction 
conditions, a 1,2-methyl shift occurred to form diene 70 in good yield. 
 
 
Scheme 17: Example of a favoured 1,2-hydrogen migration versus 1,2-methyl migration 
 
Cases involving a 1,2-aryl shift are very rare. Examples where this process can be proposed 
were described in the gold-catalysed preparation of furans from allenyl ketones (Scheme 
18).39 In this reaction nucleophilic attack of the lone pair of ketone 71 onto the allene would 
form cyclic oxonium 72. A subsequent 1,2-phenyl shift would occur to give product 74 after 
demetallation. 
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Scheme 18: Proposed 1,2-phenyl shift in the gold-catalysed formation of furan 74 from allenyl ketone 71 
 
It was also shown that allenyl ketones bearing an alkyl and a phenyl substituent, instead of 
two phenyl groups like in substrate 71, gave 1,2-phenyl migration products (Scheme 19). 
Compound 75 bearing a methyl group was transformed into furan 76 under gold catalysis, and 
allenyl ketone 77 with an ethyl substituent formed compound 78 as major product under 
similar conditions. The formation of a second furan 79 in this last case was a surprising result 
as it revealed that the 1,2-shift of the ethyl moiety competed with migration of the phenyl 
group. As a result it was suggested that this furan synthesis was probably more likely to 
involve a cationic, pathway although a carbene intermediate was not ruled out. 
 
1,2-Hydrogen migration were more commonly reported in gold-catalysed processes. An 
isomerisation of 1,5-enynes was for example described (Scheme 20).40 After a gold-catalysed 
6-endo type cyclisation of compound 80, formation of carbenoid intermediate 82 and closure 
of the cyclopropane ring were proposed. 1,2-Shift of a hydrogen or deuterium to the 
24 
carbenoid was shown to take precedence over a phenyl group migration and led to the 
formation of the corresponding bicyclic product 84. 
 
 
Scheme 19: 1,2-Phenyl and ethyl migration in gold-catalysed formation of furans from allenyl ketones 
 
 
Scheme 20: 1,2-Hydrogen or deuterium shift in 1,5-enyne isomerisation 
 
A combination of 1,2-alkyl migration with [3+2] cycloaddition was developed for the 
synthesis of tricyclic indole derivatives (Scheme 21).41 In this sequence, π-acid activation of 
the alkyne moiety by AuBr3 induced nucleophilic attack of the lone pair of imine 85. The 
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resulting intermediate evolved to a fused polycyclic structure through a [3+2] cycloaddition 
between the 1,3-dipole 87 and the electron-rich vinyl ether present in the reaction mixture. 
Finally a 1,2-methyl shift to the adjacent metal “carbenoid” center followed by demetalation 
gave the reported indole product 90 in good yield. 
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Scheme 21: Combinaison of a 1,2-alkyl migration with a [3+2] cycloaddition 
 
Another particularly effective 1,2-alkyl migration was reported in the case of a gold(I)-
catalysed regioselective acetylenic Schmidt reaction of homopropargylic azides.42 A 
mechanism involving gold(I) activation of alkyne toward nucleophilic addition was proposed. 
Loss of nitrogen gas formed species 93 and subsequent cyclobutane ring strain release 
occurred through 1,2-alkyl shift onto the carbenoid. Catalyst regeneration and tautomerisation 
gave the multiply substituted pyrrole 95 in good yield. 
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Scheme 22: An example of 1,2-migration to an adjacent gold carbenoid intermediate 
 
1.4.3  1,2-alkyl shift to an adjacent carbocation 
 
While the previous paragraph described 1,2-shifts to a carbenoid (metal-stabilised 
carbocation) intermediate, similar reorganisation was also recently used on carbocations 
formed by gold catalysed processes that are not directly connected to a metal. 
Gold(I)-catalysed ring expansion of unactivated alkynylcyclopropanes was for example 
reported for the preparation of alkylidenecyclobutanamines (Scheme 23).43 The positive 
charge developed on the alkyne by coordination of the gold fragment induced a 1,2-alkyl 
migration from the cyclopropane moiety. The resulting cyclobutane cationic intermediate 98 
was further trapped by the sulfonamide present in the reaction mixture to give compound 99 
in good yield.  
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Scheme 23: Gold-catalysed ring expansion of alkynylcyclopropanes 
 
These results showed that for substituted alkynylcyclopropanes, and under the reaction 
conditions reported, the ring expansion process was taking precedence to the competitive 
hydroamination reaction discussed previously in this chapter. On the other hand, when the 
reaction was conducted with terminal alkynylcyclopropane 100 the hydroamination process 
was this time favoured and imine 101 was formed instead of the cyclobutanamine (Scheme 
24). 
 
 
Scheme 24: Gold-catalysed hydroamination of terminal alkynylcyclopropane 
 
Previous work in this area had already reported the formation of cyclobutanes but employing 
alkynylcyclopropanols as precursors (Scheme 25).44 In that case 1,2-migration toward the 
alkyne was favoured by the presence of the alcohol functionality and cyclobutanone 105 was 
formed in good yields. 
28 
 
Scheme 25: Gold-catalysed ring expansion of alkynylcyclopropanols 
 
Another example involving cycloisomerisation on enyne 106 this time allowed elegant access 
to complex tricyclic compound 110 (Scheme 26).45 A 5-exo addition of the olefin on the 
activated alkyne was proposed to lead to carbocationic species 107. A subsequent 1,2-alkyl 
shift formed cyclobutane intermediate 108 which suffered nucleophilic attack from the alkene 
moiety forming five-membered ring species 109. This cascade reaction was ended by 
deauration and gave polycyclic product 110 in good yield. 
 
 
Scheme 26: Gold-catalysed cascade reaction of enyne 110 
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More recently the potential of regioselective and stereospecific 1,2-alkyl migration was 
highlighted in a cationic gold(I)-catalysed tandem reaction (Scheme 27).46 An initial 
intramolecular attack of the carbonyl moiety to the activated alkyne was proposed. The spiro-
bicyclic derivative would then undergo a 1,2-alkyl migration to give cationic intermediate 
113. Double bond formation followed by protodeauration would terminate the process and 
deliver the fused-bicyclic final structure in excellent yield and enantiomeric excess. 
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Scheme 27: Selected examples of 1,2-alkyl migration in gold catalysed processes 
 
1.4.4  1,2-shifts to form gold vinylidene intermediates 
 
Although well known for other metals, vinylidene intermediates were only lately discovered 
and very rarely used so far in gold-catalysed transformations. Their formation was shown to 
result from a 1,2-shift of a migrating group upon π-acid activation of a C-C triple bond 
(Scheme 28).47  
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Scheme 28: Metal mediated vinylidene intermediate formation 
 
Various alkyne substituents such as hydrogen, halogens48, silanes or stannanes49 proved 
suitable for the gold-catalysed rearrangement to take place. In the presence of a nucleophile 
the gold-vinylidene intermediate would evolve toward a vinyl-gold species through an attack 
on the carbon adjacent to the metal center. Termination of the gold-catalysed process would 
then occur in a similar manner to those described previously depending on the substrate. 
A gold(I)-mediated vinylidene rearrangement was for example proposed in a synthesis of 9-
bromophenanthrene 117 (Scheme 29).48 Under AuCl catalysis alkyne 115 would rearrange 
into intermediate 116. A Friedel-Crafts type hydroarylation would then take place to give 
product 117 after protodemetallation. 
The gold vinylidene rearrangement pathway was particularly interesting as it complemented 
another transformation where compound 118 was accessed by InCl3 catalysis. 
Another illustration of this transformation with a silicon substituent was given by a gold(III)-
catalysed synthesis of polycyclic pyrroles (Scheme 30).49 Here the vinylidene rearrangement 
was followed by nucleophilic attack from the lone pair of the nitrogen to give rise to 
zwitterion 121, which upon protodeauration released the product in good yield. 
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Scheme 29: Gold vinylidene rearrangement in phenanthrene synthesis 
 
 
 
Scheme 30: Trimethylsilane 1,2-shift to form gold vinylidene intermediate 
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1.4.5  X → C shift reactions 
 
The migratory possibilities offered by the use of aprotic heteroatom nucleophiles, such as 
ethers, thioethers, amides or sulfonylanilines were also explored.50 Unlike the widely used 
alcohols or amines which undergo deprotonation followed by protodemetallation after gold-
catalysed nucleophilic attack on alkynes (see section 1.5), those reagents would lead to 
alternate outcomes. 
As illustrated in Scheme 31 thioethers 123 and 126 were for example employed in a gold (I)-
catalysed transformation wherein a cyclisation and a formal migration of the α-alkoxy alkyl,51 
or allyl sulfide substituent occurred. 
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Scheme 31: X→C migration of α-alkoxy alkyl and allyl sulfide in gold catalysed processes 
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A similar type of migration was also presented in an intramolecular synthesis of benzopyrans 
133 (Scheme 32).52 An initial 1,2-acyloxy migration would form carbenoid 130 as introduced 
in the previous sections and intramolecular nucleophilic attack of the phenol ether would 
follow. It was proposed that subsequent expulsion of a stabilised benzylic cation would take 
place. Finally the reintegration of this cation in the molecule would occur by reaction with the 
allylgold(I) species to give 133 in good yield and enantiomeric excess. 
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Scheme 32: Proposed benzylic cation formation in a gold-catalysed benzopyran synthesis 
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This mechanism was proved in the case where a non symmetrical allyl substituent was 
engaged (Scheme 33). A similar migration was observed but inversion of the allylic moiety 
occurred to form product 137. The possible engagement of a direct 1,4-sigmatropic 
rearrangement was thus ruled out giving weight to a mechanism involving the formation of an 
allyl cation. 
 
 
Scheme 33: Allylic cation formation in a gold-catalysed benzopyran synthesis 
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1.5  Conclusion 
 
Homogeneous gold catalysis has proved a powerful tool for organic chemists in the last ten 
years. More specifically the very selective activation of C-C triple bonds of alkynes by gold 
complexes has attracted much interest and was employed in many processes where new C-X 
(X as heteroatom) and C-C bonds were formed. The high functional group tolerance and the 
convenience of mild reaction conditions associated with gold catalysis have also been 
determinant factors in the expansion of the area. 
 
Furthermore, molecular complexity has been achieved when the fundamental process of 
nucleophilic attack across an alkyne was combined with migration steps. Cascade reactions 
involving 1,2-migration to carbenoid, 1,2-shift to non-metal-stabilised carbocation or 
vinylidene rearrangement were particularly efficient in that respect and more applications of 
these processes in synthesis should emerge in the next few years. 
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1.6  Aims and objectives 
 
This work focused on a new gold catalysed synthesis of functionalised pyrroles from alkynyl 
aziridines. Our aim was to develop a regio-controlled access to 2,4- and 2,5-substituted 
pyrroles from the same aziridine precursor I under the mild conditions associated with gold 
catalysis (Scheme 34). Based on the known modes of reactivity of gold catalysis it was 
predicted that activation of the internal alkyne present in the aziridine precursor by a π-acidic 
gold species would render the carbons of the C-C triple bond electrophilic. A ring expansion 
would provide a five-membered ring cationic intermediate K which upon deprotonation 
followed by protodemetallation will lead to the formation of 2,5-substituted pyrrole L. 
Alternatively a vinylidene pathway should allow access to the 2,4-substituted pyrrole product 
N. 
 
Scheme 34: Proposed gold-catalysed access to 2,4- and 2,5-substituted pyrroles from alkynyl aziridines. 
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To study this proposal aziridines 138 and 139, bearing halogen or silyl substituents 
respectively, were prepared as both were shown suitable for the two pathways evoked 
previously (Figure 3). 
 
 
Figure 3: Chosen alkynyl aziridine precursors. 
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Chapter 2:  Gold-catalysed pyrrole synthesis via vinylidene 
rearrangement of alkynyl aziridine 
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2.1  Introduction 
 
In light of the previously introduced advances in gold catalysis, a combination of a vinylidene 
rearrangement and a ring expansion of brominated and silylated alkynyl aziridines was 
proposed (Scheme 35). 
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Scheme 35: Proposed 2,4-substituted pyrroles synthesis through vinylidene rearrangement of alkynyl 
aziridines followed by a ring expansion. 
 
According to literature precedents discussed in the previous chapter, both silyl and bromide 
are suitable C-C triple bond substituents for a gold-catalysed vinylidene rearrangement to take 
place. Under appropriate reaction conditions, formation of intermediate B should therefore be 
possible and it was anticipated that a ring expansion would occur to give organo-gold species 
C. Indeed Hashmi and Sinta have shown alkynyl oxiranes can undergo ring opening upon 
gold activation to give furans which is a good precedent for the transformation of C from B 
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(Scheme 36). Protodeauration of intermediate C would then terminate the process by 
releasing the catalyst and the aimed 2,4-substituted pyrrole D. 
 
 
Scheme 36: Hashmi and Sinha’s gold-catalysed furan synthesis from alkynyl oxirane. 
 
2.2  Starting material preparation 
 
As an efficient pyrrole synthesis would be of low impact if the alkynyl aziridines could not be 
formed quickly from readily available and simple building blocks, it was decided to prepare 
those precursors according to the method of Dai, which allows a convergent coupling of 
tosylimines and propargylic sulfonium salts (Scheme 37).53 
 
 
Scheme 37: Rapid access to alkynyl aziridine from imine and sulfonium salt. 
 
Exclusively cis-aziridines were obtained with this method when employing trimethylsilyl 
substituted sulfonium salts. 
Aryltosylimine 141 was prepared by direct condensation of benzaldehyde in a Dean-Stark 
apparatus under acidic catalysis but attempts to access alkyltosylimines by this method were 
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unsuccessful (Scheme 38).54 An alternative strategy was therefore employed to prepare these 
adducts from enolisable aldehydes. Alkylaldehydes were treated with 4-
methylbenzenesulfonamide and sodium benzenesulfinate in a mixture of water and formic 
acid (Scheme 39).55 The stable tosylamides obtained could be stored at room temperature for 
weeks without problem. Conversion to the corresponding tosylimines 144 and 145 was 
readily achieved in high yield in a mixture of CH2Cl2 and saturated solution of aqueous 
Na2CO3. 
 
 
Scheme 38: Preparation of aryltosylimine 141 
 
 
Scheme 39: Alternative imine preparation from enolisable alkylaldehyde. 
 
The synthesis of the sulfonium salt 140 was also straightforwardly realised in three steps from 
commercially available propargyl alcohol (Scheme 40). Propargyl alcohol was doubly 
deprotonated with two equivalents of n-BuLi and the corresponding lithium species was 
trapped with TMSCl.56 Propargylic alcohol 146 was obtained after aqueous workup that 
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cleaved the O-Si bond. Bromide 147 was prepared using Br2 in presence of PPh3 and its 
treatment with DMS gave sulfonium salt in good yield. This last step took three days but 
attempts to accelerate it by heating or by stopping the reaction earlier were unsuccessful and 
led to dramatic yield reduction. 
 
 
Scheme 40: Trimethylsilyl-substituted sulfonium salt preparation from propargyl alcohol. 
 
As will be rationalised later, it was also decided to synthesise the triethylsilyl version of the 
sulfonium salt. Because triethylsilyl ethers are more stable than their trimethylsilyl equivalent 
aqueous treatment would not allow us to obtain the free propargyl alcohol in that case and 
another protocol was employed. Propargyl alcohol was protected with tetrahydropyran57 as 
the ether could be directly converted to the bromide without an additional deprotection step 
(Scheme 41).58 Triethylsilyl sulfonium salt 151 was then synthesised in average yield by 
treatment with DMS. 
 
With the imines and sulfonium salts in hand, attention was turn to the preparation of the 
alkynyl aziridines. Four of them were formed in good yield by treatment of tosylimine and 
ylide with Cs2CO3 in CH2Cl2 at room temperature (Table 1). 
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Scheme 41: Preparation of triethylsilyl-substituted sulfonium salt. 
 
 
 
entry R1 R2 
Reaction 
Time (h) 
Product Yield (%)a 
1 
 
 
1 152 70 
2 
 
 
3 139 70 
3 
 
 
3 153 80 
4 
 
 
3 154 85 
Table 1: Silylated alkynyl aziridine preparation. Reactions were performed using 
1.2 equiv of sulfonium salt and Cs2CO3. aisolated yields 
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Two more brominated alkynyl aziridines were also efficiently prepared by treatment of 
trimethylsilyl-substituted substrates 139 and 152 with NBS and AgNO3 in acetone at room 
temperature (Table 2).59 
 
 
entry R Reaction Time (h) Product Yield (%)
a
 
1 
 
1 155 80 
2 
 
1 138 80 
Table 2: Brominated alkynyl aziridine preparation. aisolated yields 
 
2.3  Catalyst screening 
 
The study of the vinylidene rearrangement and ring expansion pathway was started by 
submitting aziridine 138 to different catalysts and sets of conditions (Table 3). Analysis of the 
crude mixture was performed by 1H NMR using a known quantity of an internal standard 
(1,2,4,5-tetramethylbenzene). No reaction occurred when copper (entry 9), palladium (entries 
10-12), platinum (entry 8), rhodium (entries 17-19), ruthenium (entry 16), silver (entries 13-
15) or tungsten (entry 20) catalysts were used. On the other hand, formation of the desired 
2,4-substituted pyrrole 156 was seen when AuCl3 was used as catalyst (entries 2 and 3) and 
2,5-substituted pyrrole 157 (not isolated) was observed with some cationic gold species 
(entries 6 and 7). In both cases a mono-substituted pyrrole 158 was also observed, and some 
starting material was often recovered unreacted. While complete conversion of alkynyl 
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aziridine 138 was achieved using AuCl3 in toluene (0.5 M) at 50 °C after 2 h (entry 3), 
brominated pyrrole 156 was the minor product and monosubstituted pyrrole 158 was obtained 
as major. 
 
The difference in regioselectivity when using AuCl3 or a cationic catalyst can be explain by 
the reluctance of the latter to form a vinylidene intermediate prior to ring expansion (Scheme 
42). A simple electrophilic activation of the C-C triple bond by the PPh3AuCl/AgOTf system 
is though to induce ring expansion and lead to the formation of 2,5-substituted pyrroles. On 
the other hand, AuCl3 forms a vinylidene intermediate which then reacts through a ring 
expansion to give the observed 2,4-substituted pyrrole 156. 
 
 
Scheme 42: Proposed mechanism for 2,5 and 2,4-substituted pyrrole formation. 
 
46 
 
Yield (%)b 
entry Catalyst Solvent 
Temperature 
(°C) 
Reaction 
Time (h) 156 157 158 
1 AuCl Toluene 23 then 50a 14 - - -c 
2 AuCl3 Toluene 23 then 50a 14 25 - 15d 
3 AuCl3 Toluene 50 2 20 - 60e 
4 Me2SAuCl Toluene 23 then 50a 14 - - -c 
5 PPh3AuCl Toluene 23 then 50a 14 - - -c 
6 PPh3AuCl/AgOTf Toluene 23 then 50a 14 - 29 4f 
7 PPh3Au(NTf)2 Toluene 23 then 50a 14 - 7 -g 
8 PtCl2 Toluene 23 then 50a 14 - - -c 
9 CuI Toluene 23 then 50a 14 - - -c 
10 PdCl2 Toluene 23 then 50a 14 - - -c 
11 PdCl2(PPh3)2 Toluene 23 then 50a 14 - - -c 
12 Pd(OAc)2 Toluene 23 then 50a 14 - - -c 
13 AgNO3 Toluene 23 then 50a 14 - - -c 
14 AgSbF6 Toluene 23 then 50a 14 - - -c 
15 AgBF4 Toluene 23 then 50a 14 - - -c 
16 RuCl2(PPh3)3 Toluene 23 then 50a 14 - - -c 
17 RhCl(PPh3) 3 Toluene 23 then 50a 14 - - -c 
18 
(Rh(COD)Cl)2 
+ P(pFC6H5)3 
Toluene 23 then 50a 14 - - -c 
19 
(Rh(COD)Cl)2 
+ P(pFC6H5)3 
DMF 85 14 - - -c 
20 W(CO)5(THF) THF 23 then 50a 14 - - -c 
Table 3: Catalyst screening on aziridine 138. Reactions were performed using 0.1 mmol of starting 
material (34 mg), 10 mol% catalyst and 0.5 mL of solvent (C = 0.2 M) under argon. aReaction started 
at 23 °C (2 h) and heated after at 50 °C for 12 h. bYields calculated by 1H NMR against a known 
quantity of internal standard. cOnly unreacted starting material was observed. d50 % starting 
material left. eC = 0.5 M, no starting material left, Isolated yields: 15 % of 156 and 60% of 158. f25 % 
starting material left. g46 % starting material left. 
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It was then decided to test the three active catalysts (Table 3, entries 3, 6, 7) on silylated 
alkynyl aziridine 139 (Table 4). Analysis of the crude mixtures was performed by 1H NMR 
using a known quantity of internal standard (1,2,4,5-tetramethylbenzene). The two cationic 
gold catalysts (Table 4, entries 1,2) gave solely mono-substituted pyrrole 158. In contrast to 
brominated substrate 138 no trace of either 2,4- or 2,5- substituted pyrrole was observed in the 
crude 1H NMR of the mixtures. 
When AuCl3 was used, 2,4-substituted pyrrole 159 was formed, along with some mono-
substituted product, showing vinylidene pathway could be accessed from trimethylsilane 
alkynyl aziridines. 
 
 
Yield (%)a 
entry Catalyst Solvent Temp (°C) 
139 159 160 158 
1 PPh3Au(NTf)2 Toluene 50 40 - - 11 
2 PPh3AuCl/AgOTf Toluene 50 20 - - 48 
3 AuCl3 Toluene 50 - 47 - 25 
Table 4: Catalysis on alkynyl aziridine 139. Reactions were performed using 0.1 mmol of 
starting material (34 mg), 10 mol% of catalyst, 0.2 mL of solvent (C = 0.5 M) under argon 
and were stopped after 2h. aYields calculated by 1H NMR against a known quantity of 
internal standard. 
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2.4  Optimisation of 2,4-substituted pyrrole formation 
 
Despite the observed problem of desilylation and debromination leading to formation of 
mono-substituted pyrrole 158, it had been possible to identify two types of catalysts allowing 
access to either 2,4- or 2,5-substituted pyrroles selectively, proving that the regiodivergent 
strategy was valid. However, the reaction conditions had to be optimised to maximise yields 
while preventing the formation of the debrominated and desilylated products. It was decided 
to focus first on the formation of 2,4-substituted pyrroles, mechanistically more interesting 
than the preparation of the 2,5-substituted products.  
For our following studies it was decided to use trimethylsilyl-substituted alkynyl aziridine 139 
instead of brominated aziridine 138 as this last one needed an extra step for its preparation. 
To probe the effect of solvent, various solutions of alkynyl aziridine 139 were treated with 
AuCl3 (Table 5).  
No reaction at all was observed using CH3CN (entry 2) and only traces of product were 
obtained when THF (entry 1) or ClCH2CH2Cl (entry 3) were employed. For those two last 
solvents and CH2Cl2 (entry 5), it was also noted that significant degradation had occurred 
under the reaction conditions. Therefore the best result for the transformation of 
trimethylsilyl-substituted aziridine was still obtained when toluene was used and prevention 
of the formation of mono-substituted pyrrole 158 had not been possible by changing the 
solvent. In an attempt to assess if the presence of adventitious water in the reaction mixture 
was involved in the formation of mono-subtituted pyrrole, molecular sieves were probed 
under the reaction conditions. 
Unfortunately, as reported in table 5 (entries 6, 7) the use of 4 Å activated molecular sieves 
reduced dramatically the conversion of starting material into pyrrole regardless of the solvent 
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used. The catalyst seemed to lose its reactivity under the presence of the molecular sieves and 
no conclusion could be made about the effects of traces of water. 
 
 
Yield (%)a 
entry Catalyst Solvent Temp (°C) 
139 159 158 
1 AuCl3 THF 50 55 5 5 
2 AuCl3 CH3CN 50 100 - - 
3 AuCl3 ClCH2CH2Cl 50 60 3 - 
4 AuCl3 Toluene 50 - 47 30 
5 AuCl3 CH2Cl2 23 22 34 2 
6 AuCl3 CH2Cl2b 35 70 8 - 
7 AuCl3 Tolueneb 50 25 25 13 
Table 5: Solvent screening. Reactions were performed using 0.1 mmol of starting 
material (34 mg), 10 mol% of catalyst, 0.2 mL of solvent (C = 0.5 M) under argon 
and were stopped after 2h. aYields calculated by 1H NMR against a known quantity 
of internal standard. b4 Å molecular sieve was used. 
 
To better understand the formation of desilylated pyrrole 158 it was decided to run a simple 
experiment: alkynyl aziridine 139 was submitted to catalysis using our best conditions (table 
5, entry 4) and the reaction was stopped this time after only 1 h (Scheme 43). The inseparable 
mixture of 2,4-substituted and mono-substituted pyrroles obtained was purified by flash 
chromatography and characterised before being separated in two portions. The first half of the 
mixture was simply heated in toluene while the second half was resubmitted to AuCl3 
catalysis. 
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Scheme 43: Identification of AuCl3 as direct or indirect desilylating agent. 
 
As expected, heating in toluene alone did not change the ratio of pyrroles in the mixture and 
total conversion to the mono-substituted pyrrole was observed in the presence of AuCl3. This 
experiment proved that the gold species used was involved in the degradation of the silylated 
pyrrole after its formation. 
Similar observation had already been published by Hashmi and co-workers, desilylation of 
furans occurred when using NaAuCl4 as a gold (III) catalyst in a hydroarylation of silylated γ-
alkynyl furans (Scheme 44).60 The isolation of F in that case showed that desilylation of the 
furan precursor occured. The absence of silylated phenols as products suggested that the 
hydroarylation was happening after desilylation of the starting material. Moreover the ratio of 
phenols observed corresponded to the one obtained when a non-silylated version of the furan 
precursor was used (G:H; 3:2).61 
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Scheme 44: Hashmi and collaborators observed desilylation during a hydroarylation of silylated γ-alkynyl 
furans. 
 
The desilylation process was thought to occur after total conversion of the starting material 
and so stopping the reaction at the right time would allow us to access clean trimethylsilyl-
substituted pyrroles in better yields. Therefore catalysis were run again with alkynyl aziridine 
139 under our best conditions and to follow the advancement of the reaction GC-MS 
monitoring was chosen for this experiment as pyrroles 159 and 158 were not distinguishable 
by simple TLC. 
Toluene was used as solvent at a concentration of 0.5 M, with 10 mol% AuCl3 and heating at 
50 °C. The reaction mixture was sampled every 5 min in the beginning and every 20 min after 
25 min. The samples were filtered through a small pad of silica to get rid of the gold residues 
and analysis was made by GC-MS. The reaction was stopped after 2h and the results of the 
study are display in Graphic 1. 
Despite the represented yields in Graphic 1 being based on area ratios from uncorrected GC-
MS values, a qualitative indication of the reaction could be obtained. 
The study showed quick formation of the silylated pyrrole and consumption of the alkynyl 
aziridine. Some desilylated pyrrole was already formed after 5 min and its quantity increased 
relatively slowly during the reaction up to 60 min. At this point formation of desilylated 
pyrrole 158 accelerated slightly, and the quantity of silylated pyrrole 159 started to decrease.  
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From those observations it was concluded that desilylation occurred from the beginning of the 
reaction, as soon as some silylated pyrrole 159 was formed. Stopping the reaction at the time 
of maximum formation of pyrrole 159 could not be a solution as an unseparable mixture with 
desilylated pyrroles would be obtained. 
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Graphic 1: GC-MS monitoring of reaction between alkynyl aziridine 139 and AuCl3. 
 
In order to make our gold-catalysed method to form 2,4-substituted pyrroles interesting 
synthetically prevention of desilylation was needed from the start of the reaction. 
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It was thought that differencing parameters of the reaction (temperature, concentration, 
quantity of catalyst) could affect the profile observed in Graphic 1 and might provide us with 
a set of conditions to gain increased ratio of silylated pyrrole and reduced quantities of the 
side product. For that purpose a series of experiments followed by GC-MS were carried out 
(Graphics in appendix A). 
The loading of AuCl3 in the reaction was probed with the temperature set at 50 °C and a 
concentration of 0.5 M. The graphics obtained clearly showed that 2 or 5 mol% were not 
sufficient to form reasonable amount of products, and only a loading of 10 to 20 mol% were 
satisfactorily giving around 70% of silylated pyrrole at their maximum. A 20 mol% loading of 
catalyst was considered too much, and this parameter was fixed at 10 mol%. 
The influence of concentration was then studied; reactions at 0.05 M, 0.2 M, 0.3 M, 0.4 M 
and 0.6 M were compared to the one obtained previously at 0.5 M. Analysis of the results 
showed that complete consumption of the starting material was not obtained for 
concentrations of 0.4 M or below. At 0.6 M the reaction rate was accelerated, as was 
desilylation. Deactivation of the catalyst stopped progress of the reaction after 20 min. Total 
conversion occurred only when the concentration was fixed at 0.5 M and after 2h (Graphic 1). 
Finally the effect of temperature on the reaction was tested. Reactions were performed at 30, 
40, 60 and 70 °C. At 30 °C the reaction was incomplete and no progress was observed after 
90 min. At 40 °C almost all the starting material was consumed but the maximum formation 
of the silylated 2,4-substituted pyrrole 159 was lower than when a temperature of 50 °C was 
applied. Increasing the heating to 60 or 70 °C proved dramatic for the reaction as conversion 
stopped after 30 and 15 min respectively without improving upon the maximum quantity of 
product observed at 50°C. 
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The result for the factors studied were relatively disappointing as no improvement of the 
reaction had been possible. The best conditions were still obtained using toluene at 0.5 M, 50 
°C with a catalyst loading of 10 mol% and desilylation had not been prevented. 
In a last effort to improve the reaction outcome, the impact of additives was investigated. 
Different substances were therefore tested, added to the mixture of starting material, solvent 
(0.5 M) and catalyst (10 mol%) at 50 °C (Table 6).  
In order to check if traces of acid could account for the degradation of silylated pyrrole 159 
into desilylated product 158, pTsOH.H2O and HCl were tested as additives (table 6, entry 1, 
2). When 10 mol% of HCl was used degradation of the material occurred and no identifiable 
products were obtained. In the other hand, the reaction with one equivalent of pTsOH.H2O did 
not go to completion (entry 1). After 2 h 9 % of starting material was still unreacted and only 
1% of pyrrole 159 was present. Almost all silylated pyrrole had been transformed into 
monosubstituted product 158 (80% 1H NMR yield). In comparison, 30% of desilylated 
pyrrole was previously observed when running the reaction without the acid additive for the 
same period (table 5, entry 4). 
These results gave weight to a possible action of traces of acid formed during the course of 
the reaction when no additives were employed and therefore the impact of base on the 
transformation was probed. 
Surprisingly no reaction happened at all when DIPEA was used (entry 3), and only traces of 
pyrroles were seen when K2CO3 was used (entries 4, 5). 
No less than 1 equivalent of base was tried during the course of our studies as it was decided 
to move on to another part of the project. 
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Yield (%)a 
entry Additive 
139 159 158 
1 pTsOH.H2O (1 eq) 9 1 80 
2 HCl (10 mol%) -b - - 
3 DIPEA (1 eq) 88 - - 
4 K2CO3 (1 eq) 89c - - 
5 K2CO3 (dry, 1 eq) 90c - - 
Table 6: Effect of additives on catalysis. Reactions were performed using 
0.1 mmol of starting material (34 mg), 10 mol% of catalyst, 0.15 mL of 
solvent (C = 0.5 M) under argon and were stopped after 2h. aYields 
calculated by 1H NMR against a known quantity of internal standard. 
bDegradation observed. cTraces of products detected. 
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2.5  Application of the optimised conditions 
 
Despite many attempts, the formation of the desilylated product could not be stopped but the 
optimised reaction conditions were applied to different alkynyl aziridines to assess if this 
problem could be only substrate dependent. In order to try to maximise the yield in 2,4-
substituted pyrrole the best conditions obtained previously were employed with acetylenyl 
aziridine 139 (table 5, entry 4) using 10 mol% of AuCl3 in toluene (0.5 M) at 50 °C and the 
reactions were stopped after 60 min as it corresponded to the maximum formation of pyrrole 
159 in Graphic 1. 
Alkynyl aziridine 139 was first submitted to catalysis (Scheme 45). Stopping the reaction 
after 1 h did provide silylated pyrrole 159 but in a poor 1.7:1 ratio  with desilylated product 
158 (ratio determined by 1H NMR). This result was disappointing because a better ratio was 
expected from stopping the reaction after a 1 h period as the GC studies had indicated 
(Graphic 1). 
Changing the trimethylsilyl alkyne substituent with a more robust silyl group was also tried. 
Alkynyl aziridine 153 was prepared to that purpose but access to the TBDPS- or TBDMS-
substituted alkynyl aziridines were not possible as preparation of the corresponding sulfonium 
salts failed. Nevertheless, substrate 153 was submitted to catalysis and pyrrole 161 was 
obtained (Scheme 45). Despite the formation of some desilylated pyrrole 158, this result 
proved vinylidene pathway could be accessed from triethylsilane alkynyl aziridines. To the 
best of our knowledge this was the first time triethylsilane functional group was engaged in a 
gold-catalysed vinylidene rearrangement. 
When alkynyl aziridine 154 bearing a cyclohexyl substituent was used, a mixture of silylated 
pyrrole 162 and mono-substituted pyrrole 163 was also obtained. 
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Scheme 45: Application of the optimised condition to silylated alkynyl aziridines. 
 
After changing the alkyl substituent on the aziridine ring did not have any major impact on 
the outcome of the reaction it was decided to test an aryl substituent. Surprisingly, 
trimethylsilyl-substituted alkynyl aziridines 152 proved unreactive and the starting material 
was left untouched (Scheme 46). The use of the bromo-substituted aziridine 155 did not give 
better results, showing reluctance of phenyl-substituted aziridines to react under the reaction 
conditions. 
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Scheme 46: Reluctance of phenyl-substituted aziridines to form pyrroles under AuCl3 catalysis 
 
As the formation of the desilylated pyrrole 158 and 163 could not be avoided during the 
study, an experiment to maximise their formation from alkynyl aziridine 139 and 154 was 
tried. Leaving the reactions for 4 h under the standard reaction conditions employed 
previously led to total conversion of the starting material into the corresponding mono-
substituted pyrrole 158 and 163 in 80% and 76% yield respectively (Scheme 47). 
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Scheme 47: Preparation of mono-substituted pyrroles 158 and 163 
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2.6 Summary 
 
A new gold-catalysed preparation of brominated or silylated 2,4-substituted pyrroles from 
alkynyl aziridines was tested and discussed. Conceptually the strategy to obtain this class of 
pyrrole proved correct as the desired gold-catalysed vinylidene rearrangement of brominated 
or silylated alkynyl aziridines took place and complete regioselectivity in favour of the 2,4-
pyrrole was observed using AuCl3. However, despite efforts to study the effects of solvent, 
concentration, temperature, catalyst loading and additives, it was not possible to prevent the 
formation of the desilylated or debrominated side product. The optimised reaction conditions 
were used to give average to good yields of mixtures of 2,4-substituted silylated and 
desilylated products after 1h, and good yield of mono-substituted pyrrole could be obtained 
by extending the reaction time to 4 h. 
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Chapter 3:  Cycloisomerisation of alkynyl aziridines by 
cationic gold electrophilic activation 
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3.1  Introduction 
 
In the previous chapter brominated or silylated 2,4-substituted pyrroles have been prepared 
from alkynyl aziridines showing that the concept of a gold mediated vinylidene rearrangement 
followed by ring expansion of the generated intermediate was valid. A screen of various 
catalysts had indicated that AuCl3 was the best gold species to facilitate this process and it had 
also highlighted that cationic gold catalysts were able to form 2,5-substituted pyrroles. It was 
therefore decided to turn attention to the formation of these products. As cationic gold 
complexes offered possibilities of variation through modification of their ligands and 
counterions it was expected that specific reaction conditions capable of forming specifically 
these 2,5-substituted pyrroles could be found (Scheme 48). 
 
 
 
Scheme 48: Proposed synthesis of 2,5-substituted pyrroles from alkynyl aziridine 
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3.2  Starting material preparation 
 
Following the method reported in the previous chapter, alkynyl aziridines were formed from 
imines and sulfonium salts (Scheme 37). A variety of substituents were investigated on these 
two precursors: as before, aromatic-substituted imines were obtained by direct condensation 
of aldehyde and sulfonamide under acidic conditions in a Dean-Stark apparatus (Table 7, 
method A), and a two steps process was used for enolisable aldehydes (Table 7, method B). 
 
 
Entry R Method Product Yield (%)a 
1 
 
A 141 80 
2 
 
A 164 88 
3 
 
A 165 80 
4 
 
A 166 85 
5 
 
A 167 80 
6 
 
B 144 69b 
7 
 
B 145 72b 
8 
 
B 168 70b 
Table 7: Tosylimine preparation: Method A: tosylamide, MS 4Å, amberlyst 15, 
toluene, 110 °C, 12 h. Method B: 1) tosylamine, sodium benzenesulfinate, 
H2O:HCOOH (1:1), rt, 12h. 2) Na2CO3, CH2Cl2:H2O (3:2), 2h. aIsolated yields. 
bYield over two steps. 
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Sulfonium salts were prepared from commercially available terminal alkynes in a three step 
sequence. Low temperature deprotonation with n-BuLi followed by trapping with 
paraformaldehyde was performed to access propargylic alcohols.62 Subsequent treatment with 
Br2 in the presence of PPh3 gave the corresponding propargylic bromides which were 
transformed into the sulfonium salts using dimethylsulfide (Table 8). 
 
 
Alcohol Bromide Sulfonium salt 
Entry R 
Product Yield (%)a Product 
Yield 
(%)a Product 
Yield 
(%)a 
1 
 
169 90 173 92 177 87 
2 
 
170 85 174 91 178 55 
3 
 
171 86 175 75 179 72 
4 
 
172 87 176 95 180 60 
Table 8: Preparation of sulfonium salts via hydroxymethylation followed by bromination and 
dimethylsulfidation. aIsolated yields. 
Two more sulfonium salts were prepared using alternative methods. Allylation of propargyl 
alcohol63 followed by bromide formation was performed in a 90% yield over two steps. 
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Treatment with DMS led to the corresponding sulfonium salt 183 in low yield after 3 days 
(Scheme 49). 
 
 
Scheme 49: Preparation of sulfonium salt 183 
 
The 4-bromobenzene-substituted sulfonium salt 186 was also prepared from propargyl 
alcohol and an adapted Sonogashira reaction in triethylamine64 introduced the aryl substituent. 
Functional group interconversion afforded bromide 185 which was transformed into 
sulfonium salt 186 in 79% yield. (Scheme 50). 
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Scheme 50: Preparation of sulfonium salt 186 
 
With those imines and sulfonium salts in hand alkynyl aziridines were synthesised using 
Cs2CO3 in CH2Cl2 at room temperature. In these cases, unlike when a silylated sulfonium salt 
was used (Chapter 2), mixtures of cis and trans products were obtained (Table 9). The 
formation of electron-rich aziridine derived from p-methoxyphenyl-substituted tosylimine 
was also tried but this compound proved extremely unstable and could not be isolated 
(Scheme 51). 
 
 
Scheme 51: Attempted formation of p-methoxybenzyl-substituted alkynyl aziridine 
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Entry R1 R2 Reaction Time (h) 
cis/trans 
Ratio Product 
Yield 
(%)a 
1 
 
 
2.5 9/1 187 65 
2 
 
 
3 8/1 188 79 
3 
Br
 
 
4 20/1 189 73 
4 
 
 
8 7/1 190 79 
5 
 
 
3.5 7/1 191 50 
6 
  
1.5 7/1 192 85 
7 
  
8 >50/1 193 65 
8 
 
 
12 >50/1 194 40 
9 
 
 
2 25/1 195 60 
10 
  
6 >50/1 196 80 
11 
 
 
4 25/1 197 40 
12 
  
3.5 25/1 198 51 
13 
 
 
3 15/1 199 50 
14 
  
6 11/1 200 70 
15 
 
 
8 15/1 201 75 
Table 9: Aziridine preparation from imine and sulfonium salt. Reactions were performed using 1.2 
equiv of sulfonium salt and Cs2CO3. a Determined by 1H NMR. bIsolated yields. 
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3.3  Survey of reaction conditions for the cycloisomerisation of alkynyl 
aziridines 
 
It was decided to start our studies by using alkynyl aziridine 187 to screen different reaction 
conditions for the cycloisomerisation (Table 10). Analysis of the crude reaction mixture was 
performed by 1H NMR using a known quantity of an internal standard (1,2,4,5-
tetramethylbenzene). Cationic gold catalysts were used as they had proved most successful in 
forming 2,5-substituted pyrrole in the catalyst screening described in Chapter 2 (Table 3). The 
catalysts were formed in situ from PPh3AuCl and a silver salt (AgX), apart from PPh3AuNTf2 
which was used directly in its commercially available and stable cationic form.65 
As expected 2,5-substituted pyrrole 202 was obtained when alkynyl aziridine 187 was 
submitted to a standard combination of PPh3AuCl and AgOTf in toluene, but we were 
surprised to observe the formation of a minor second isomeric product, later identified as the 
2,4-substituted pyrrole 203 (Table 10, entry 1). 
It was then decided to investigate other solvents for the reaction using the same catalyst 
system PPh3AuCl/AgOTf, to assess their impact on the yield and ratio of products 202 and 
203. When CH3CN or DMF were used as the solvent no reaction occurred, probably due to 
poisoning of the cationic catalyst by those solvents (entry 12-13). When CH2Cl2, 
ClCH2CH2Cl, nitromethane or chloroform were employed (entries 3-6), the unexpected 2,4-
isomer was obtained as the major product. Alternatively ethanol, methanol, ether, benzene 
and o-xylene (entries 7-11) favoured the formation of the 2,5-substituted pyrrole 202.  
The effect of the catalyst counterion on the yield and ratio of products was then studied. A 
similar trend as for triflate counterion was observed with triflimidate and hexafluorophosphate 
counterions in toluene and CH2Cl2 (entries 14-17). On the other hand, switching to 
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hexafluoroantimonate or tetrafluoroborate led predominantly to the formation of 2,5-
substituted pyrrole 202 regardless of the solvent (entries 18-20). 
Surprisingly, the 2,5-substituted pyrrole was obtained as the sole product when a tosylate 
counterion was employed (entries 22-23). This catalytic system seemed less active than the 
other cationic gold species as heating to 70 °C was needed to obtain total conversion of the 
starting material (entry 24).  
Finally the use of the P(pCF3-C6H4)3 ligand, which is more electron-deficient than PPh3 was 
investigated. It was thought that using this ligand could be beneficial for the reaction as more 
alkynophilic character should be induced in the gold complex. It has, subsequently to our 
study, been shown that the ligand, like the counterion, could affect the reactivity of the gold 
complex by affecting the electron density on the metal or by influencing the position of the 
counterion.66 When using this P(pCF3-C6H4)3 ligand, a reduction of the rate of the reaction 
was observed and the ratio of products obtained were no better than when PPh3 was employed 
(entries 25-27). 
When the non-aromatic substituted alkynyl aziridine 198 was used in CH2Cl2 with the 
cationic gold system Ph3PAuCl/AgOTf, formation of only 2,5-substituted pyrrole 204 was 
observed (Scheme 52). This result showed that only aromatic-substituted alkynyl aziridines 
were able to form the 2,4-substituted isomer, probably through an aryl-migration pathway. 
 
Scheme 52: Reaction of a non-aromatic-substituted alkynyl aziridine under cationic gold catalysis. 
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Entry X Solvent Reaction Time (h) Yield (%)
a,b
 
Ratioc  
(202:203) 
1 OTf toluene 4 75 24:1 
2 OTf toluened 0.75 81 2.3:1 
3 OTf CH2Cl2 0.75 60 1:7.6 
4 OTf ClCH2CH2Cl 1 50 1:24 
5 OTf CH3NO2 20 29 0:1 
6 OTf CH3Cl 20 72 1.1:1 
7 OTf EtOH 2 56 >50:1 
8 OTf MeOH 0.75 45 >50:1 
9 OTf Et2O 20 79 >50:1 
10 OTf benzene 20 66 6.3:1 
11 OTf o-xylene 20 79 15:1 
12 OTf DMFe 20 - - 
13 OTf CH3CNe 20 - - 
14 NTf2 CH2Cl2 20 42 1:5 
15 NTf2 toluene 20 45 2.8:1 
16 PF6 CH2Cl2 36 60 2:1 
17 PF6 toluene 48 63 20:1 
18 SbF6 CH2Cl2 2.5 40 1:4.7 
19 SbF6 toluene 20 34 1:2.4 
20 BF4 CH2Cl2 20 <10 1:1.8 
21 NO3 CH2Cl2 20 - - 
22 OTs ClCH2CH2Cl 24 <10 1:0 
23 OTs Toluene 24 <10 1:0 
24 OTs ClCH2CH2Clf 3 98 1:0 
25 OTf CH2Cl2g 1.5 60 1:3.6 
26 OTf Tolueneg 20 74 5.2:1 
27 OTf ClCH2CH2Clg 20 64 1:2.4 
Table 10: Survey of reaction conditions for cycloisomerisation of alkynyl aziridines. aAgX (5 
mol%), PPh3AuCl (5 mol%), 187 (0.1 mmol), solvent (0.5 mL) with all reactions run at rt 
unless otherwise specified. bYields calculated by 1H NMR against a known quantity of 
internal standard. cDetermined by 1H NMR. dReaction performed at 50 °C. eNo reaction 
occurred. fReaction performed at 70 °C. gP(pCF3-C6H4)3AuCl was used instead of PPh3AuCl. 
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3.4  Reaction mechanism proposition 
 
Based on this survey of reaction conditions a mechanism explaining the regiodivergence 
observed was proposed (Scheme 53). 
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Scheme 53: Possible regiodivergent pathways 
 
The results summarised in Table 10 could be explained by considering the basicity of the 
counterions used in System A, B and C. When a relatively basic counterion such as tosylate 
was present (System C), deprotonation of intermediate B (Scheme 53) followed by 
protodemetallation would be efficient and would lead to the formation of the 2,5-substituted 
isomer D (Scheme 53, Path I). In the absence of such a counterion, an aromatic or weakly 
Lewis basic solvent would also facilitate this pathway (System B) as observed in the 
optimisation of the reaction conditions (Table 10, entries 7-11). When both counterion and 
solvent were insufficiently basic (System A), an alternative pathway involving a 1,2-aryl shift 
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would take precedence, giving intermediate E and ultimately the 2,4-substituted pyrrole G 
(Scheme 53, Path II).  
The intermediacy of the vinyl gold intermediate B was supported by the selective 
incorporation of deuterium at the metal position when an experiment was conducted using 
Ph3PAuCl/AgOTs in D2O-washed ClCH2CH2Cl (Scheme 54). 
 
 
Scheme 54: Cyclisation of alkynyl aziridine 190 in the presence of D2O-washed ClCH2CH2Cl 
 
It is important to note that submitting 2,5-substituted pyrrole 202 to the reaction conditions of 
System A did not lead to formation of any 2,4-substituted isomer (Scheme 55).  
 
 
Scheme 55: Attempt to interconvert 2,5-substituted pyrrole into 2,4-substituted product 
 
The scope of the formation of both 2,4- and 2,5-substituted pyrroles was then studied as the 
possibility of controlling the substituent pattern of the product through reaction conditions 
change could have important applications in the synthesis of pyrroles. Moreover the high 
yielding formation of 2,5-substituted pyrrole 202 when using AgOTs presented the potential 
for the development of a clean and efficient method to access this class of products. 
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3.5  A comparaison of the reaction conditions against structural alteration 
 
In light of the results of the study into optimisation of the reaction conditions, it was decided 
to proceed with three sets of catalytic systems: System A employing AgOTf in CH2Cl2 at 
room temperature; System B employing AgOTf in toluene at room temperature; System C 
employing AgOTs in ClCH2CH2Cl at 70 °C (Table 11). 
System A was selected because it favoured the formation of 2,4-substituted pyrroles in good 
yield. On the other hand, both System B and C allowed access to 2,5-pyrroles preferentially. 
Despite System C being superior in terms of yield and selectivity, System B was used as a 
chlorinated-solvent free option, this being more attractive for industrial applications. 
Various aryl-substituted alkynyl aziridines were submitted to the three sets of conditions. As 
predicted by the previously proposed mechanism (Scheme 57), System C gave almost 
quantitative yield of the single 2,5-substituted pyrrole isomer for all the substrates. 
As observed during the reaction conditions survey, System B generally gave a mixture of 
isomers in favour of the 2,5-substituted pyrrole while System A favoured formation of the 
2,4-substituted product. 
Aziridines with electron-deficient aryl substituents gave less of the 2,4-substituted pyrrole 
product with Systems A and B than when a phenyl group was used (entries 4-5 and 7-8). On 
the other hand, the more electron-rich the aromatic moiety the greater the selectivity for the 
2,4-substituted pyrrole (entries 1-2, 10-11, 13-14, 16-17). These results were in line with the 
proposed mechanism as electron-rich aryl substituents would be more prone to perform a 1,2-
shift than electron-deficient ones. 
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Products 
Entry R1 R2 
Reaction 
Time (h) 
Systema 
I II 
Yield 
(%)b,c 
Ratio 
(I:II) 
1 2 A 60 1:7.6 
2 5 B 75 24:1 
3  
 
3.5 C 
202 203 
98 1:0 
4 2.5 A 74 1:1.1 
5 12 B 85 1:0 
6  
 
4 C 
206 207 
98 1:0 
7 3 A 90 3:1 
8 12 B 75 50:1 
9 
Br
 
 
4 C 
208 209 
98 1:0 
10 1.5 A 32 1:50 
11 1 B 30 1.5:1 
12  
 
5 C 
210 211 
98 1:0 
13 0.5 A 98 1:6 
14 5 B 79 1.4:1 
15   3 C 
212 213 
98 1:0 
16 0.5 A 65 0:1 
17 1 B 60 0:1 
18   3.5 C 
214 215 
98 1:0 
Table 11: Gold-catalysed synthesis of 2,4 and 2,5-substituted pyrroles. aSystem A employed AgOTf in 
CH2Cl2 at RT; System B employed AgOTf in toluene at RT; System C employed AgOTs in ClCH2CH2Cl 
at 70 °C. bAll reactions were carried out using 0.2 mmol of substrate with 5 mol% of gold and silver 
species at 0.2 M. cIsolated percentage yields of pyrrole products with ratio of isomers determined by 1H 
NMR. 
74 
3.6  Synthesis of 2,5-substituted pyrroles 
 
The optimised conditions for the formation of 2,5-substituted pyrroles (System C) were then 
applied to the other alkynyl aziridines prepared (Table 9) including those with alkyl 
substitutents on the three-membered ring (Table 12, entries 1-7). Almost quantitative yields 
were obtained and the purification of those 2,5-substituted products consisted only of an 
expedient and economical filtration through a plug of silica followed by solvent removal 
under reduced pressure. In only three cases purification by flash chromatography was 
necessary after the filtration step (entries 1, 3 and 8). Notably the reaction was efficient at 
room temperature when the alkyne moiety was substituted by a phenyl group. This could be 
rationalised by an extra stabilisation of intermediate I in the presence of the phenyl group 
(Scheme 56). Its formation would therefore be more favoured in that case than when a non-
stabilising alkyl substituent was employed and cyclisation would proceed without the need for 
heating. 
 
 
Scheme 56: Extra stabilisation by phenyl substituent allowing room temperature cyclisation 
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Entry R1 R2 
Reaction 
Time (h) 
Product Yield (%)a,b 
1 
 
 
12 216 95 
2 
 
 
3 217 98 
3 
 
 
12 218 95c 
4 
  
12 219 98c 
5 
 
 
4 220 98 
6 
  
3 204 98 
7 
 
 
12 202 98c 
8 
  
4 221 95 
9 
 
 
3 222 98 
10 
 
 
12 158 98c,d 
11 
 
 
12 163 98c,d 
12 
 
 
12 158 98c,d 
Table 12: Preparation of 2,5-substituted pyrroles. aAll reactions were carried out using 0.2 mmol of 
substrate with 5 mol% of gold and silver species at 0.2 M. bIsolated yields. cReaction at rt. 
dDesilylated pyrrole isolated. 
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As well as alkyl and phenyl substituents, other functional groups such as allyl and p-
bromobenzene (entries 1 and 9) were successfully employed. The products of these reactions 
were particularly interesting as they would provide opportunities for later elaboration to more 
complex molecules.67  
The use of silylated alkynyl aziridines (entries 10-12) gave monosubstituted pyrroles under 
the cationic gold reaction conditions as when AuCl3 was used as catalyst in Chapter 2 
(Scheme 47). However, the transformation was more efficient this time as 98% yields were 
achieved compare to the 80% previously reported. 
 
Subsequent to our publication,68 Dai and co-workers reported a similar gold-catalysed 
preparation of functionalised pyrroles from N-tosyl-substituted alkynyl aziridines (Scheme 
57).69 The cationic gold system Ph3PAuCl/AgOTf was employed in a mixture of THF and 
MeOH to give 2,5-substituted pyrroles in good yields. No 2,4-pyrroles were reported when 
aromatic substituents were submitted to these reaction conditions. This was in agreement with 
our results as 2,5-substituted pyrrole was formed predominantly when MeOH was used as 
solvent with the catalytic system Ph3PAuCl/AgOTf (Table 10, entry 8). Moreover our 
reaction conditions employing Ph3PAuCl/AgOTs gave better yields every time similar 
alkynyl aziridines were used. 
 
 
Scheme 57: Dai and co-workers gold-catalysed synthesis of 2,5-substituted pyrroles 
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3.7  Attempts to extend the method to the formation of furans  
 
A study was undertaken to investigate whether aryl-substituted alkynyl epoxides would show 
similar reactivity and allow the preparation of 2,4-disubstituted furans by aryl shift. 
Phosphonium salt 223 was synthesised and engaged in a Wittig reaction with benzaldehyde. 
The enyne obtained was reacted with mCPBA under basic conditions to access a mixture of 
cis and trans oxirane 225 (Scheme 58). 
 
 
Scheme 58: Alkynyl oxirane preparation 
 
Alkynyl epoxide 225 was submitted to the optimal conditions for the selective formation of 
either 2,4 or 2,5-substituted pyrroles (Scheme 59). 
Under the conditions shown to favour formation of 2,4-substituted pyrrole, a mixture of 
furans was also obtained. 2,4-Substituted furan 227 was identified as the major product and 
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the 2,5-substituted furan as the minor. When AgOTs was used only the 2,5-substituted furan 
was observed. 
Both results showed that alkynyl epoxides reacted in a similar way as alkynyl aziridines under 
cationic gold catalysis. The shift of an aryl moiety was favoured when a triflate counterion 
was employed and 2,5-disubstituted epoxide 226 was obtained as sole isomer when a tosylate 
one was used.  
Unfortunately contrary to their pyrrole equivalents which were accessed efficiently, 2,4- and 
2,5-disubstituted furans were obtained in very low yields by this method. 
 
 
Scheme 59: Furan formation under the optimal reaction conditions for alkynyl aziridine cyclisation 
 
3.8  Attempts to extend the method to the formation of more complex 
pyrroles 
 
The method developed for the formation of tosylated 2,5-substituted pyrroles was a success as 
almost quantitative yields were obtained for all the alkynyl substrates tested during the course 
of our studies. However more complex substituents such as TBDMS-protected alcohols could 
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not be incorporated in the imine or sulfonium salt alkynyl aziridine precursors (Scheme 60 
and 61). 
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Scheme 60: Failed attempts to form imine from aldehyde 229 
 
 
Scheme 61 : Failed attempts to form sulfonium salt from bromide 232 
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The method used for the formation of alkynyl aziridines was showing its limitations and it 
was decided to investigate other modes of preparation. 
Many aziridination techniques had been developed in the past but most employed fastidious 
linear synthesis and their use would considerably reduce the interest of our gold-catalysed 
transformation. 
Therefore attention was turned to another expedient method that had been used to form N-
phthalimide alkynyl aziridines M from 1,3-enynes L under oxidative conditions (Scheme 
62).70 It was expected that formation of the corresponding pyrrole would be possible under 
gold catalysis in a similar way as for the tosylated alkynyl aziridines studied previously. 
Moreover this technique was anticipated to allow access to trisubstituted alkynyl aziridines 
which could potentially allow formation of trisubstituted pyrroles. 
 
 
Scheme 62: Direct aziridination of 1,3-enynes and a possible route to trisubstituted pyrroles 
 
Therefore 1,3-enyne 224 was prepared from bromide 173 following a sequence previously 
described for epoxide 225 formation (Scheme 58). The N-phthalimide alkynyl aziridine 233 
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was obtained by treatment of enyne 224 with N-aminophthalimide in the presence of 
Pb(OAc)4 and base (Scheme 63). The use of very toxic Pb(OAc)4 was not ideal but enabled 
access to the aziridine required to investigate the ring expansion. 
 
 
Scheme 63: Preparation of N-phthalimide alkynyl aziridine 233 
 
Compound 233 was submitted to different reaction conditions summarised in Table 13. The 
reaction conditions discussed previously leading to the selective preparation of 2,5-substituted 
N-tosyl pyrroles proved almost ineffective as only very little N-phthalimide pyrrole was 
formed according to 1H NMR of the crude mixture (Table 13, entries 1). Most of the starting 
material was recovered but partial degradation was also observed. A similar result was 
obtained when dichloro(pyridine-2-carboxylato)gold was employed (entry 7). The use of 
AuCl3 at 70 °C or Ph3PAuCl/AgOTf at room temperature led to complex mixtures with the 
formation of small amounts of product and total consumption of the starting material (entries 
2, 9). Moreover no reaction occurred in the presence of AuCl or PtCl2 in ClCH2CH2Cl 
regardless of the temperature (entries 3-6). 
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Entry Catalyst Solvent T (°C) Yield (%)a,b 
1 PPh3AuCl/AgOTs ClCH2CH2Cl 70 5c 
2 PPh3AuCl/AgOTf CH2Cl2 23 7d 
3 AuCl ClCH2CH2Cl 23 -e 
4 AuCl ClCH2CH2Cl 70 -e 
5 PtCl2 ClCH2CH2Cl 23 -e 
6 PtCl2 ClCH2CH2Cl 70 -e 
7 Au(III)f ClCH2CH2Cl 70 9c 
8 AuCl3 ClCH2CH2Cl 23 -e 
9 AuCl3 ClCH2CH2Cl 70 5d 
Table 13: Catalysts screening to form 2,5-substituted pyrroles from alkynyl aziridine 
233. aAll reactions were run for 12 h using 0.2 mmol of substrate with 5 mol% of gold 
and silver species at 0.2 M. bYields calculated by 1H NMR against a known quantity of 
internal standard. cMost starting material was left untouched. dComplex mixture, no 
starting material recovered. eNo pyrrole product observed by crude 1H NMR, partial 
degradation of the starting material occurred. fDichloro(pyridine-2-carboxylato) gold 
was used. 
 
At that stage it was envisioned to screen other gold catalysts and to study the impact of 
solvent on the reaction. However, Liu and co-workers published their work on the preparation 
of functionalised pyrroles from similar N-phthalimide-substituted alkynyl aziridines and it 
was decided to halt the project (Scheme 64).71 
 
The method described by Liu and co-workers employed the cationic gold system 
Ph3PAuCl/AgOTf in THF at 50 °C and good yields of pyrrole were reported from strictly cis-
alkenyl aziridines. The same combination of gold complex and silver salt had been tested in 
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our study on aziridine 233, but had been employed at room temperature in CH2Cl2 and very 
low conversion to pyrrole 234 had been observed at the time (Table 13, entry 2). To access 
the aziridine precursor a similar method to ours was employed from enynes but the toxic 
Pb(OAc)4 was replaced by PIDA. This reaction tolerated a range of alkyl and aryl functional 
groups for substituents R2 and R3 (Scheme 64) but it was limited to esters and phenyl in 
position 2 of the aziridine ring (R1 in Scheme 64). Despite this restriction, disubstituted and 
trisubstituted enynes were accessed and gold catalysis under the reported conditions led to the 
formation of a series of disubstituted or trisubstituted pyrroles. 
 
 
Scheme 64: Liu and co-workers gold-catalysed synthesis of N-phthalimide substituted pyrrole. 
 
3.9  Summary 
 
A new and efficient gold-catalysed 2,4- and 2,5-substituted pyrrole synthesis from N-tosyl 
alkynyl aziridine has been developed. The effect of the counterion on the outcome of the 
reaction was demonstrated and allowed preferentially formation of one isomer or the other. 
Ph3PAuOTs proved to be the catalyst of choice to form 2,5-substituted pyrrole in an atom-
economic manner as almost quantitative yields were obtained. Changing the catalyst to 
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Ph3PAuOTf afforded the 2,4-substituted isomer highlighting the importance of counterion 
selection for gold catalysed processes as it can play an important role in determining the 
reaction pathway. Furthermore the applicability of the reaction developed for this pyrrole 
synthesis was also investigated on N-phthalimide alkynyl aziridine and alkynyl oxirans 
proving unfortunately that the optimised reaction conditions could not be directly transposed. 
Improvement of the scope of the reaction would probably be possible but would need 
advances in the access of the N-tosyl alkynyl aziridine precursors as this proved to be a 
limiting factor in this project. 
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Chapter 4:  Mechanistic studies 
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4.1  Introduction 
 
The preceding chapter described the development of new gold-catalysed pyrrole syntheses. 
The use of OTf or OTs as the counterion to gold was proven to be critical in determining 
whether the reaction pathway led to the formation of either a 2,5- or 2,4-substituted pyrrole as 
the major product. During studies into the role of the counterion, solvent effect, and the 
impact of the alkynyl aziridine aryl substituent a reaction mechanism was proposed which 
rationalised the reaction outcomes through a 1,2-aryl shift (Scheme 65).  
In order to prove this hypothesis correct or not, deuterium labelling was explored to tell us 
about the movement of the protons during the course of the reaction, and 13C labelling was 
investigated to learn about the behaviour of the carbon skeleton.  
 
 
Scheme 65: Mechanism proposed in Chapter 3 
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4.2  Deuterium labelled studies 
 
In order to probe the proposed reaction mechanism, it was decided to synthesise an alkynyl 
aziridine bearing a deuterium label at the benzylic position (Scheme 66, structure A). Indeed, 
with such an aziridine isolation of compound G would prove the 1,2-aryl shift, and isolation 
of compound D would validate Path I under the standard reaction conditions. 
 
 
Scheme 66: Anticipated outcome of the reaction of deuterium labelled alkynyl aziridine 
 
It was decided to prepare deuterium labelled alkynyl aziridine 237 bearing a tolyl group 
because this substituent had given among the greatest amount of rearrangement product 
(Chapter 3, Scheme 11). The n-butyl functionality was preferred to a phenyl one in order to 
simplify the aromatic region of 1H NMR spectra and so facilitate interpretation of results. 
Ethyl 4-methylbenzoate was reduced using LiAlD4 to give the deuterated 4-methylbenzyl 
alcohol72 and oxidation using the Dess-Martin procedure gave the desired aldehyde 235 in 
high yield (Scheme 67). The corresponding deuterated imine 236 was formed by condensation 
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with tosylamine under the previously described conditions and used to prepare deuterated 
alkynyl aziridine 237. 
 
 
Scheme 67: Preparation of deuterated alkynyl aziridine 237 
 
Aziridine 237 was then subjected to the two sets of reaction conditions previously developed: 
Ph3PAuCl/AgOTs in ClCH2CH2Cl at 70 °C and Ph3PAuCl/AgOTf in CH2Cl2 at room 
temperature. 
 
4.2.1  Deuterium labelled studies employing Ph3PAuCl/AgOTs 
 
As in the non-labelled series, the use of AgOTs with PPh3AuCl led exclusively to 2,5-
substituted pyrroles (Scheme 68). 
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Scheme 68: Deuterium labelling study employing Ph3PAuCl/AgOTs 
 
The 1H NMR of the mixture of products obtained (Figure 4) clearly showed the presence of 
non-deuterated pyrrole product 210 which had been previously synthesised and characterised 
(Figure 5). According to the 1H NMR spectra of this non-deuterated pyrrole 210 (Figure 5), 
the doublet at 6.04 ppm corresponded to H4 as this proton is only coupled with its neighbour 
H3. The pattern observed for H3 at 6.02 ppm was a more complex doublet of triplets due to 
coupling not only with H4 but also with the first CH2 of the n-Bu moiety (4J coupling). 
In addition to the signals from compound 210 two unequal singlets were observed at 6.04 and 
6.02 ppm (Figure 4). Considering the previous pattern attribution for H3 and H4, the new 
singlet at 6.04 ppm was assigned to a proton at position 4 in pyrrole 205 with an adjacent 
deuterium in position 3. The presence of the second small singlet at 6.02 ppm was attributed 
to a small amount of deuterated pyrrole 238 bearing a proton in position 3 and deuterium in 
position 4 this time. 
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Figure 4: Selected area of 1H NMR from the mixture of pyrroles obtained after reaction on deuterated 
alkynyl aziridine 237 using PPh3AuCl/AgOTs 
 
Figure 5: 1H NMR of non-deuterated pyrrole 210 
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At the light of these experimental results a refined reaction mechanism was proposed (Scheme 
69). 
 
 
Scheme 69: Mechanistic rationale for the deuterium labelling study using Ph3PAuCl/AgOTs 
After cationic gold activation of deuterated alkynyl aziridine 237, cycloisomerisation would 
lead to intermediate B. Through path I, abstraction of the deuterium at that stage would give 
intermediate C which could evolve into product 205 by reincorporating the lost deuterion. 
The second product 210 would be obtained by proton exchange with the reaction mixture, 
from traces of water or acid for example. Another possibility from intermediate B would be 
the 1,2-shift of the deuterium to give H through path III. This migration could be rationalised 
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by the formation of a tertiary carbocation stabilised by the adjacent heteroatom and aryl 
group. From H, product I would be obtained by loss of proton, subsequent protodemetalation 
would give deuterated pyrrole 238. 
 
4.2.2  Deuterium labelled studies employing Ph3PAuCl/AgOTf 
 
When deuterium labelled alkynyl aziridine 237 was reacted with AgOTf and Ph3PAuCl, a 
mixture of 2,5-substituted (minor) and 2,4-substituted (major) pyrroles was produced as 
expected (Scheme 70). Surprisingly a yield of 18% of pyrrole mixture was obtained while 
32% were reported in the non-deuterated series (Chapter 3, Table 11, entry 10). Repeating the 
reaction afforded the same 18% yield of products. When another deuterium-labelled alkynyl 
aziridine bearing a phenyl-substituted alkyne (instead of an n-butyl moiety as for 237) was 
reacted with AgOTf and Ph3PAuCl, complete degradation occurred. 
 
 
Scheme 70: Deuterium labelling study employing Ph3PAuCl/AgOTf 
 
The 1H NMR of the mixture of pyrroles (Figure 6) showed evidence of the presence of small 
amount of previously synthesised non-deuterated product 211. The 1H NMR of this non-
labelled 2,4-substituted pyrrole (Figure 7) showed two resonances coupled together, a doublet 
at 7.54 ppm (H5) and a doublet of triplets at 6.30 ppm (H3), the pattern due to long range 
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coupling with the -CH2 of the n-butyl moiety (4J coupling). The products of deuterated 
alkynyl aziridine 237 gave a mixture of pyrroles in which the doublet of triplets at 6.30 ppm 
was easily identified. The doublet at 7.54 ppm could not be seen, probably being covered by 
the presence of a net singlet from deuterium-labelled pyrrole 239 at 7.54 ppm. 
Moreover trace amount of non-deuterated product 210 was also identified by a doublet at 6.04 
ppm and a doublet of triplets at 6.02 ppm (not represented in Figure 6, 7). 
 
With these data the mechanism was then re-examined. 
As in the former deuterium labelled study employing AgOTs, the presence of traces of pyrrole 
210 was explained by path I, through loss of deuterium from intermediate B followed by 
protodeauration. Pyrroles 205 and 238, from path I and path III respectively, were probably 
below 1H NMR detection limit and were not observed. 
The formation of pyrroles 211 and 239 could be explained through path II. Intermediate B 
would lead to J after a 1,2-aryl shift (Scheme 71). A subsequent 1,2-H migration would 
deliver intermediate K, perhaps leading to a more stabilised tertiary carbocation. Loss of 
deuterium at that stage would give M and protodemetalation or deuterium exchange would 
form pyrroles 211 and 239. However, loss of proton from K would give intermediate L and 
compound 240 should have been detected in the 1H NMR of the mixture. 
Lack of product 240 raised questions about the validity of the proposed mechanism for the 
formation of the 2,4-substituted products and the mechanistic investigations were pursued. 
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Figure 6: Selected parts of 1H NMR of pyrrole mixture obtained employing Ph3PAuCl/AgOTf 
 
Figure 7: 1H NMR of non-deuterated pyrrole 211 
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Scheme 71: Mechanistic rationale for the deuterium labelled study using Ph3PAuCl/AgOTf 
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4.3  13C labelled studies  
 
Although control studies had shown no H/D exchange under the reaction conditions (Scheme 
72), more information was required to ascertain a likely mechanism. 
 
 
Scheme 72: Control study ruling out H/D exchange under the reaction conditions 
 
It was therefore decided to continue with 13C labelling studies in order to obtain information 
about the behaviour of the carbon skeleton during the reaction. 
An alkynyl aziridine bearing a 13C-enriched center bonded to an aryl moiety on the three-
membered ring was employed (Structure A’, Scheme 73). With the 13C-enriched carbon in 
that position, it was expected to give weight to the proposed Path I by forming product D’. 
Isolation of pyrrole G’ would allow us to validate the 1,2-aryl shift pathway that could not be 
proved by the deuterium experiments. 
 
The 13C-enriched alkynyl aziridine 243 was prepared from commercially available 13C-
enriched benzoic acid, as 1:5 13C:12C mixture, in a four-step sequence (Scheme 74). 
Reduction of the carboxylic acid with LiAlH4 was followed by Dess-Martin oxidation to give 
aldehyde 241.73,74 Condensation with tosylamine under acidic conditions afforded the 
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corresponding imine 242. Reaction with sulfonium salt 180 and Cs2CO3 gave the 13C-
enriched alkynyl aziridine 243. 
 
 
Scheme 73: Anticipated outcome of the reaction of 13C-enriched alkynyl aziridine 
 
 
Scheme 74: Preparation of 13C-enriched alkynyl aziridine 243  
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Aziridine 243 was then subjected to the two sets of reaction conditions previously developed: 
Ph3PAuCl/AgOTs in ClCH2CH2Cl at 70 °C and Ph3PAuCl/AgOTf in CH2Cl2 at room 
temperature. 
 
4.3.1  13C labelling study employing Ph3PAuCl/AgOTs  
 
Under catalysis with 243 Ph3PAuCl/AgOTs, alkynyl aziridine 243 afforded the expected 2,5-
substituted pyrrole 244 exclusively. 13C enrichment was observed at only one resonance in the 
13C NMR spectrum (Appendix B), corresponding to C-5, as expected from the proposed 
mechanism (Scheme 75). 
 
 
Scheme 75: 13C labelling study using AgOTs/PPh3AuCl with alkynyl aziridine 243. 
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4.3.2  13C labelling study employing Ph3PAuCl/AgOTf  
 
When 13C-enriched alkynyl aziridine 243 was submitted to catalysis using Ph3PAuCl/AgOTf 
a mixture of three 13C-enriched isomers was obtained (Appendix B) rather than the two 
expected. All resonances could be attributed to either the 2,5- or 2,4-pyrrole isomers (Scheme 
76). 
 
.  
Scheme 76: 13C labelling study using AgOTf/PPh3AuCl with alkynyl aziridine 243. 
 
Two products were readily identifiable as the 13C-enriched 2,5-substituted pyrrole 244 
described above, and the expected 2,4-substituted pyrrole 245 with 13C-enrichment at 117.7 
ppm in the 13C NMR spectrum (Figure 8). 
The other 13C-enriched quaternary signal at 126.8 ppm was explained by the 2,4-substituted 
pyrrole 246 with 13C-enrichement at C-4, the carbon directly linked to the aryl motif. 
HMBC experiments were run to confirm this analysis. Clear 3J coupling between the C-4 13C-
enriched quaternary centre and the protons of the aryl group was observed, proving pyrrole 
246 structure and enrichment site. 
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Figure 8: 13C NMR of mixture of pyrroles after treatment of alkynyl aziridine 243 with AgOTf/Ph3PAuCl. 
 
The formation of 13C-enriched pyrrole 245, showing the aryl moiety had migrated during the 
course of the reaction, was in agreement with Path II of the mechanistic proposal suggesting a 
1,2-aryl shift (Scheme 73 and 77). 
 
The presence of 13C-enriched pyrrole 246 could not be explained by this pathway. Taken with 
the D-labelling data, it was apparent that an alternate pathway was operating. 
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Scheme 77: Proposed mechanism for the formation of 2,4-substituted pyrrole 245 
 
4.4  New mechanistic proposal 
 
When activated by a gold catalyst, alkynyl aziridines could cycloisomerise to form five-
membered ring intermediates as was proposed previously (Structure B, Scheme 73). But in 
fact three distinct pathways could be suggested for that first step (Scheme 78). 
A stepwise ring-expansion could take place with reversible alkynyl aziridine ring opening 
followed by attack of the nitrogen on the alkyne-gold complex (Path A). As two possible ring 
openings of the three-membered ring could be possible, intermediates I and II would be 
formed and would lead to IV or V respectively after cyclisation onto the alkyne. 
In Path B, direct migration of one of the C-N σ-bond from the aziridine to the activated 
alkyne would happen to form IV. 
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Alternatively, the lone pair of the aziridine nitrogen could perform a nucleophilic attack 
across the alkyne rendered electrophilic by the catalyst (Path C). Intermediate V and IV could 
then be formed from strain release by path c or d respectively. 
Despite being very different from one another mechanistically, none of these three pathways 
could be ruled out. Nevertheless, the most important for our study was that two pathways 
were allowing the formation of a four- and five-membered ring intermediate. Path B could 
also lead to intermediate V if interconvertion between IV and V was possible. 
 
 
Scheme 78: Distinct pathways for the alkynyl aziridine opening 
 
The 13C labelling study showed previously that the five-membered ring intermediate could 
explain the formation of 13C-enriched 2,5-substituted pyrrole 244 (Scheme 75) and 13C-
enriched 2,4-substituted pyrrole 245 (Scheme 77). 
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On the other hand, it was thought that the four-membered ring intermediate could explain the 
formation of 13C-enriched 2,4-substituted pyrrole 246 (Scheme 79). 
In this case, the secondary carbocation of intermediate L’ would be stabilised by the adjacent 
aryl group. This species would then evolve into intermediate M’ by a 1,2-vinyl migration. 
Proto-deauration would finally give 13C-enriched 2,4-substituted pyrrole 246. 
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Scheme 79: New mechanism proposal for the cycloisomerisation of alkynyl aziridine 243 using 
Ph3PAuCl/AgOTf. 
 
As well as explaining the formation of a pyrrole with 13C-enrichment at C-4 this mechanism 
also accounts for the results of the deuterium labelling experiments where almost only 
deuterium insertion was observed in position 3 (Scheme 70). 
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Under this new mechanism, starting with deuterium-labelled aziridine 237, the transformation 
of four-membered ring intermediate N into structure O (Scheme 80) positions deuterium at C-
4. Aromatisation proceeds by loss of deuterium to form the organo-gold species M. Gold-
deuterion exchange would then lead to deuterated 2,4-substituted pyrrole 314. On the other 
hand proto-demetalation of intermediate M would give 2,4-substituted product 211. 
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Scheme 80: Mechanistic rationale for the deuterium labelling study using Ph3PAuCl/AgOTf. 
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4.5  Tests on the new mechanism 
 
In order to confirm the new mechanistic proposal preparation of 13C-enriched alkynyl 
aziridine 247 from 13C-enriched imine 242 was performed (Scheme 81). 
 
 
Scheme 81: preparation of 13C-enriched alkynyl aziridine 247 
 
The new substrate was then submitted to catalysis using Ph3PAuCl/AgOTf. In contrast to the 
use of 13C-enriched alkynyl aziridine 243, 13C NMR of the purified pyrrole mixture did not 
reveal any trace of 13C-enrichment at C-4 of a 2,4-substituted product (Scheme 82, Appendix 
B). 
 
 
Scheme 82: 13C labelling study using AgOTf/Ph3PAuCl with alkynyl aziridine 247 
 
In light of this result the new mechanism was reevaluated, paying particular attention to the 
two intermediates H’ and L’ where the process diverged (Scheme 79). The only variation in 
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the two 13C-enriched alkynyl aziridines considered was the substituent to the alkyne which 
was either an alkyl or a phenyl moiety. Switching this group would not appear to significantly 
affect the stability of 4-membered ring L’ (Scheme 79), but it could have a significant effect 
on the 5-membered ring intermediate H’. 
The presence of a phenyl substituent allows greater stabilisation of O’ by extended 
delocalisation of aromatic electrons (Scheme 83), thus potentially favouring O’ at the expense 
of R’. This could explain the formation of only one 13C-enriched 2,4-disubstituted pyrrole in 
the case of a phenyl-substituted alkynyl aziridine. In the absence of this extra stabilisation, 
using n-butyl-substituted alkynyl aziridine 243, the two pathways could be competitive and 
give the mixture of two 2,4-substituted pyrroles isomers. 
 
 
Scheme 83: Extra stabilisation of intermediate O’. 
 
It was then decided to prepare three other 13C-enriched substrates to assess the validity of this 
explanation (Figure 9). 
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Figure 9: Proposed 13C-enriched substrates to test the validity of mechanistic proposal 
 
13C-Enriched alkynyl aziridine 252, bearing an alkyl moiety, was synthesised in order to 
confirm that no further stabilisation of five-membered ring intermediate O’ (Scheme 83) 
would lead to a mixture of 2,4-substituted pyrroles P’, S’ with Q’ as when n-butyl-substituted 
alkynyl aziridine 243 was employed. 
13C-enriched alkynyl aziridine 250, bearing an electron-rich aryl group, was expected to 
stabilise intermediate O’ (Scheme 83) to a greater extent than when 13C-phenyl-substituted 
alkynyl aziridine 247 was used. Therefore formation of pyrroles P’ and Q’ only was 
anticipated. 
In the other hand, 13C-enriched alkynyl aziridine 251, bearing an electron-deficient aryl group, 
was expected to destabilise intermediate O’ (Scheme 83) relative to phenyl substituted 247 
and so would potentially give a mixture of 13C-enriched pyrroles P’, S’ and Q’ by enabling 
Path IV to be competitive. 
To access to these 13C-enriched alkynyl aziridines, sulfonium salts 255 and 258 were prepared 
(Scheme 84). 
Sonogashira type reaction between propargyl alcohol and 4-methoxyiodobenzene gave 
alcohol 253. Treatment with PPh3 and bromine led to bromide 254 which was reacted with 
dimethylsulfide to form sulfonium salt 255. The same sequence of reactions was used to form 
sulfonium salt 258 from 4-(trifluoromethyl)iodobenzene. 
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Scheme 84: Preparation of sulfonium salt 255 and 258  
 
13C-enriched alkynyl aziridines 250, 251 and 252 were then synthesised via reaction of 
sulfonium salts 255, 258 and 179 with 13C-enriched imine 242 (Scheme 85). 
The impact of the alkyne substituent was probed by running catalysis on those new alkynyl 
aziridines with the system AgOTf/PPh3AuCl (Scheme 86).  
As predicted the presence of an electron donating aryl substituent on 13C-enriched alkynyl 
aziridine 250 led to formation of only 13C-enriched 2,4-substituted pyrrole isomer 260 
(Appendix B). Moreover, electron deficient aryl-substituted alkynyl aziridine 251 and alkyl 
substituted 252 gave mixtures of 13C-enriched 2,4-substituted pyrroles as was anticipated 
(Appendix B). 
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These results were in perfect agreement with the mechanism proposal where a competition 
between five-membered ring O’ and a four-membered ring R’ was suggested for the 
cycloisomerisation of aryl-substituted alkynyl aziridines (Scheme 83). 
 
 
Scheme 85: Preparation of 13C-enriched alkynyl aziridines 250, 251 and 252 
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Scheme 86: Mixture of isomers obtained when submitting 13C-enriched alkynyl aziridine 250, 251 and 252 
to Ph3PAuCl/AgOTf 
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4.6  Summary 
 
The reaction mechanisms proposed in Chapter 3 were put to the test using deuterium labelling 
and 13C labelling studies. The deuterium experiments were consistent with the proposed 
pathway for the formation of 2,5-substituted pyrroles. Further confirmation came from using 
13C-enriched alkynyl aziridines under the same cationic gold catalytic system employing 
Ph3PAuCl/AgOTs. On the other hand the studies showed that formation of 2,4-substituted 
pyrroles with Ph3PAuCl/AgOTf was a more complex process than expected, and a new 
mechanism has been proposed to account for experimental outcomes. The 13C labelling could 
prove that two different pathways were active leading to 2,4-substituted pyrroles. A ring 
expansion via a five membered ring was shown to give 2,5-substituted pyrrole and a 2,4-
substituted isomer from a 1,2-aryl shift. Another pathway, through a four membered ring this 
time, was shown to lead to a 2,4-substituted pyrrole by alternative skeletal rearrangement. 
When alkynyl aziridine bearing an electron deficient or an alkyl substituted alkyne was used, 
competition between the five and four membered ring intermediate led to the formation of the 
two 2,4-substituted pyrroles with labelling at two sites. The use of alkynyl aziridine bearing 
an electron-rich substituted alkyne gave only 2,4-substituted pyrrole with enrichment at only 
one site thanks to an extra-stabilisation of the five membered ring intermediate favouring this 
pathway.  
Those results showed how seemingly relatively simple gold-catalysed reactions could reveal 
themselves to be complex when mechanistic studies were run to explain their outcome. It also 
showed the importance of such studies to allow strongly supported mechanistic proposal to be 
made. 
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4.7  Overall summary 
 
Two new gold-catalysed strategies have been developed to access a range of substituted 
pyrroles from alkynyl aziridines. 
Brominated or silylated 2,4-substituted pyrroles were prepared regioselectively via a AuCl3-
catalysed vinylidene rearrangement when brominated or silylated alkynyl aziridines were 
employed. Despite the formation of debrominated or desilylated side product, the concept of 
the reaction involving a rarely described gold-vinylidene intermediate was validated. 
Another strategy using cationic gold catalysis has also been successfully developed to 
synthesise 2,4- and 2,5-substituted pyrroles from alkynyl aziridines. The catalytic system 
Ph3PAuCl/AgOTs allowed us to access 2,5-substituted pyrroles in almost quantitative yield. 
The 2,4-substituted isomers were formed preferentially when Ph3PAuCl/AgOTf was 
employed. A study of the reaction mechanism employing 13C and deuterium-labelling 
supports a straightforward 3,5-ring expansion to the formation of 2,5-substituted pyrroles, 
with no skeletal rearrangement. On the other hand, a competition between two pathways was 
revealed for the formation of the 2,4-substituted pyrroles. Depending on the initial ring 
opening step, both a 1,2-aryl migration in a five membered ring intermediate, or a 1,2-vinyl 
migration in a four membered ring intermediate are proposed to account for the observed 
reaction outcomes. 
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Chapter 5:  Synthesis of α,β-unsaturated imides from 
ynamides 
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5.1  Introduction 
 
As discussed in Chapter 1 (section 1.6.1), previous studies have shown the ability of 
propargylic carboxylates to rearrange under gold catalyst activation to form gold carbenoid 
species. Various nucleophiles have been employed to react on these intermediates and sulfides 
were for example recently used to perform an intermolecular coupling under gold catalysis 
(Scheme 87).75 Generation of gold carbenoid species 267 by rearrangement followed by 
nucleophilic attack of the sulfide led to formation of an ylide 268. This intermediate could 
then rearrange again when an allyl substituted sulfide was employed, allowing complex 
molecules to be obtained from simple building blocks. 
 
 
 
Scheme 87: Coupling reaction between alkyne and sulfide developed in the group 
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Following those results, further processes employing even simpler alkynes were developed. 
The use of an internal sulfoxide 270, while reducing unfavourable gold-sulfur interactions, 
allowed an internal redox process to simultaneously generate the carbenoid and sulfide 
components necessary for ylide 274 formation (Scheme 88). 
 
 
Scheme 88: Alkyne as direct precursor for the formation of sulfur ylide 
 
Zhang and co-workers had also recently published results showing the use of an in situ 
formed N-oxide 277 in an intramolecular preparation of α-oxogold carbenoid species 278. 
This very reactive intermediate was employed in a cyclisation process leading to 
tetrahydrobenz[b]azepin-4-one 279 (Scheme 89).76 
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Scheme 89: Preparation of tetrahydrobenz[b]azepin-4-ones 
 
Considering the previous work above, it was thought that the formation of a gold carbenoid 
from an alkyne and an external oxidizing agent, where the oxygen delivery system would not 
be incorporated in the product, would be of significant interest. 
To ensure site-specificity of carbenoid introduction, controlled by the cyclisation in 
intramolecular processes, ynamides were selected as substrates (Scheme 90).77 
 
 
Scheme 90: Ynamides as equivalents of α,α-disubstituted imidocarbenoids 
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Indeed, heteroatom lone pair participation should favour a gold-ketene-iminium resonance 
form C and develop an electrophilic site adjacent to the nitrogen (Scheme 90). It was 
therefore anticipated that nucleophilic addition of an external oxidant, a sulfoxide or N-oxide 
for example, would occur selectively to form intermediate D. Cleavage of the O-X bond 
would lead to the formation of an α-oxo gold carbenoid species E which could be used in 
different subsequent reactions. 
A phenyl substituted ynamide G could for example lead to the formation of carbenoid 
intermediate I (Scheme 91). Cyclisation could then be envisaged to give indolinone product 
K. 
 
 
Scheme 91: Proposed cyclisation of phenyl-substituted imidocarbenoid intermediate 
 
In order to assess this concept, ynamides bearing a N-phenyl substituent were prepared. 
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5.2  Starting material preparation 
 
Synthesis of the ynamide precursors was achieved employing a copper-catalysed coupling 
between a terminal alkyne and an amide under aerobic conditions (Scheme 92).78 This atom-
economical method allowed the use of a range of electron-withdrawing secondary amides and 
a variety of substituents were tolerated. Furthermore good to excellent yields of ynamides 
were reported. 
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Scheme 92: Stahl aerobic method to synthesise ynamides from terminal alkynes 
 
The reaction mechanism was proposed to feature a catalytic sequential activation of alkyne L 
and amide N to give organocopper intermediate O (Scheme 93). A C-N reductive elimination 
step would provide the ynamide product P and the catalyst would be reoxidised under the 
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aerobic conditions. An excess of nitrogen nucleophile was required to prevent the formation 
of a bisalkynyl copper complex Q responsible for the formation of diyne side product R. 
 
 
Scheme 93: Proposed mechanism for the copper-catalysed ynamide preparation from alkyne 
 
Tosyl and mesyl-substituted anilines 280 and 281 were prepared in good yield by simple slow 
addition of the appropriate sulfonylchloride to a mixture of aniline and pyridine in CH2Cl2 
(Scheme 94).79 Diisopropylaniline was also employed under the same conditions to give 282 
in 91% yield. 
 
Scheme 94:Preparation of sulfonylanilines 
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Coupling reactions were performed using commercially available alkynes, CuCl2, pyridine 
and Na2CO3 in toluene at 70 °C under O2 atmosphere (table 14). Excellent yields of product 
were obtained with the mesylated or tosylated anilines and as expected a range of substituent 
could be employed including alkyl chloride, propargylic methoxyether and phenyl (table 14, 
entries 2, 3, 4). It is important to note that the excess of secondary amine employed to prepare 
each ynamide was always easily recovered after purification by flash chromatography. 
 
 
entry R1 R2 Product Yield (%)a,b 
1 
 
 
283 98 
2 
  
284 98 
3 
 
 
285 86 
4 
 
 
286 92 
5 
 
 
287 98 
6 
 
 
288 98 
7 
 
 
289 98 
Table 14: Ynamide preparation from terminal alkyne. aAll reactions performed using alkyne 
(2 mmol), amine (10 mmol), Na2CO3 (4 mmol), CuCl2 (0.4 mmol) and toluene (10 
mL).bIsolated yields. 
 
The use of amide 282 led to the formation of the diyne side product and no trace of ynamide 
was observed. The steric hindrance due to the two isopropyl substituent was thought to be 
responsible for the lack of reactivity of this substrate. 
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To complete our selection of substrates desilylation of ynamide 288 using KOH in a 1:1 
mixture of H2O and CH3CN was tried but degradation occurred and the expected ynamide 
could not be isolated (Scheme 95). 
 
 
Scheme 95: Attempt of ynamide 288 desilylation using KOH. 
 
Unfortunately, apart form ynamide 288, all the other substrates proved unstable and were 
starting to form an unidentified side product 30 min after purification. 
Therefore those substrates were engaged in catalysis immediately after synthesis and 
purification. 
 
5.3  Optimisation of the reaction conditions 
 
Ynamide 283 was submitted to various catalysts and reaction conditions using commercially 
available diphenylsulfoxide as a starting point (table 15). Only traces of an unknown 
compound were observed by TLC regardless of the solvent used and increase of the 
temperature led to degradation of the starting material. Varying the catalyst from PtCl2 to 
cationic gold or AuCl3 was not successful as no trace of the expected product was observed 
by 1H NMR of the crude reaction mixtures. 
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entry Oxidant Catalyst Solvent 
Temperature 
(°C) 
Yield (%)a 
1 
 
PtCl2 toluene 23 - 
2 
 
PtCl2 toluene 80 -b 
3 
 
PPh3AuCl/AgOTf CH3CN 23 - 
4 
 
PPh3AuCl/AgOTf CH2Cl2 23 - 
5 
 
PPh3AuCl/AgOTs CH2Cl2 23 - 
6 
 
PPh3AuCl/AgOTf ClCH2CH2Cl 70 -b 
7 
 
AuCl3 CH2Cl2 23 - 
Table 15: Use of diphenylsulfoxide as oxidant in attempts to form indolinones. aReactions performed 
on 0.1 mmol starting material with 1eq sulfoxide and 5 mol% catalyst at a concentration of 0.2 M. 
bComplete degradation of the starting material was observed. 
 
Diphenylsulfoxide was then replaced by the stable, crystalline and commercially available 
pyridine N-oxide. This reagent was expected to be more nucleophilic than the sulfoxide as 
extra stabilisation by electron delocalisation in the aromatic pyridine ring was possible. 
Moreover the oxygen of the N-oxide should also be more accessible because it is less 
sterically hindered than in diphenylsulfoxide. 
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Ynamide 283 was therefore submitted to catalysis using Ph3PAuCl/AgOTs and pyridine N-
oxide (Scheme 96). Pleasingly total conversion of the starting material into a new product was 
observed after 12 h at room temperature. However, after filtration of the reaction mixture 
through a pad of silica and evaporation of the solvent, crude 1H NMR did not reveal any 
traces of the expected cyclised compound. Isolation of the reaction products was performed 
and they were identified as (E)- and (Z)-α,β-unsaturated imides 294. 
The products of the reaction were though to come from formation of intermediate 291 by 
nucleophilic attack of pyridine N-oxide onto the gold-activated ynamide (Scheme 96). 
Cleavage of the O-N bond would release pyridine and generate intermediate 292/293 
displaying carbenoid character. A 1,2-H insertion on the carbene would then form the 
observed (E)- and (Z)-α,β-unsaturated imides 294. 
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Scheme 96: Gold-catalysed reaction of ynamide 283 with pyridine N-oxide 
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In order to avoid 1,2-H insertion in the carbenoid species formed in situ, phenyl-substituted 
ynamide 286 was used with Ph3PAuCl/AgOTs and pyridine N-oxide. In that case formation of 
the cyclised indolinone product was expected. 
This time with only one equivalent N-oxide the reaction did not go to completion and a 
different product was formed according to TLC and 1H NMR of the crude mixture. A second 
test was attempted with 2.2 equivalents of N-oxide and total consumption of the ynamide 
precursor was observed after 12 h. The product of the reaction was isolated and identified as 
dioxidated oxoacetamide 298 (Scheme 97). 
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Scheme 97: Gold-catalysed formation of oxoacetamide 298 from ynamide 286 
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Access to the dioxidated product 298 was explained by oxidation of the carbenoid 
intermediate 296 formed during the course of the reaction, justifying the need for two 
equivalents of N-oxide to completely convert the starting material into product (Scheme 97). 
This result was consistent with previous work from Toste and co-workers where diphenyl 
sulfoxide could be used to trap different preformed gold carbene intermediates to give 
carbonyl compounds in good yield (Scheme 98).80 
 
 
Scheme 98: Toste and co-workers trapping of gold carbene with Ph2SO 
 
Carbene formation from oxidation of ynamides had already been reported in the literature 
employing DMDO as electrophilic oxidant (Scheme 99). The novelty brought by the use of a 
gold catalyst and pyridine N-oxide was that opposite regiochemistry to that previously 
established was obtained (T vs V).81 
Furthermore the gold-catalysed formation of the dioxidated oxoacetamide from ynamide and 
N-oxide complements the existing reaction employing electrophilic oxidants to form this class 
of compounds (Scheme 100).82 
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Scheme 99: Opposite regioselectivity of electrophilic versus nucleophilic oxidation of ynamides 
 
 
Scheme 100: Preparation of dioxidated oxoacetamide by electrophilic or nucleophilic oxidation 
 
When the trimethylsilyl substituted ynamide 288 (Table 14, entry 6) was reacted with 
PPh3AuCl/AgOTs and pyridine N-oxide, very complex mixtures of products and degradation 
were observed. 
Despite evidence for the formation of the expected gold carbenoid species during the course 
of the reaction with ynamides 283 and 286, no cyclised products had been observed. But the 
possibility to access α,β-unsaturated imides in two steps from a sulfonamide and a terminal 
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alkyne represented an attractive transformation and therefore the reaction was explored in 
greater details. 
 
Screening of reaction conditions was performed using ynamide 283 as test substrate and 
pyridine N-oxide as nucleophile (Table 16). 
Every gold (I) and gold (III) species tried gave the expected α,β-unsaturated imide in average 
to good yields (Table 16, entries 1-8) and platinum salts were inactive for this transformation 
(Table 16, entries 9, 10). Test reactions using NBS or p-TsOH in place of the metal salts were 
unsuccessful and starting material was recovered. Moreover employment of TfOH led to 
degradation of the starting material without observable formation of the expected α,β-
unsaturated imide product. 
 
Considering all the systems tested, two sets of conditions were particularly interesting: 
System A used air-stable dichloro(pyridine-2-carboxylato)gold (III) precatalyst (Au-I)83 in 
ClCH2CH2Cl at 70 °C (Table 16, entry 20) and was the quickest to completely convert the 
starting material into product in high yield. System B avoided the use of chlorinated solvent, 
employing AuBr3 at room temperature in THF and was giving the best (E)-selectivity in high 
yield (Table 16, entry 17). 
Therefore it was decided that both system would be applied to a selection of different 
ynamide in order to probe the scope of the reaction. 
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entry Catalyst Solvent Time (h) 
Temperature 
(°C) 
Yield in % 
(E:Z ratio)a,b  
1 Me2SAuCl CH2Cl2 12 RT 61 (3.9:1) 
2 PPh3AuCl/AgOTs ClCH2CH2Cl 12 70 80 (3.7:1) 
3 PPh3AuNTf2 CH2Cl2 12 RT 44 (1:1) 
4 AuCl CH2Cl2 12 RT 61 (3.8:1) 
5 AuCl ClCH2CH2Cl 0.25 80 76 (2.3:1) 
6 NaAuCl4.H2O CH2Cl2 12 RT 54 (2.4:1) 
7 Au-I CH2Cl2 12 RT 48 (3.0:1) 
8 Au-I Toluene 12 RT 52 (2.5:1) 
9 PtBr2 Toluene 12 70 -c 
10 PtCl2 Toluene 12 70 -c 
14 AuCl3 CH2Cl2 12 RT 42 (3.3:1) 
15 AuBr3 ClCH2CH2Cl 0.33 70 82 (2.5:1) 
16 AuBr3 Toluene 3 RT 84 (2.0:1) 
17 AuBr3 THF 12 RT 86 (3.2:1) 
18 AuBr3 CH3NO2 24 RT 60 (3.8:1) 
19 Au-I ClCH2CH2Cl 2 50 66 (2.3:1) 
20 Au-I ClCH2CH2Cl 0.17 70 82 (2.3:1)d 
21 Au-I ClCH2CH2Cl 0.25 80 45 (2.5:1) 
Table 16: Survey of reaction conditions. aReactions were performed using 0.1 mmol of ynamide, 5 
mol% of catalyst, 0.11 mmol of pyridine N-oxide and 0.5 mL of solvent (0.2 M). bNMR yields against 
a known quantity of internal standard and ratios determined by 1H NMR. cThe starting material was 
partially recovered. d71 % isolated yield after flash chromatography. 
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5.4  Application of the optimised conditions 
 
The ynamides prepared previously were then submitted to the two sets of condition selected 
after the optimisation work: System A employing dichloro(pyridine-2-carboxylato)gold (III) 
precatalyst (Au-I) in ClCH2CH2Cl at 70 °C; System B employing AuBr3 at room temperature 
in THF. 
Both N-tosyl and N-mesyl substituted ynamides gave the expected mixture of (E) and (Z) α,β-
unsaturated imides in good yield with the (E) isomer as the major (Table 17). 
Other functionalities than simple alkyl were tolerated, notably an alkyl chloride (entry 2) and 
an alkoxy group (entry 3). In this last case complete selectivity toward the synthetically 
valuable (E)-α,β-unsaturated imide was even achieved. Apart from this example and when the 
symmetrical cyclohexane substituent was used (entry 5), only moderate (E):(Z )selectivity 
was observed and System B proved superior than System A in every cases for the preparation 
of the (E)-isomer. System A always gave slightly better yield of the mixture of isomers than 
System B. 
 
During the course of our studies Zhang and co-workers reported a similar use of pyridine N-
oxides in a new synthesis of dihydrofuran-3-ones (Scheme 101).84 Like in the reaction 
described above it was thought that nucleophilic attack of the pyridine N-oxide derivative 
across the terminal alkyne would take place to give intermediate 308.  
Formation of an α-oxo gold carbenoid species C would result from expulsion of the pyridine 
derivative (Scheme 101). Internal nucleophilic attack of the carbenoid by the alcohol would 
then terminate the process and give product 311. 
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Entry R1 R2 Product System 
Yield in % 
(E:Z ratio)a,b 
A 71 (2.3:1) 
1 
 
Ts 
 
B 70 (3.7:1) 
A 73 (1.9:1) 
2 
 
Ts 
 
B 70 (3.5:1) 
A 70c 
3 O
 
Ts 
 
B 65c 
A 75 (3.0:1) 
4 
 
Ms 
 
B 71 (4.0:1) 
A 80 
5 
 
Ts 
 
B 78 
Table 17: Synthesis of α,β-unsaturated imides. aReaction were performed using 0.3 mmol of 
ynamide, 5 mol% of catalyst, 0.33 mmol of pyridine N-oxide and 1.5 mL of solvent. bIsolated 
yields, ratio of isomers determined by 1H NMR after purification. cOnly E-isomer was observed. 
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Scheme 101: Zhang and co-workers gold-catalysed preparation of dihydrofuran-3-ones 
 
A broad range of functional groups were tolerated such as halogenated alkyls, azides or 
various substituted aromatic rings. But the drawback of the method was the need for an acid 
in the reaction mixture. It was proposed that the pyridine formed during the course of the 
reaction deactivated the catalyst as than 10% yield of product was reported when no acid was 
employed. It was worth to note that such effect were not observed in the case of the (E) and 
(Z) α,β-unsaturated imides synthesis reported above. 
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5.5 Summary 
 
A new gold catalysed reaction has been developed employing an external oxidizing agent to 
form a gold carbenoid intermediate from ynamides. Despite the fact that none of the expected 
indolinones was formed, the predicted site-specific introduction of the gold carbenoid moiety 
was demonstrated. This intermediate was indeed employed for the preparation of a variety of 
α,β-unsaturated imides in good yields with a good functionality tolerance. It was also shown 
that access to one oxoacetamide compound was possible in good yield and under mild 
reaction conditions when an aryl substituted substrate was used with two equivalents of N-
oxide. 
Those results also demonstrate that ynamides can be employed as direct equivalents to α,α-
disubstituted-diazo amides for regiospecific access to gold carbenes (Scheme 102). Therefore 
the gold-catalysed methods described above might lead to further developments in synthesis 
while avoiding the use of the potentially hazardous diazo functionality. 
 
 
Scheme 102: Ynamides as equivalents to α,α-disubstituted-diazo amides 
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Chapter 6:  Experimental 
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6.1  Instruments 
 
Asynt DrySin heating blocks on stirrer hotplates were employed for reactions with 
temperature controlled via external probe. Infra-red spectra were recorded neat on a Perkin–
Elmer Spectrum 100 FT-IR spectrometer. Only selected absorbencies (νmax) are reported in 
cm-1. High resolution mass spectra (HRMS) were recorded on a VG ProSpec or a VG-
ZabSpec at 70 eV when utilising electron impact ionisation (EI). A Micromass LCT using a 
methanol mobile phase was used for HRMS utilising electrospray ionisation. In both case (EI 
or ES), HRMS was obtained using a lock-mass to adjust the calibrated mass scale. MS data 
are reported as m/z. NMR: Spectra were recorded on Bruker AC300 (1H = 300 MHz, 13C = 
75.5 MHz), Bruker AV300 (1H = 300 MHz, 13C = 75.5 MHz) or Bruker AV400 (1H = 400 
MHz, 13C = 101 MHz), in the solvents indicated; Chemical shifts (δ) are given in ppm relative 
to TMS. The solvent signals were used as references and the chemical shifts converted to the 
TMS scale (CDCl3: δC ≡ 77.0 ppm; residual CHCl3 in CDCl3: δH ≡ 7.26 ppm; DMSO-d6: δC ≡ 
39.52 ppm; residual DMSO-d5 in DMSO-d6: δH ≡ 2.50 ppm). Coupling constants (J) are 
reported in Hz. Multiplicity is denoted in 1H NMR by: s (singlet), d (doublet), t (triplet), q 
(quadruplet), quint (quintuplet), sept (septuplet) and m (multiplet). 13C NMR spectra were 
recorded using the PENDANT pulse sequence from the Bruker standard pulse program 
library. Melting points were recorded using open glass capillaries on a Stuart Scientific 
apparatus and are uncorrected. 
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6.2  Reactions  
 
Reactions were followed by thin layer chromatography (TLC) using Macherey Nagel silica 
gel 60F254 analytical plates (plastic support) which were developed using standard 
visualizing agents: UV fluorescence (254 and 366 nm), and potassium permanganate/∆. 
Purification by Flash chromatography was performed using Fluorochem silica gel 60 (0.043-
0.063 mm). 
 
All reactions in non-aqueous solvents were conducted in flame-dried glassware under a argon 
atmosphere and with magnetic stirring. Volumes of less than 0.2 mL were measured and 
dispensed with gastight syringes. Evaporation and concentration under reduced pressure was 
performed at 10-700 mbar at 40 °C. All pure products of reactions were dried under high 
vacuum (1 mbar). 
 
6.3  Chemicals and Reagents 
 
All reagents were obtained from commercial sources and used without further purification. 
All reactions were carried out under argon in flame-dried glassware and with magnetic 
stirring. The solvents used were purified by distillation over the drying agents indicated and 
were transferred under argon: tetrahydrofuran (sodium benzophenone ketyl), diethyl ether 
(sodium benzophenone ketyl), toluene (sodium), dichloromethane (CaH2) and dichloroethane 
(CaH2). Pyridine and triethylamine were distilled from CaH2 and were stored over 4 Å 
molecular sieves. N-bromosuccinimide was recrystallised from hot water and was dried 
thoroughly under high vacuum. Dess-Martin periodinane was prepared from 2-iodoxybenzoic 
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acid (IBX)85 following a known procedure.86 The following cooling bath were used; 0 °C 
(ice/water) and -78 °C (dry ice/acetone). 
 
6.4  Procedure and Characterisation 
 
6.4.1  Procedure and characterisation for Chapters 2, 3 and 4 
 
Aryltosylimine preparation: General procedure 1 (GP1):  
To a solution of aldehyde (10 mmol) in toluene (30 mL) were added 4-methyl-
benzenesulfonamide (9 mmol, 1.54 g), amberlyst 15 ion-exchange resin (1 g) and activated 
4Å powdered molecular sieve (1 g). The reaction mixture was heated at reflux (110 ºC) for 12 
h in a Dean-Stark apparatus. The temperature was cooled down to room temperature and the 
reaction mixture was filtered. The solvent was removed under reduced pressure and the 
residue was triturated with hexane. The crystals obtained were filtered off, washed with n-
pentane (2 × 40 mL) and dried to give pure imine. 
 
Preparation of propargylic alcohols from terminal alkynes and formaldehyde: General 
procedure 2 (GP2) 
n-BuLi (20 mmol, 8.0 mL of a 2.5M solution in hexane) was added dropwise to a solution of 
alkyne (20 mmol) in THF (80 mL) at -78 ºC. The reaction mixture was stirred 30 min at -78 
ºC before paraformaldehyde (20 mmol, 0.60 g) was added. The temperature was raised to 
room temperature and the reaction mixture stirred for 12 h. NH4Cl solution (50 mL) was 
added to quench the reaction and the THF was removed under reduced pressure. Et2O (40 
mL) was added and the phases were separated. The aqueous phase was washed with Et2O (3 × 
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40 mL) and the combined organic extracts were washed with brine (30 mL), dried (Na2SO4) 
and concentrated under reduced pressure. Purification by flash chromatography of the residue 
gave the corresponding propargylic alcohol. 
 
Formation of aziridines from imine and sulfonium salt: General Procedure 3 (GP 3): 
The corresponding sulfonium salt (1.2 mmol) and then the Cs2CO3 (1.2 mmol) were added 
sequentially to a solution of imine (1.0 mmol) in CH2Cl2 (10 mL). The reaction mixture was 
stirred at room temperature until completion and filtered through a pad of silica to remove the 
inorganic salts. The filtrate was then concentrated under reduced pressure and the residue was 
purified by flash chromatography to afford the alkynyl aziridine. 
 
AuCl3 catalysed pyrrole formation: General Procedure 4 (GP 4): 
To AuCl3 (0.01 mmol, 3.0 mg) under argon was added a solution of the corresponding 
aziridine (0.1 mmol) in toluene (0.2 mL) and the mixture was immediately heated at 50 °C. 
Stirring was maintened for the indicated time and a quick filtration through a pad of silica was 
performed using ethyl acetate. The solvents were removed under reduced pressure and the 
residue purified by flash chromatography [hexanes:ethyl acetate:triethylamine (25:1:1%)]. 
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Sonogashira coupling of aryliodides with propargyl alcohol: General procedure 5 (GP5) 
To a solution of aryliodide (25 mmol) in toluene (30 mL) at room temperature were added 
Pd(PPh3)2Cl2 (0.75 mmol, 530 mg), CuI (1.5 mmol, 285 mg) and piperidine (47.8 mmol, 4.72 
mL). After stirring 5 min at room temperature, propargyl alcohol (25.5 mmol, 1.48 mL) was 
added dropwise. The reaction mixture was then heated at 40 °C for 12h. After cooling down 
to room temperature, the reaction was filtered through a plug of silica, eluting with EtOAc. 
The filtrate was concentrated under reduced pressure and purification of the residue by flash 
chromatography gave pure propargylic alcohol. 
 
Gold-catalysed cycloisomerisations of alkynyl aziridines using Ph3PauCl/AgOTs: 
general procedure 6 (GP6):  
The catalyst system was prepared by addition of anhydrous ClCH2CH2Cl (0.5 mL) to 
Ph3PAuCl (0.01 mmol, 5.0 mg) and AgOTs (0.01 mmol, 2.8 mg) in a flame-dried Schlenk 
flask under argon. After stirring for 10 min at room temperature, a white precipitate of AgCl 
was observed and a solution of the corresponding acetylenyl aziridine (0.2 mmol) in 
anhydrous ClCH2CH2Cl (0.5 mL) was added. The reaction mixture was stirred at the 
indicated temperature until complete consumption of aziridine before being filtered through a 
pad of silica. The filtrate was then concentrated under reduced pressure. When required the 
residue was purified by flash chromatography as indicated. 
 
Gold-catalysed cycloisomerisations of alkynyl aziridines using Ph3PauCl/AgOTf: 
general procedure 7 (GP7):  
The catalyst system was prepared by addition of anhydrous CH2Cl2 (0.5 mL) to Ph3PAuCl 
(0.01 mmol, 5.0 mg) and AgOTf (0.01 mmol, 2.5 mg) in a flame-dried Schlenk flask under 
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argon. After stirring for 10 min at room temperature, a white precipitate of AgCl is observed 
and a solution of the corresponding acetylenyl aziridine (0.2 mmol) in anhydrous CH2Cl2 (0.5 
mL) was added. The reaction mixture was stirred at room temperature until complete 
consumption of aziridine before being filtered through a pad of silica. The filtrate was then 
concentrated under reduced pressure. The residue was purified by flash chromatography as 
indicated. 
 
Preparation of propargylic bromides from propargylic alcohols: General procedure 8 
(GP8) 
To a solution of PPh3 (1.1 equiv.) in CH2Cl2 at 0 °C was added Br2 (1.9 equiv.) dropwise. The 
reaction mixture was stirred for 20 min at 0 °C before a solution of alcohol (1 equiv.) in 
CH2Cl2 was added dropwise. The reaction mixture was warmed to room temperature and 
stirred for 1 h. Water (25 mL) was added to quench the reaction and the two phases were 
separated. The aqueous phase was washed with CH2Cl2 (3 × 20 mL) and the combined 
organic extracts were washed with brine (20 mL), dried (Na2SO4) and concentrated under 
reduced pressure. Purification by flash chromatography of the residue gave the corresponding 
propargylic bromide. 
 
Sulfonium salt preparation: General procedure 9 (GP9) 
Dimethylsulfide (15.0 mmol, 932 mg, 1.1 ml) was added to a solution of bromide (5 mmol) in 
acetone (5 mL) and the reaction mixture was stirred at room temperature for 3 days. A white 
solid was formed which was filtered off, washed with diethyl ether (4 × 10 mL) and dried to 
afford the corresponding pure sulfonium salt. 
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N-Benzylidene-4-methylbenzenesulfonamide (141) 
 
Following GP1 using benzaldehyde (1.06 g, 1.02 mL) gave imine 141 as a white solid (1.86 
g, 80%); mp 104-105 ºC; νmax (neat)/cm-1 2932, 2864, 1650, 1570,1415, 1381, 1320, 1280, 
1158, 1092, 1064, 960, 861, 820, 753; δH (300 MHz; CDCl3) 2.43 (3H, s, CH3), 7.34 (2H, d, J 
8.2, 2 × CH), 7.45-7.50 (2H, m, 2 × CH), 7.60-7.87 (5H, m, 5 × CH), 9.03 (1H, s, CH); δC (75 
MHz; CDCl3) 21.6 (CH3), 128.0 (2C, 2 × CH), 129.1 (2C, 2 × CH), 129.8 (2C, 2 × CH), 
131.2 (2C, 2 × CH), 132.3 (CH), 134.9 (Cquat), 136.6 (Cquat), 144.5 (Cquat), 170.1 (CH). 
 
Data were in agreement with those reported in the literature.87 
 
N-(1-Benzenesulfonyl-2-methyl-propyl)-4-methylbenzenesulfonamide (142) 
 
To a 1:1 mixture of water (50 mL) and formic acid (50 mL) were added 4-methyl-
benzenesulfonamide (34 mmol, 5.82 g,), 2-methylpropionaldehyde (40 mmol, 2.94 g, 2.3 mL) 
and sodium benzenesulfinate (40 mmol, 6.57 g). The reaction mixture was stirred for 12 h at 
room temperature and the resulting white precipitate was filtered off, washed with water (2 × 
35 mL) and then pentane (2 × 35 mL) to give pure 4-methylbenzene sulfonamide 142 as a 
white solid (11.32 g, 77%); 114-115 °C; νmax (neat)/cm-1 3298, 3056, 2967, 1342, 1306, 1166, 
1134, 1082, 1055, 886, 806; δH (300 MHz; CDCl3) 0.84 (3H, d, J 6.9, CH3), 1.04 (3H, d, J 
6.9, CH3), 2.40 (3H, s, CH3), 2.73 (1H, m, CH), 4.52 (1H, dd, J 10.7 and 3.2, CH), 5.17 (1H, 
d, J 10.7, NH), 7.17 (2H, d, J 8.2, 2 × CH), 7.45-7.51 (4H, m, 4 × CH), 7.62-7.66 (1H, m, 
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CH), 7.82 (2H, d, J 7.2, 2 × CH); δC (75 MHz; CDCl3) 16.5 (2C, 2 × CH3), 20.9 (CH), 21.5 
(CH3), 77.5 (CH), 126.6 (2C, 2 × CH), 129.1 (2C, 2 × CH), 129.3 (2C, 2 × CH), 129.6 (2C, 2 
× CH), 134.0 (CH), 137.0 (Cquat), 137.9 (Cquat), 143.7 (Cquat). 
 
N-(Benzenesulfonyl-cyclohexyl-methyl)-4-methylbenzenesulfonamide (143) 
 
To a 1:1 mixture of water (50 mL) and formic acid (50 mL) were added 4-methyl-
benzenesulfonamide (34 mmol, 5.82 g,), cyclohexanecarboxaldehyde (40 mmol, 4.49 g, 4.9 
mL) and sodium benzenesulfinate (40 mmol, 6.57 g). The reaction mixture was stirred for 12 
h at room temperature and the resulting white precipitate was filtered off, washed with water 
(2 × 35 mL) and then pentane (2 × 35 mL) to give pure 4-methylbenzene sulfonamide 143 as 
a white solid (12.69 g, 80%); 119-121 °C; νmax (neat)/cm-1 3300, 3056, 2934, 1446, 1337, 
1304, 1161, 1145, 1078, 1055, 810, 750; δH (300 MHz; CDCl3) 0.86-1.11 (2H, m, CH2), 1.15-
1.46 (2H, m, CH2), 1.49-2.01 (6H, m, 3 × CH2), 2.40 (3H, s, CH3), 4.48 (1H, dd, J 10.7 and 
3.4, CH), 5.52 (1H, d, J 10.7, NH), 7.16 (2H, d, J 8.0, 2 × CH), 7.44-7.53 (4H, m, 4 × CH), 
7.60-7.65 (1H, m, CH), 7.79-7.81 (2H, m, 2 × CH); δC (75 MHz; CDCl3) 21.5 (CH3), 25.5 
(2C, 2 × CH2), 25.7 (2C, 2 × CH2), 29.6 (CH2), 36.8 (CH), 77.2 (CH), 126.2 (2C, 2 × CH), 
128.7 (2C, 2 × CH), 128.9 (2C, 2 × CH), 129.2 (2C, 2 × CH), 133.5 (CH), 137.0 (Cquat), 137.8 
(Cquat), 143.2 (Cquat). 
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N-Isobutylidene-4-methyl-benzenesulfonamide (144) 
 
A Na2CO3 solution (70 mL) was added to a solution of 4-methylbenzenesulfonamide 142 (10 
mmol, 3.67 g) in CH2Cl2 (100 mL). The reaction mixture was stirred at room temperature for 
2 h and the two phases were separated. The aqueous phase was washed with CH2Cl2 (3 × 50 
mL) and the combined organic extracts were dried (Na2SO4) and concentrated under reduced 
pressure to give pure imine 144 as a white solid (2.02 g, 90%); mp 78-80 ºC; νmax (neat)/cm-1 
3305, 3066, 2971, 1632, 1601, 1458, 1313, 1161, 1140, 1088, 817, 749; δH (300 MHz; 
CDCl3) 1.20 (6H, d, J 7.2, 2 × CH3), 2.41 (3H, s, CH3), 2.72 (1H, m, CH), 7.31 (2H, d, J 8.2, 
2 × CH), 7.80 (2H, d, J 8.2, 2 × CH), 8.51 (1H, d, J 4.3, CH); δC (75 MHz; CDCl3) 17.9 (2C, 
2 × CH3), 21.5 (CH3), 34.6 (CH), 128.0 (2C, 2 × CH), 129.7 (2C, 2 × CH), 134.6 (Cquat), 
144.6 (Cquat), 181.8 (CH). 
 
Data were in agreement with those reported in the literature.55 
 
N-Cyclohexylmethylene-4-methyl-benzenesulfonamide (145) 
 
A Na2CO3 solution (70 mL) was added to a solution of 4-methylbenzenesulfonamide 143 (10 
mmol, 4.07 g) in CH2Cl2 (100 mL). The reaction mixture was stirred at room temperature for 
2 h and the two phases were separated. The aqueous phase was washed with CH2Cl2 (3 × 50 
mL) and the combined organic extracts were dried (Na2SO4) and concentrated under reduced 
pressure to give pure imine 145 as a white solid (2.39 g, 90%); mp 103-105 ºC; νmax 
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(neat)/cm-1 3307, 3062, 2960, 1630, 1602, 1452, 1385, 1310, 1180, 1159, 1130, 1092, 810, 
750, 690; δH (300 MHz; CDCl3) 1.16-1.37 (4H, m, 2 × CH2), 1.63-1.88 (6H, m, 3 × CH2), 
2.42-2.44 (4H, m, CH and CH3), 7.32 (2H, d, J 8.3, 2 × CH), 7.79 (2H, d, J 8.3, 2 × CH), 8.46 
(1H, d, J 4.4, CH); δC (75 MHz; CDCl3) 21.6 (CH3), 25.1 (2C, 2 × CH2), 25.6 (CH2), 28.4 
(2C, 2 × CH2), 43.7 (CH), 128.0 (2C, 2 × CH), 129.7 (2C, 2 × CH), 134.8 (Cquat), 144.5 
(Cquat), 181.0 (CH). 
 
Data were in agreement with those reported in the literature.55 
 
3-(Trimethylsilyl)-2-propyn-1-ol (146) 
 
n-BuLi (108 mmol, 43.2 mL of a 2.5M solution in hexane) was added dropwise to a solution 
of propargyl alcohol (54 mmol, 3.03 g, 3.1 mL) in THF (150 mL) at -78 ºC. The reaction 
mixture was stirred for 30 min at -78 ºC before TMSCl (157 mmol, 17.06 g, 20 mL) was 
added. The temperature was raised to room temperature and the reaction mixture stirred for 4 
h. NH4Cl solution (40 mL) was added to quench the reaction and the THF was removed under 
reduced pressure. Et2O (40 mL) was added and the phases were separated. The aqueous phase 
was washed with Et2O (3 × 40 mL) and the combined organic extracts were washed with 
brine (20 mL), dried (Na2SO4) and concentrated under reduced pressure. Purification by 
distillation under reduced pressure (95 ºC, 60 mmHg) gave alcohol 146 as a colourless liquid 
(6.36 g, 90%); νmax (neat)/cm-1 3342, 2960, 2180, 1255, 1043, 847, 701; δH (300 MHz; 
CDCl3) 0.17 (9H, s, 3 × CH3), 1.86 (1H, s, OH), 4.26 (2H, s, CH2); δC (75 MHz; CDCl3) -0.7 
(3C, 3 × CH3), 51.1 (CH2), 90.1 (Cquat), 103.1 (Cquat). 
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Data were in agreement with those reported in the literature.88 
 
1-Bromo-3-(trimethylsilyl)-2-propyne (147) 
 
Following GP8 using PPh3 (11 mmol, 2.88 g), Br2 (10.9 mmol, 0.55 mL) and alcohol 146 
(1.28 g) in CH2Cl2 (30 mL). Purification by flash chromatography (n-pentane) gave bromide 
147 as a colourless oil (1.62 g, 85%); νmax (neat)/cm-1 2970, 2172, 1247, 1219, 1039, 841, 
745; δH (300 MHz; CDCl3) 0.18 (9H, s, 3 × CH3), 3.91 (2H, s, CH2); δC (75 MHz; CDCl3) -
0.4 (3C, 3 × CH3), 14.5 (CH2), 92.3 (Cquat), 100.0 (Cquat). 
 
Data were in agreement with those reported in the literature89 
 
Dimethyl(3-(trimethylsilyl)prop-2-yn-1-yl)sulfonium bromide (140) 
 
Following GP9 using bromide 147 (955 mg) gave dimethyl(3-(trimethylsilyl)prop-2-yn-1-
yl)sulfonium bromide 140 (949 mg, 75%); mp 156-157 °C;νmax (neat)/cm-1 3013, 2918, 2181, 
1318, 1253, 1190, 1038, 991, 845, 761, 639 cm-1; δH (300 MHz; CDCl3) 0.22 (9H, s, 3 × 
CH3), 3.18 (6H, s, 2 × CH3), 4.93 (2H, s, CH2); δC (75 MHz; CDCl3) -0.7 (3C, 3 × CH3), 24.1 
(2C, 2 × CH3), 33.2 (CH2), 89.7 (Cquat), 97.5 (Cquat); HRMS m/z (TOF ES+) 173.0819. 
C8H17SSi requires 173.0815.  
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2-Prop-2-ynyloxy-tetrahydropyran (148) 
 
Dihydropyran (50 mmol, 4.21 g, 4.6 mL) and p-toluenesulfinic acid monohydrate (1 mmol, 
0.20 g) were added to a solution of propargylic alcohol (50 mmol, 2.80 g, 2.9 mL) in CH2Cl2 
(30 mL) at 0 ºC. After 30 min the reaction mixture was allowed to stirr at to room 
temperature. After 3 h the reaction was quenched by the addition of Na2CO3 solution (15 mL). 
The phases were separated and the aqueous phase was washed with CH2Cl2 (3×15 mL). The 
combined organic extracts were washed with brine (15 mL), dried (Na2SO4) and concentrated 
under reduced pressure. Purification of the residue by flash chromatography 
[hexane:ethylacetate (20:1)] gave ether 148 as colourless oil (6.460 g, 92%); νmax (neat)/cm-1 
3288, 2941, 2873, 2121, 1445, 1387, 1263, 1181, 1122, 1020, 959, 899, 667; δH (300 MHz; 
CDCl3) 1.52-1.88 (6H, m, 3 × CH2), 2.41 (1H, m, CH), 3.50-3.57 (1H, m, CH), 3.80-3.88 
(1H, m, CH), 4.26 (2H, dd, J 15.0 and 2.5, 2 × CH), 4.82 (1H, m, CH); δC (75 MHz; CDCl3) 
19.0 (CH2), 25.3 (CH2), 30.2 (CH2), 54.0 (CH2), 61.8 (CH2), 73.8 (CH), 79.5 (Cquat), 96.6 
(CH). 
 
Data were in agreement with those reported in the literature.90 
 
Triethyl(3-(tetrahydro-2H-pyran-2-yloxy)prop-1-ynyl)silane (149) 
 
n-BuLi (7.05 mmol, 2.8 mL of a 2.5M solution in hexane) was added dropwise to a solution 
of protected alcohol 148 (7.13 mmol, 1.0 g) in THF (20 mL) at -78 ºC. The reaction mixture 
was stirred for 30 min at -78 ºC before TESCl (6.41 mmol, 1.08 mL) was added. The 
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temperature was raised to room temperature and the reaction mixture stirred for 4 h. NH4Cl 
solution (20 mL) was added to quench the reaction and the THF was removed under reduced 
pressure. Et2O (30 mL) was added and the phases were separated. The aqueous phase was 
washed with Et2O (3 × 30 mL) and the combined organic extracts were washed with brine (15 
mL), dried (Na2SO4) and concentrated under reduced pressure. Purification of the residue by 
flash chromatography [hexane:ethylacetate (20:1)] gave ether 149 as a pale yellow liquid 
(1.76 g, 97%); δH (300 MHz; CDCl3) 0.60 (6H, q, J 8.0 and 7.7, 3 × CH2), 0.98 (9H, t, J 8.0 
and 7.7, 3 × CH3), 1.50-1.88 (6H, m, 2 × CH3), 3.44-3.56 (1H, m, CH), 3.81-3.89 (1H, m, 
CH), 4.29 (2H, s, CH2), 4.86 (1H, m, CH); δC (75 MHz; CDCl3) 4.4 (3C, 3 × CH2), 7.8 (3C, 3 
× CH3), 18.8 (CH2), 25.2 (CH2), 30.1 (CH2), 54.0 (CH2), 61.8 (CH2), 90.1 (Cquat), 96.8 (CH), 
103.2 (Cquat); HRMS m/z (TOF ES+) 277.1602. C14H26O2NaSi requires 277.1600. 
 
3-(Bromo-prop-1-ynyl)-triethylsilane (150) 
 
Following GP8 using PPh3 (7.6 mmol, 1.99 g), Br2 (7.5 mmol, 0.38 mL) and ether 149 (1.76 
g) in CH2Cl2 (20 mL). Purification by flash chromatography (n-pentane) gave bromine 150 as 
a colourless oil (1.75 g, 75%); νmax (neat)/cm-1 2959, 2914, 2176, 1456, 1413, 1235, 1038, 
1019, 955, 895; δH (300 MHz; CDCl3) 0.61 (6H, q, J 7.7, 3 × CH2), 0.99 (9H, t, J 7.7, 3 × 
CH3), 3.93 (2H, s, CH2); δC (75 MHz; CDCl3) 4.5 (3C, 3 × CH2), 7.6 (3C, 3 × CH3), 14.8 
(CH2), 89.6 (Cquat), 100.3 (Cquat). 
 
Data were in agreement with those reported in the literature.91 
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Dimethyl(3-(triethylsilyl)prop-2-yn-1-yl)sulfonium bromide (151) 
 
Following GP9 using bromide 150 (1.166 g) gave sulfonium salt 151 as a white solid (886 
mg, 60%); mp 149-150 °C; νmax (neat)/cm-1 3013, 2918, 2181, 1318, 1253, 1190, 1038, 991, 
845, 761, 639; δH (300 MHz; CDCl3) 0.61 (6H, q, J 7.7, 3 × CH2), 0.96 (9H, t, J 7.7, 3 × 
CH3), 3.21 (6H, s, 2 × CH3), 5.06 (2H, s, CH2); δC (75 MHz; CDCl3) 4.0 (3C, 3 × CH2), 7.4 
(3C, 3 × CH3), 24.4 (2C, 2 × CH3), 33.7 (CH2), 90.9 (Cquat), 95.4 (Cquat); HRMS m/z (TOF 
ES+) 215.1291. C11H23SSi requires 215.1284. 
 
cis-2-Phenyl-1-(toluene-4-sulfonyl)-3-((trimethylsilyl)ethynyl)aziridine (152) 
N
S OO
Si
 
Following GP3 using imine 141 and sulfonium salt 140 for 1 h. Purification by flash 
chromatography [hexane:ethylacetate:triethylamine (20:1:1%)] gave cis-aziridine 152 as a 
yellow solid (258 mg, 70%); mp 80-81 °C; νmax (neat)/cm-1 3028, 2850, 2176, 1586, 1444, 
1326, 1251, 1160, 860, 795, 650; δH (300 MHz; CDCl3) -0.01 (9H, s, 3 × CH3), 2.43 (3H, s, 
CH3), 3.63 (1H, d, J 6.9, CH), 3.94 (1H, d, J 6.9, CH), 7.27-7.35 (7H, m, 7 × CH), 7.87 (2H, 
d, J 8.3, 2 × CH); δC (75 MHz; CDCl3) -0.7 (3C, 3 × CH3), 21.7 (CH3), 35.9 (CH), 46.4 (CH), 
91.5 (Cquat), 97.4 (Cquat), 127.9 (4C, 4 × CH), 128.0 (2C, 2 × CH), 128.4 (CH), 129.9 (2C, 2 × 
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CH), 131.9 (Cquat), 134.5 (Cquat), 144.9 (Cquat); HRMS m/z (TOF ES+) 392.1112. 
C20H23NO2NaSSi requires 392.1116. 
 
cis-2-Isopropyl-1-(toluene-4-sulfonyl)-3-((trimethylsilyl)ethynyl)aziridine (139) 
N
S OO
Si
 
Following GP3 using imine 144 and sulfonium salt 140 for 3 h. Purification by flash 
chromatography [hexane:ethylacetate:triethylamine (25:1:1%)] gave cis-aziridine 139 as a 
white solid (235 mg, 70%); mp 59-61 °C; νmax (neat)/cm-1 2966, 2913, 2178, 1601, 1472, 
1405, 1351, 1322, 1308, 1291, 1250, 1154, 1092, 1076, 945, 873, 840, 814, 759; δH (300 
MHz; CDCl3) 0.12 (9H, s, 3 × CH3), 0.79 (3H, d, J 6.8, CH3), 0.98 (3H, d, J 6.8, CH3), 1.50-
1.60 (1H, m, CH), 2.45 (3H, s, CH3), 2.49 (1H, dd, J 6.9 and 2.6, CH), 3.38 (1H, d, J 6.9, 
CH), 7.34 (2H, d, J 8.3, 2 × CH), 7.84 (2H, d, J 8.3, 2 × CH); δC (75 MHz; CDCl3) -0.4 (3C, 3 
× CH3), 18.4 (CH3), 20.1 (CH3), 21.7 (CH3), 28.4 (CH), 33.9 (CH), 51.0 (CH), 90.0 (Cquat), 
97.9 (Cquat), 128.2 (2C, 2 × CH), 129.6 (2C, 2 ×CH), 134.6 (Cquat), 144.7 (Cquat); HRMS m/z 
(TOF ES+) 358.1281. C17H21NO2NaS requires 358.1273. 
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cis-2-Isopropyl-1-(toluene-4-sulfonyl)-3-((triethylsilyl)ethynyl)aziridine (153) 
N
S OO
Si
 
Following GP3 using imine 144 and sulfonium salt 151 for 3 h. Purification by flash 
chromatography [hexane:ethylacetate:triethylamine (25:1:1%)] gave cis-aziridine 153 as a 
white solid (302 mg, 80%); mp 49-50 °C; νmax (neat)/cm-1 3047, 2958, 2875, 2230, 1323, 
1160, 1093, 876, 725; δH (300 MHz; CDCl3) 0.55 (6H, q, J 8.0, 3 × CH2), 0.81 (3H, d, J 6.7, 
CH3), 0.93 (9H, t, J 8.0, 3 × CH3), 0.98 (3H, d, J 6.7, CH3), 1.58-1.65 (1H, m CH), 2.44 (3H, 
s, CH3), 2.51 (1H, dd, J 9.7 and 6.9, CH), 3.37 (1H, d, J 6.9, CH), 7.33 (2H, d, J 8.3, 2 × CH), 
7.83 (2H, d, J 8.3, 2 × CH); δC (75 MHz; CDCl3) 4.1 (3C, 3 × CH2), 7.3 (3C, 3 × CH3), 18.5 
(CH3), 20.2 (CH3), 21.7 (CH3), 28.5 (CH), 34.0 (CH), 51.0 (CH), 87.5 (Cquat), 99.0 (Cquat), 
128.1 (2C, 2 ×CH), 129.6 (2C, 2 × CH), 134.7 (Cquat), 144.6 (Cquat); HRMS m/z (TOF ES+) 
400.1733. C20H31NO2NaS requires 400.1742. 
 
cis-2-Cyclohexyl-1-(toluene-4-sulfonyl)-3-((trimethylsilyl)ethynyl)aziridine (154) 
N
S OO
Si
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Following GP3 using imine 145 and sulfonium salt 140 for 3 h. Purification by flash 
chromatography [hexane:ethylacetate:triethylamine (20:1:1%)] gave cis-aziridine 154 as a 
beige solid (319 mg, 85%); mp 76-77 °C; νmax (neat)/cm-1 2937, 2902, 2852, 2178, 1598, 
1448, 1410, 1368, 1326, 1245, 1222, 1158, 1135, 1089, 1061, 958, 838, 824, 815, 749, 701; 
δH (300 MHz; CDCl3) 0.13 (9H, s, 3 × CH3), 0.90-1.34 (6H, m, 3 × CH2), 1.43-1.79 (5H, m , 
2 × CH2 and CH), 2.43 (3H, s, CH3), 2.55 (1H, dd, J 6.9 and 2.6, CH), 3.35 (1H, d, J 6.9, 
CH), 7.33 (2H, d, J 8.2, CH2), 7.83 (2H, d, J 8.2, CH2); δC (75 MHz; CDCl3) -0.5 (3C, 3 × 
CH3), 21.6 (CH3), 25.2 (CH2), 25.4 (CH2), 25.9 (CH2), 28.8 (CH2), 30.3 (CH2), 33.4 (CH), 
37.3 (CH), 49.3 (CH), 89.7 (Cquat), 98.0 (Cquat), 128.0 (2C, 2 × CH), 129.6 (2C, 2 × CH), 
134.4 (Cquat), 144.6 (Cquat); HRMS m/z (TOF ES+) 398.1590. C20H29NO2NaSSi requires 
398.1586. 
 
cis-2-Bromoethynyl-3-phenyl-1-(toluene-4-sulfonyl)aziridine (155) 
N
S OO
Br
 
Silver nitrate (0.07 mmol, 12 mg) and NBS (0.77 mmol, 136 mg) were added to a solution of 
aziridine 152 (0.70 mmol, 258 mg) in acetone (10 mL) and the mixture was stirred at room 
temperature for 1 h. Water (10 mL) was added and the organic phase was separated. The 
aqueous phase was extracted with ethyl acetate (3 × 10 mL). The combined organics were 
dried over Na2SO4, filtered and the solvent was removed under reduced pressure. The residue 
was then purified by flash chromatography [hexane:ethyl acetate:triethylamine (8:1:1%)] to 
give cis-aziridine 155 as a white solid (210 mg, 80%); mp 90-92 °C; νmax (neat)/cm-1 3047, 
150 
2858, 2190, 1550, 1401, 1323, 1164, 876, 790, 672; δH (300 MHz; CDCl3) 2.44 (3H, s, CH3), 
3.64 (1H, d, J 6.8, CH), 3.97 (1H, d, J 6.8, CH), 7.31-7.36 (7H, m, 7 × CH), 7.87 (2H, d, J 
8.3, 2 × CH); δC (75 MHz; CDCl3) 21.7 (CH3), 36.2 (CH), 46.0 (CH), 48.4 (Cquat), 72.5 
(Cquat), 127.6 (2C, 2 × CH), 127.9 (2C, 2 × CH), 128.2 (2C, 2 × CH), 128.6 (CH), 129.9 (2C, 
2 ×CH), 131.6 (Cquat), 134.4 (Cquat), 145.1 (Cquat); HRMS m/z (TOF ES+) 397.9837. 
C17H14NO2NaS79Br requires 397.9826. 
 
cis-2-Bromoethynyl-3-isopropyl-1-(toluene-4-sulfonyl)-aziridine (138) 
N
S OO
Br
 
Silver nitrate (0.07 mmol, 12 mg) and NBS (0.77 mmol, 136 mg) were added to a solution of 
aziridine 139 (0.70 mmol, 234 mg) in acetone (10 mL) and the mixture was stirred at room 
temperature for 1 h. Water (10 mL) was added and the organic phase was separated. The 
aqueous phase was extracted with ethyl acetate (3 × 10 mL). The combined organics were 
dried over Na2SO4, filtered and the solvent was removed under reduced pressure. The residue 
was then purified by flash chromatography [hexane:ethyl acetate:triethylamine (15:1:1%)] to 
give cis-aziridine 138 as a white solid (191 mg, 80%); mp 71-72 °C; νmax (neat)/cm-1 3050, 
2963, 2145, 1326, 1164, 1089, 941, 873, 829, 815, 758; δH (300 MHz; CDCl3) 0.81 (3H, d, J 
6.8, CH3), 0.99 (3H, d, J 6.8, CH3), 2.45 (3H, s, CH3), 2.52 (1H, dd, J 6.8 and 2.9, CH), 3.38 
(1H, d, J 6.8, CH), 7.35 (2H, d, J 8.3, 2 × CH), 7.83 (2H, d, J 8.3, 2 × CH); δC (75 MHz; 
CDCl3) 18.7 (CH3), 20.1 (CH3), 21.7 (CH3), 28.4 (CH), 34.1 (CH), 44.5 (CH), 50.8 (Cquat), 
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73.1 (Cquat), 128.2 (2C, 2 × CH), 129.7 (2C, 2 × CH), 134.3 (Cquat), 144.9 (Cquat); HRMS m/z 
(TOF ES+) 363.9992. C14H16NO2NaS79Br requires 363.9983. 
 
4-bromo-2-isopropyl-1-(toluene-4-sulfonyl)-1H-pyrrole (156). 
N
Br
S OO
 
Following GP4 using aziridine 138 (34 mg) for 2 h gave a pyrroles 156 as a brown oil (5 mg, 
15%); νmax (neat)/cm-1 3002, 2971, 1588, 1359, 1181, 715, 678. δH (300 MHz; CDCl3) 1.09 
(6H, d, J 6.8, 2 × CH3), 2.41 (3H, s, CH3), 3.26 (1H, sept, J 6.8, CH), 6.02 (1H, d, J 1.9, CH), 
7.25 (1H, d, J 1.9, CH), 7.30 (2H, d, J 8.3, 2 × CH), 7.63 (2H, d, J 8.3, 2 × CH); δC (75 MHz; 
CDCl3) 21.4 (CH3), 23.4 (2C, 2 × CH3), 26.1 (CH), 100.4 (Cquat), 112.5 (CH), 120.5 (CH), 
126.5 (2C, 2 × CH), 129.8 (2C, 2 × CH), 135.9 (Cquat), 143.6 (Cquat), 144.9 (Cquat); HRMS m/z 
(TOF ES+) 363.9980. C14H16NO2NaS79Br requires 363.9983. 
 
2-Isopropyl-1-(toluene-4-sulfonyl)-1H-pyrrole (158). 
N
S OO
 
Following GP4 using aziridine 138 (34 mg) for 2 h gave 158 as a white solid (16 mg, 60%). 
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Following GP4 using aziridine 154 (34 mg) for 4 h gave 158 as a white solid (21 mg, 80%). 
Following GP6 using aziridine139 at 70 °C for 12 h or aziridine 153 at 70 °C for 12 h gave 
pyrrole 158 as a white solid (51 mg, 98%); mp 85-86 °C; νmax (neat)/cm-1 3010, 2967, 2871, 
1597, 1366, 1179, 1189, 812, 704, 682; δH (300 MHz; CDCl3) 1.13 (6H, d, J 6.7, 2 × CH3), 
2.41 (3H, s, CH3), 3.29 (1H, sept, J 6.7, CH), 6.05 (1H, m, CH), 6.22 (1H, dd, J 3.4 and 3.3, 
CH), 7.26 (1H, dd, J 3.3 and 1.6, CH), 7.28 (2H, d, J 8.3, 2 × CH), 7.61 (2H, d, J 8.3, 2 × 
CH); δC (75 MHz; CDCl3) 21.6 (CH3), 23.8 (2C, 2 × CH3), 26.3 (CH), 109.8 (CH), 111.4 
(CH), 122.2 (CH), 126.5 (2C, 2 × CH), 129.9 (2C, 2 × CH), 136.9 (Cquat), 143.1 (Cquat), 144.6 
(Cquat); HRMS m/z (TOF ES+) 286.0874. C14H17NO2NaS requires 286.0878. 
 
2-Isopropyl-1-(toluene-4-sulfonyl)-4-(trimethylsilyl)-1H-pyrrole (159) 
N
S OO
Si
 
Following GP4 using aziridine 139 (34 mg) for 1 h gave a mixture of pyrroles 159 and 158 
(25 mg, 1.7:1 159:158); νmax (neat)/cm-1 3013, 2976, 1591, 1369, 1254, 1185, 818, 711, 681. 
2-Isopropyl-1-(toluene-4-sulfonyl)-4-(trimethylsilyl)-1H-pyrrole: δH (300 MHz; CDCl3) 
0.19 (9H, s, 3 × CH3), 1.13 (6H, d, J 6.8, 2 × CH3), 2.42 (3H, s, CH3), 3.25 (1H, sept, J 6.8, 
CH), 6.07 (1H, d, J 1.7, CH), 7.27 (1H, d, J 1.7, CH), 7.30 (2H, d, J 8.3, 2 × CH), 7.62 (2H, d, 
J 8.3, 2 × CH); δC (75 MHz; CDCl3) -0.7 (3C, 3 × CH3), 21.6 (CH3), 23.8 (2C, 2 × CH3), 26.2 
(CH), 113.7 (CH), 121.3 (Cquat), 126.5 (2C, 2 × CH), 127.0 (CH), 129.7 (2C, 2 × CH), 137.1 
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(Cquat), 143.6 (Cquat), 144.5 (Cquat); HRMS m/z (TOF ES+) 358.1271. C17H25NO2NaSSi 
requires 358.1273. 
 
2-Isopropyl-1-(toluene-4-sulfonyl)-4-(triethylsilyl)-1H-pyrrole (161) 
N
S OO
Si
 
Following GP4 using aziridine bd (38 mg) for 1 h gave a mixture of pyrroles 161 and 158 (26 
mg, 80%, 1.3:1 161:158); νmax (neat)/cm-1 3020, 2988, 1596, 1390, 1375, 1260, 1180, 825, 
715. 2-Isopropyl-1-(toluene-4-sulfonyl)-4-(triethylsilyl)-1H-pyrrole: δH (300 MHz; CDCl3) 
0.67 (6H, q, J 7.5, 3 × CH2), 0.93 (9H, t, J 7.5, 3 × CH3), 1.09 (6H, d, J 6.8, 2 × CH3), 2.38 
(3H, s, CH3), 3.21 (1H, sept, J 6.8, CH), 6.00 (1H, d, J 1.6, CH), 7.23 (1H, d, J 1.6, CH), 7.25 
(2H, d, J 8.4, 2 × CH), 7.55 (2H, d, J 8.4, 2 × CH); δC (75 MHz; CDCl3) 3.7 (3C, 3 × CH2), 
7.4 (3C, 3 × CH3), 21.5 (CH3), 23.8 (2C, 2 × CH3), 26.2 (CH), 114.3 (CH), 117.9 (Cquat), 
126.3 (2C, 2 × CH), 128.1 (CH), 129.8 (2C, 2 × CH), 136.9 (Cquat), 143.5 (Cquat), 144.4 
(Cquat); HRMS m/z (TOF ES+) 400.1739. C20H31NO2NaSSi requires 400.1742. 
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2-cyclohexyl-1-(toluene-4-sulfonyl)-4-(trimethylsilyl)-1H-pyrrole (162) 
N
S OO
Si
 
Following GP4 using aziridine 154 (38 mg) for 1 h gave a mixture of pyrroles 162 and 163 
(21 mg, 60%, 2:1 162:162); νmax (neat)/cm-1 3012, 2963, 1596, 1456, 1368, 1252, 1188, 990, 
815, 711, 688. 2-cyclohexyl-1-(toluene-4-sulfonyl)-4-(trimethylsilyl)-1H-pyrrole: δH (300 
MHz; CDCl3) 0.19 (9H, s, 3 × CH3), 1.07-1.34 (6H, m, 3 × CH2), 1.60-1.80 (4H, m, 2 × CH2), 
2.40 (3H, s, CH3), 2.87 (1H, t, J 10.8, CH), 6.01 (1H, d, J 1.7, CH), 7.23 (1H, d, J 1.7, CH), 
7.28 (2H, d, J 8.3, 2 × CH), 7.63 (2H, d, J 8.3, 2 × CH); δC (75 MHz; CDCl3) -0.7 (3C, CH3), 
21.5 (CH3), 26.0 (CH2), 26.7 (2C, 2 × CH2), 34.4 (2C, 2 × CH2), 36.0 (CH), 113.9 (CH), 
121.0 (Cquat), 126.6 (3C, 3 × CH), 129.8 (2C, 2 × CH), 136.8 (Cquat), 142.5 (Cquat), 144.5 
(Cquat); HRMS m/z (TOF ES+) 398.1580. C20H29NO2NaSSi requires 398.1586. 
 
2-Cyclohexyl-1-(toluene-4-sulfonyl)-1H-pyrrole (163) 
N
S OO
 
Following GP4 using aziridine 154 (38 mg) for 4 h gave pyrrole 163 as a white solid (23 mg, 
76%). 
Following GP6 using aziridine 154 at 70 °C for 12 h gave pyrrole 163 as a white solid (59 
mg, 98%); mp, 70-72 °C; νmax (neat)/cm-1 3015, 2969, 2873, 1599, 1450, 1362, 1188, 1181, 
155 
810, 701, 684; δH (300 MHz; CDCl3) 1.09-1.38 (6H, m, 3 × CH2), 1.64-1.83 (4H, m, 2 × 
CH2), 2.44 (3H, s, CH3), 2.94 (1H, t, J 11.0, CH), 6.04 (1H, dd, J 3.4 and 1.7, CH), 6.24 (1H, 
dd, J 3.4 and 3.3, CH), 7.27 (1H, dd, J 3.3 and 1.7, CH), 7.31 (2H, d, J 8.3, 2 × CH), 7.65 
(2H, d, J 8.3, 2 × CH); δC (75 MHz; CDCl3) 21.5 (CH3), 25.9 (CH2), 26.6 (2C, 2 × CH2), 34.4 
(2C, 2 × CH2), 36.0 (CH), 110.1 (CH), 111.3 (CH), 121.8 (CH), 126.5 (2C, 2 × CH), 129.8 
(2C, 2 × CH), 136.8 (Cquat), 142.0 (Cquat), 144.6 (Cquat); HRMS m/z (TOF ES+) 326.1187. 
C17H21NO2NaS requires 326.1191. 
 
Data were in agreement with those reported in the literature.69 
 
N-(2-bromobenzylidene)-4-methylbenzenesulfonamide (164) 
 
Following GP1 using 2-bromobenzaldehyde (1.85 g, 1.16 mL) gave imine 164 as a white 
solid (2.68 g, 88%); mp 137-138 ºC; νmax (neat)/cm-1 3002, 2854, 1643, 1582,1428, 1376, 
1315, 1260, 1150, 1088, 952, 860, 749; δH (300 MHz; CDCl3) 2.43 (3H, s, CH3), 7.35 (2H, d, 
J 8.4, 2 × CH), 7.40-7.50 (2H, m, 2 × CH), 7.62 (1H, dd, J 7.9 and 1.6, CH), 7.88 (2H, d, J 
8.4, 2 × CH), 9.43 (1H, s, CH); δC (75 MHz; CDCl3) 21.6 (CH3), 126.3 (CH), 127.9 (2C, 2 × 
CH), 127.9 (Cquat), 129.5 (CH), 130.5 (2C, 2 × CH), 131.1 (Cquat), 133.7 (CH), 134.5 (Cquat), 
135.7 (CH), 144.9 (Cquat), 169.2 (CH). 
 
Data were in agreement with those reported in the literature.92 
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N-(4-bromobenzylidene)-4-methylbenzenesulfonamide (165) 
 
Following GP1 using 4-bromobenzaldehyde (1.85 g) gave imine 165 as a white solid (2.44 g, 
80%); mp 188-190 ºC; νmax (neat)/cm-1 3066, 2986, 2909, 1649, 1599,1585, 1481, 1315, 
1302, 1282, 1158, 1087, 1064, 1008, 868, 812, 704; δH (300 MHz; CDCl3) 2.46 (3H, s, CH3), 
7.36 (2H, d, J 8.0, 2 × CH), 7.64 (2H, d, J 7.7, 2 × CH), 7.81 (2H, d, J 8.0, 2 × CH), 7.90 (2H, 
d, J 7.7, 2 × CH), 9.00 (1H, s, CH); δC (75 MHz; CDCl3) 21.6 (CH3), 128.2 (2C, 2 × CH), 
129.9 (2C, 2 × CH), 130.2 (Cquat), 131.2 (Cquat), 132.4 (2C, 2 × CH), 132.6 (2C, 2 × CH), 
133.6 (Cquat), 144.8 (Cquat), 168.8 (CH). 
 
Data were in agreement with those reported in the literature.87 
 
4-methyl-N-(4-methylbenzylidene)benzenesulfonamide (166) 
 
Following GP1 using 4-methylbenzaldehyde (1.20 g, 1.18 mL) gave imine 166 as a white 
solid (2.09 g, 85%); mp 103-104 ºC; νmax (neat)/cm-1 3044, 1593, 1561, 1512, 1367, 1314, 
1302, 1288, 1155, 1085, 1019, 874, 790, 761; δH (300 MHz; CDCl3) 2.43 (6H, s, 2 × CH3), 
7.28 (2H, d, J 7.9, 2 × CH), 7.34 (2H, d, J 7.9, 2 × CH), 7.81 (2H, d, J 8.2, 2 × CH), 7.88 (2H, 
d, J 8.2, 2 × CH), 9.00 (1H, CH); δC (75 MHz; CDCl3) 21.6 (CH3), 22.0 (CH3), 128.0 (2C, 2 × 
CH), 129.7 (2C, 2 × CH), 129.9 (2C, 2 × CH), 131.4 (2C, 2 × CH), 135.4 (Cquat), 144.4 (2C, 2 
× Cquat), 146.4 (2C, 2 × Cquat). 
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N-(4-methoxylbenzylidene)-4-methylbenzenesulfonamide (167) 
 
Following GP1 using 4-methoxylbenzaldehyde (1.36 g, 1.22 mL) gave imine 167 as a white 
solid (2.08 g, 80%); mp 123-125 ºC; νmax (neat)/cm-1 3023, 2970, 1657, 1578,1420, 1327, 
1279, 1164, 1088, 965, 869, 850, 757, 656; δH (300 MHz; CDCl3) 2.43 (3H, s, CH3), 3.89 
(3H, s, CH3), 6.98 (2H, d, J 8.3, 2 × CH), 7.32 (2H, d, J 8.3, 2 × CH), 7.85-7.91 (4H, m, 4 × 
CH), 8.95 (1H, s, CH); δC (75 MHz; CDCl3) 21.6 (CH3), 55.9 (CH3), 114.7 (2C, 2 × CH), 
125.2 (Cquat), 127.9 (2C, 2 × CH), 129.7 (2C, 2 × CH), 133.7 (2C, 2 × CH), 135.3 (Cquat), 
144.3 (Cquat), 165.3 (Cquat), 169.2 (CH). 
 
Data were in agreement with those reported in the literature.87 
 
4-methyl-N-pentylidenebenzenesulfonamide (168) 
 
 
To a 1:1 mixture of water (15 mL) and formic acid (15 mL) were added 4-methyl-
benzenesulfonamide (9 mmol, 1.54 g,), valeraldehyde (10 mmol, ) and sodium 
benzenesulfinate (10 mmol, 1.64 g). The reaction mixture was stirred for 12 h at room 
temperature and the resulting white precipitate was filtered off, washed with water (2 × 10 
mL) and then pentane (2 × 10 mL). The solid was dissolved in CH2Cl2 (25 mL) and a Na2CO3  
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solution was added (20 mL). The reaction mixture was stirred at room temperature for 2h and 
the two phases were separated. The aqueous phase was washed with CH2Cl2 and the 
combined organic extracts were dried (Na2SO4) and concentrated under reduced pressure to 
give pure imine 168 as a beige solid (1.50 g, 70%); mp 92-95 ºC; νmax (neat)/cm-1 3992, 3050, 
2956, 1633, 1600, 1453, 1369, 1320, 1151, 1117, 1086, 807, 754, 688; δH (300 MHz; CDCl3) 
0.91 (3H, t, J 7.3, CH3), 1.35 (2H, m, CH2), 1.62 (2H, m, CH2), 2.45 (3H, m, CH3), 2.53 (2H, 
m, CH2), 7.35 (2H, d, J 8.0, 2 × CH), 7.81 (2H, d, J 8.0, 2 × CH), 8.58 (1H, d, J 4.5, CH); δC 
(75 MHz; CDCl3) 13.6 (CH3), 21.5 (CH3), 22.3 (CH2), 26.7 (CH2), 35.6 (CH2), 128.0 (2C, 2 × 
CH), 129.7 (2C, 2 × CH), 134.7 (Cquat), 144.6 (Cquat), 178.8(CH). 
 
Data were in agreement with those reported in the literature.55 
 
3-phenylprop-2-yn-1-ol (169) 
 
Following GP2 using phenylacetylene (2.04 g, 2.19 mL). Purification by flash 
chromatography [hexane:ethylacetate (4:1)] gave alcohol 169 as a colourless oil (2.37 g, 
90%); νmax (neat)/cm-1 3345, 2923, 2875, 2863, 2240, 1601, 1499, 1115, 1033, 960, 785, 726; 
δH (300 MHz; CDCl3) 3.12 (1H, s, OH), 4.53 (2H, s, CH2), 7.24-7.39 (3H, m, 3 × CH), 7.42-
7.51 (2H, m, 2 × CH); δC (75 MHz; CDCl3) 51.3 (CH2), 85.4 (Cquat), 87.3 (Cquat), 122.5 
(Cquat), 128.2 (2C, 2 × CH), 128.3 (2C, 2 × CH), 131.5 (CH). 
 
Data were in agreement with those reported in the literature.93 
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3-Cyclohexylprop-2-yn-1-ol (170) 
 
Following GP2 using cyclohexylacetylene (2.16 g, 2.61 mL). Purification by flash 
chromatography [hexane:ethylacetate (3:1)] gave alcohol 170 as a colourless oil (2.35 g, 
85%); νmax (neat)/cm-1 3345, 2933, 2866, 2655, 2289, 1450, 1368, 1360, 1302, 1244, 1136, 
1079, 982, 860, 765; δH (300 MHz; CDCl3) 1.20-1.58 (6H, m, 3 × CH2), 1.62-1.85 (4H, m, 2 
× CH2), 2.36 (1H, m, CH), 4.24 (2H, s, CH2); δC (75 MHz; CDCl3) 24.9 (2C, 2 × CH2), 25.8 
(CH2), 29.1 (CH), 32.6 (2C, 2 × CH2), 51.5 (CH2), 78.2 (Cquat), 90.7 (Cquat). 
 
Data were in agreement with those reported in the literature.93 
 
5-phenylpent-2-yn-1-ol (171) 
 
Following GP2 using 4-phenyl-1-butyne (2.60 g, 2.81 mL). Purification by flash 
chromatography [hexane:ethylacetate (6:1)] gave alcohol 171 as a colourless oil (2.75 g, 
86%); νmax (neat)/cm-1 3360, 3091, 3061, 2955, 2286, 2230, 1605, 1523, 1497, 1155, 1011, 
955, 736, 712; δH (300 MHz; CDCl3) 1.53 (1H, s, OH), 2.50-2.59 (2H, m, CH2), 2.90 (2H, t, J 
7.6, CH2), 4.28 (2H, t, J 2.0, CH2), 7.23-7.35 (3H, m, 3 × CH), 7.36-7.42 (2H, m, 2 × CH); δC 
(75 MHz; CDCl3) 20.9 (CH2), 35.0 (CH2), 51.4 (CH2), 79.1 (Cquat), 85.8 (Cquat), 126.3 (2C, 2 
× CH), 128.4 (3C, 3 × CH), 140.5 (Cquat); HRMS m/z (TOF EI+) 160.0892. C11H12O requires 
160.0888. 
 
Data were in agreement with those reported in the literature.93 
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Hept-2-yn-1-ol (172) 
 
Following GP2 using hex-1-yne (1.64 g, 2.30mL). Purification by flash chromatography 
[hexane:ethylacetate (5:1)] gave alcohol 172 as a colourless oil (2.37 g, 87%); νmax (neat)/cm-1 
3355, 2930, 2885, 2226, 1459, 1139, 1011, 816, 731; δH (300 MHz; CDCl3) 0.91 (3H, t, J 7.2, 
CH3), 1.34-1.54 (4H, m, 2 × CH2), 2.10 (1H, s, OH), 2.20 (2H, t, J 6.8, CH2), 4.25 (2H, m, 
CH2); δC (75 MHz; CDCl3) 13.6 (CH3), 18.4 (CH2), 21.8 (CH2), 30.7 (CH2), 51.5 (CH2), 78.2 
(Cquat), 86.6 (Cquat). 
 
Data were in agreement with those reported in the literature.94 
 
(3-Bromoprop-1-ynyl)benzene (173) 
 
Following GP8 using PPh3 (19.7 mmol, 5.16 g), Br2 (19.5 mmol, 0.98 mL) and alcohol 169 
(2.37 g) in CH2Cl2 (50 mL). Purification by flash chromatography (n-pentane) gave bromide 
173 as a colourless oil (3.21 g, 92%); νmax (neat)/cm-1 3057, 2223, 1676, 1591, 1493, 1273, 
1120, 1003, 988, 860; δH (300 MHz; CDCl3) 4.17 (2H, s, CH2), 7.30-7.40 (3H, m, 3 × CH), 
7.42-7.51 (2H, m, 2 × CH); δC (75 MHz; CDCl3) 15.3 (CH2), 84.2 (Cquat), 86.7 (Cquat), 122.1 
(Cquat), 128.3 (2C, 2 × CH), 128.8 (2C, 2 × CH), 131.8 (CH). 
 
Data were in agreement with those reported in the literature.95 
161 
 
(3-Bromoprop-1-ynyl)cyclohexane (174) 
 
Following GP8 using PPh3 (24.8 mmol, 6.49 g), Br2 (24.5 mmol, 1.23 mL) and alcohol 170 
(2.35 g) in CH2Cl2 (60 mL). Purification by flash chromatography (n-pentane) gave bromide 
174 as a colourless oil (3.11 g, 91%); δH (300 MHz; CDCl3) 1.15-1.57 (6H, m, 3 × CH2), 
1.60-1.79 (4H, m , 2 × CH2), 2.35-2.42 (1H, m, CH), 3.93 (2H, d, J 2.1, CH2); δC (75 MHz; 
CDCl3) 15.8 (CH2), 24.7 (2C, 2 × CH2), 25.8 (CH2), 29.3 (CH), 32.3 (2C, 2 × CH2), 
75.3(Cquat), 92.1 (Cquat). 
Data were in agreement with those reported in the literature. 96 
 
(5-Bromopent-3-ynyl)benzene (175) 
 
Following GP8 using PPh3 (18.9 mmol, 4.95 g), Br2 (18.7 mmol, 0.94 mL) and alcohol 171 
(2.75 g) in CH2Cl2 (50 mL). Purification by flash chromatography (hexane) gave bromide 175 
as a colourless oil (2.87 g, 75%); νmax (neat)/cm-1 3029, 2935, 2870, 2235, 1609, 1520, 1499, 
1344, 1202, 1160, 816; δH (300 MHz; CDCl3) 2.59 (2H, tt, J 7.5 and 2.4, CH2), 2.88 (2H, t, J 
7.5, CH2), 3.96 (2H, t, J 2.4, CH2), 7.23-7.30 (3H, m, 3 × CH), 7.31-7.44 (2H, m, 2 × CH); δC 
(75 MHz; CDCl3) 15.5 (CH2), 21.1 (CH2), 34.5 (CH2), 76.0 (Cquat), 87.2 (Cquat), 126.3 (CH), 
128.3 (2C, 2 × CH), 128.4 (2C, 2 × CH), 140.2 (Cquat); HRMS m/z (TOF EI+) 222.0040. 
C11H1179Br requires 222.0044. 
 
Data were in agreement with those reported in the literature.97 
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1-Bromohept-2-yne (176) 
 
Following GP8 using PPh3 (10.2 mmol, 2.67 g), Br2 (10.1 mmol, 0.51 mL) and alcohol 172 
(2.37 g) in CH2Cl2 (30 mL). Purification by flash chromatography (n-pentane) gave bromide 
176 as a colourless oil (1.54 g, 95%); νmax (neat)/cm-1 2959, 2914, 2882, 2239, 1612, 1572, 
1463, 1310, 1269, 1101, 996; δH (300 MHz; CDCl3) 0.91 (3H, t, J 7.1, CH3), 1.39-1.50 (4H, 
m, 2 × CH2), 2.24 (2H, m, CH2), 3.93 (2H, t, J 2.3, 2H); δC (75 MHz; CDCl3) 13.5 (CH3), 
18.5 (CH2), 21.9 (CH2), 30.4 (CH2), 31.5 (CH2), 75.2 (Cquat), 88.3 (Cquat). 
 
Data were in agreement with those reported in the literature.98 
Dimethyl(3-phenylprop-2-ynyl)sulfonium bromide (177) 
 
Following GP9 using bromide 173 (975 mg) sulfonium salt 177 as a white solid (1.11 g, 
87%); mp 138-139 °C; νmax (neat)/cm-1 2977, 2908, 2867, 2235, 1487, 1422, 1408, 1187, 
1044, 1009, 979, 762, 691, 635; δH (300 MHz; DMSO- d6) 3.00 (6H, s, 2 × CH3), 4.82 (2H, s, 
CH2), 7.41-7.48 (3H, m, 3 × CH), 7.58-7.62 (2H, m, 2 × CH); δC (75 MHz; DMSO- d6) 26.0 
(2C, 2 × CH3), 34.5 (CH2), 78.5 (Cquat), 91.2 (Cquat), 123.3 (Cquat), 131.1 (2C, 2 × CH), 132.1 
(CH), 134.3 (2C, 2 × CH); HRMS m/z (TOF ES+) 177.0734. C11H13S requires 177.0738. 
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(3-cyclohexylprop-2-yn-1-yl)dimethylsulfonium bromide (178) 
 
Following GP9 using bromide 174 (1.00 g) gave sulfonium salt 178 as a white solid (723 mg, 
55%); mp 110-111 °C;νmax (neat)/cm-1 3001, 2951, 2929, 2889, 2233, 1458, 1419, 1325, 
1248, 1187, 1153, 1050, 1001, 928, 721, 638; δH (300 MHz; CDCl3) 1.12-1.85 (10H, m, 5 × 
CH2), 2.44 (1H, m, CH), 3.18 (6H, s, 2 × CH3), 4.95 (2H, s, CH2); δC (75 MHz; CDCl3) 18.0 
(CH), 24.2 (2C, 2 × CH3), 24.7 (2C, 2 × CH2), 25.5 (CH2), 32.3 (2C, 2 × CH2), 33.4 (CH2), 
65.1 (Cquat), 96.7 (Cquat); HRMS m/z (TOF ES+) 183.1210. C11H19S requires 183.1202. 
 
Dimethyl(5-phenylpent-2-yn-1-yl)sulfonium bromide (179) 
 
Following GP9 using bromide 175 (1.12 g) gave sulfonium salt 179 as a white solid (1.026 g, 
72%); mp 103-104 °C; νmax (neat)/cm-1 2988, 2918, 2231, 1601, 1494, 1452, 1410, 1323, 
1261, 1206, 1151, 1056, 1005, 939, 742, 701; δH (300 MHz; CDCl3) 2.65 (2H, tt, J 6.9 and 
2.1, CH2), 2.84 (2H, t, J 6.9, CH2), 2.87 (6H, s, 2 × CH3), 4.85 (2H, t, J 2.1, CH2), 7.17-7.24 
(3H, m, 3 × CH), 7.26-7.33 (2H, m, 2 × CH); δC (75 MHz; CDCl3) 20.3 (CH2), 24.0 (2C, 2 × 
CH3), 33.3 (CH2), 34.0 (CH2), 66.3 (Cquat), 91.4 (Cquat), 126.8 (CH), 128.4 (2C, 2 × CH), 
128.7 (2C, 2 × CH), 139.6 (Cquat); HRMS m/z (TOF ES+) 205.1055. C13H17S requires 
205.1051. 
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Hept-2-ynyldimethylsulfonium bromide (180) 
 
Following GP9 using bromide 176 (875 mg) gave sulfonium salt 180 as a white solid (711 
mg, 60%); mp 74-75 °C ; νmax (neat)/cm-1 2997, 2954, 2931, 2888, 2230, 1456, 1423, 1320, 
1251, 1183, 1148, 1047, 1004, 930, 725, 639; δH (300 MHz; CDCl3) 0.88 (3H, t, J 2.2, CH3), 
1.30-1.53 (4H, m, 2 × CH2), 2.26 (2H, dt, J 6.9 and 2.2, CH2), 3.19 (6H, s, 2 × CH3), 4.94 
(2H, t, J 2.2, CH2); δC (75 MHz; CDCl3) 18.4 (CH2), 21.9 (CH2), 24.3 (2C, 2 × CH3), 28.6 
(CH3), 30.3 (CH2), 33.4 (CH2), 65.2 (Cquat), 92.7 (Cquat); HRMS m/z (TOF ES+) 157.1054. 
C9H17S requires 157.1051. 
 
Hex-5-en-2-yn-1-ol (181) 
 
To a solution of propargyl alcohol (10 mmol, 0.60 mL) in water (10 mL) were added allyl 
bromide (15 mmol, 0.64 mL), K2CO3 (10 mmol, 1.38 g), Na2SO3 (5 mmol, 630 mg) and CuI 
(0.2 mmol, 38 mg). The reaction mixture was stirred at 30 °C for 12h. After cooling down to 
room temperature, NH4Cl solution (20 mL) and CH2Cl2 (20 mL) were added to the reaction 
mixture. The phases were separated and the aqueous phase was washed with CH2Cl2 (3 × 20 
mL). The combined organic extracts were washed with brine (20 mL), dried (Na2SO4) and 
concentrated under reduced pressure. The residue was purified by distillation (75 °C at 20 
mmHg) to give alcohol 181 as a colourless oil (720 mg, 75%); νmax (neat)/cm-1 3445, 3010, 
2991, 2231, 1645, 1582, 1554, 1465, 1366, 1267, 1186, 1149, 930, 902, 845, 770; δH (300  
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MHz; CDCl3) 2.85 (1H, s, OH), 3.01 (2H, m, CH2), 4.29 (2H, m, CH2), 5.12 (1H, ddt, J 8.8 
and 1.7 and 1.7, CH), 5.32 (1H, ddt, J 17.2 and 1.7 and 1.7, CH), 5.81-5.84 (1H, m, CH); δC 
(75 MHz; CDCl3) 23.0 (CH2), 50.9 (CH2), 80.6 (Cquat), 82.6 (Cquat), 116.9 (CH2), 132.3 (CH). 
 
Data were in agreement with those reported in the literature.99 
 
 
6-Bromohex-1-en-4-yne (182) 
 
Following GP8 using PPh3 (8.2 mmol, 2.15 g), Br2 (8.15 mmol, 0.41 mL) and alcohol 181 
(720 mg) in CH2Cl2 (20 mL). Purification by flash chromatography (n-pentane) gave bromide 
182 as a colourless oil (1.07 g, 90%); νmax (neat)/cm-1 3015, 2999, 2236, 1645, 1560, 1523, 
1466, 1209, 1153, 1026, 963, 812; δH (300 MHz; CDCl3) 3.20 (2H, m, CH2), 3.95 (2H, m, 
CH2), 5.05-5.07 (1H, m, CH), 5.20 (1H, ddt, J 17.6 and 1.8 and 1.8, CH), 5.72-5.76 (1H, m, 
CH); δC (75 MHz; CDCl3) 15.9 (CH2), 24.6 (CH2), 79.1 (Cquat), 81.2 (Cquat), 116.7 (CH2), 
132.3 (CH); HRMS m/z (TOF EI+) 157.9735. C6H7Br requires 157.9731. 
 
Hex-5-en-2-yn-1-yldimethylsulfonium bromide (183) 
 
Following GP9 using bromide 182 (795 mg) gave sulfonium salt 183 as a white solid (387 
mg, 35%); νmax (neat)/cm-1 3090, 3020, 2915, 2191, 1825, 1640, 1323, 1193, 1035, 991, 925, 
840, 760, 642; δH (300 MHz; CDCl3) 3.41 (6H, s, 2 × CH3), 3.70 (2H, m, CH2), 4.80 (2H, s, 
CH2), 5.47 (1H, dd, J 11.0 and 1.8, CH), 5.56 (1H, dd, J 18.0 and 1.8, CH), 6.01 (1H, m, CH); 
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δC (75 MHz; CDCl3) 23.3 (CH2), 24.6 (2C, 2 × CH3), 34.3 (CH2), 76.6 (Cquat), 81.5 (Cquat), 
117.5 (CH2), 133.1 (CH); HRMS m/z (TOF ES+) 141.0740. C8H13S requires 141.0732. 
 
 
3-(4-bromophenyl)prop-2-yn-1-ol (184) 
 
Following GP5 using 1-bromo-4-iodobenzene (7.07 g). Purification by flash chromatography 
[hexane:ethylacetate (5:1)] gave alcohol 184 as a brown oil (4.64 g, 88%); νmax (neat)/cm-1 
3335, 2870, 2226, 1579, 1560, 1486, 1405, 1387, 1262, 1166, 1080, 1015, 955, 831, 753; δH 
(300 MHz; CDCl3) 1.87 (1H, s, OH), 4.48 (2H, s, CH2), 7.28 (2H, d, J 8.4, 2 × CH), 7.42 (2H, 
d, J 8.4, 2 × CH); δC (75 MHz; CDCl3) 14.9 (CH2), 86.7 (Cquat), 86.9 (Cquat), 121.5 (Cquat), 
123.2 (CH2), 131.7 (2C, 2 × CH), 133.3 (2C, 2 × CH); HRMS m/z (TOF EI+) 209.9676. 
C9H7O79Br requires 209.9680. 
 
Data were in agreement with those reported in the literature.93 
 
1-Bromo-4-(3-bromoprop-1-ynyl)benzene (185) 
 
Following GP8 using PPh3 (11 mmol, 2.88 g), Br2 (10.9 mmol, 0.55 mL) and alcohol 184 
(2.11 g) in CH2Cl2 (30 mL). Purification by flash chromatography (n-pentane) gave bromide 
185 as a colourless oil (2.68 g, 98%); νmax (neat)/cm-1 3010, 2230, 1906, 1603, 1591, 1489, 
1396, 1278, 1216, 1206, 1120, 1075, 988, 906, 845; δH (300 MHz; CDCl3) 4.15 (2H, s, CH2), 
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7.29 (2H, d, J 8.3, 2 × CH), 7.45 (2H, d, J 8.3, 2 × CH); δC (75 MHz; CDCl3) 14.9 (CH2), 
85.2 (Cquat), 85.5 (Cquat), 121.1 (Cquat), 123.3 (Cquat), 131.6 (2C, 2 × CH), 133.2 (2C, 2 × CH). 
 
Data were in agreement with those reported in the literature.100 
 
(3-(4-bromophenyl)prop-2-yn-1-yl)dimethylsulfonium bromide (186) 
 
Following GP9 using bromide 185 (1.369 g) gave sulfonium salt 186 as a white solid (1.327 
g, 79%); mp 132-134 °C; νmax (neat)/cm-1 3012, 2929, 2884, 2241, 1628,1401, 1325, 1221, 
1163, 1135, 1112, 1072, 1039, 1001, 982, 840, 805, 778, 722; δH (300 MHz; CDCl3) 3.39 (6 
H, s, 2 × CH3), 5.51 (2H, s, CH2), 7.44 (2H, d, J 8.4, 2 × CH), 7.55 (2H, d, J 8.4, 2 × CH); δC 
(75 MHz; CDCl3) 23.9 (2C, 2 × CH3), 30.2 (CH2), 79.9 (Cquat), 87.5 (Cquat), 122.6 (Cquat), 
122.8 (Cquat), 132.1 (2C, 2 × CH), 135.6 (2C, 2 × CH); HRMS m/z (TOF ES+) 254.9845. 
C11H12S79Br requires 254.9838. 
 
2-Hex-1-ynyl-3-phenyl-1-(toluene-4-sulfonyl)aziridine (187) 
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Following GP3 using imine 141 and sulfonium salt 180 for 2.5 h. Purification by flash 
chromatography [hexane:ethylacetate (12:1)] gave aziridine 187 as a beige solid (229 mg, 
65%, 9:1 cis:trans); νmax (neat)/cm-1 3053, 2957, 2926, 2243, 1320, 1162, 1091, 1021, 875, 
787; HRMS m/z (TOF ES+) 376.1344. C21H23NO2NaS requires 376.1347; aziridine cis-187: 
δH (300 MHz; CDCl3) 0.74 (3H, t, J 7.2, CH3), 1.03-1.15 (2H, m, CH2), 1.19-1.28 (2H, m, 
CH2), 1.99 (2H, td, J 6.8 and 1.7, CH2), 2.41 (3H, s, CH3), 3.63 (1H, dt, J 6.9 and 1.7, CH), 
3.93 (1H, d, J 6.9, CH), 7.25-7.33 (7H, m, 7 × CH), 7.87 (2H, d, J 8.3, 2 × CH); δC (75 MHz; 
CDCl3) 13.4 (CH3), 18.2 (CH2), 21.4 (CH2), 21.6 (CH3), 30.0 (CH2), 36.2 (CH), 46.1 (CH), 
72.1 (Cquat), 86.7 (Cquat), 127.7 (2C, 2 × CH), 127.9 (4C, 4 × CH), 128.2 (CH), 129.8 (2C, 2 × 
CH), 132.2 (Cquat), 134.7 (Cquat), 144.7 (Cquat). 
 
2-(4-Bromophenyl)-3-hex-1-ynyl-1-(toluene-4-sulfonyl)aziridine (188) 
N
S OO
Br
 
Following GP3 using imine 165 and sulfonium salt 180 for 3 h. Purification by flash 
chromatography [hexane:ethylacetate (35:1)] gave aziridine 188 as a yellow solid (341 mg, 
79%, 8:1 cis:trans); νmax (neat)/cm-1 3053, 2959, 2929, 2861, 2243, 1594, 1488, 1405, 1375, 
1322, 1159, 1088, 1010, 900, 851, 839, 805, 775; HRMS m/z (TOF ES+) 454.0445. 
C21H22NO2NaS79Br requires 454.0452; aziridine cis-188: δH (300 MHz; CDCl3) 0.77 (3H, t, J 
7.2, CH3), 1.04-1.30 (4H, m, 2 × CH2), 2.01 (2H, td, J 6.9 and 1.7, CH2), 2.44 (3H, s, CH3), 
3.62 (1H, dt, J 6.9 and 1.7, CH), 3.88 (1H, d, J 6.9, CH), 7.19 (2H, d, J 8.5, 2 × CH), 7.34 
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(2H, d, J 8.4, 2 × CH), 7.42 (2H, d, J 8.5, 2 × CH), 7.86 (2H, d, J 8.4, 2 × CH); δC (75 MHz; 
CDCl3) 13.5 (CH3), 18.3 (CH2), 21.5 (CH2), 21.7 (CH3), 30.0 (CH2), 36.2 (CH), 45.5 (CH), 
71.9 (Cquat), 87.0 (Cquat), 122.4 (Cquart), 127.9 (3C, 3 × CH), 129.4 (3C, 3 × CH), 129.8 (CH), 
131.1 (CH), 131.4 (Cquat), 134.6 (Cquat), 144.9 (Cquat). 
 
2-(2-Bromophenyl)-3-hex-1-ynyl-1-(toluene-4-sulfonyl)aziridine (189) 
N
S OO
Br
 
Following GP3 using imine 164 and sulfonium salt 180 for 4 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] gave aziridine 189 as yellow solid (315 mg, 
73%, 20:1 cis:trans); νmax (neat)/cm-1 2957, 2931, 2871, 2249, 1331, 1159, 1090, 1018, 870, 
778, 752; HRMS m/z (TOF ES+) 454.0467. C21H22NO2NaS79Br requires 454.0452; aziridine 
cis-189: δH (300 MHz; CDCl3) 0.70 (3H, t, J 7.2, CH3), 0.91-1.20 (4H, m, 2 × CH2), 1.93 
(2H, td, J 6.7, CH2), 2.45 (3H, s, CH3), 3.70 (1H, dt, J 6.9 and 1.7, CH), 4.12 (1H, d, J 6.9, 
CH), 7.12-7.27 (3H, m, 3 × CH), 7.36 (2H, d, J 8.4, 2 × CH), 7.52 (1H, dd, J 7.8 and 1.3, 
CH), 7.90 (2H, d, J 8.4, 2 × CH); δC (75 MHz; CDCl3) 13.4 (CH3), 18.2 (CH2), 21.3 (CH2), 
21.7 (CH3), 29.9 (CH2), 36.2 (CH), 46.8 (CH), 71.9 (Cquat), 86.0 (Cquat), 123.3 (Cquart), 126.9 
(CH), 128.0 (2C, 2 × CH), 129.5 (3C, 3 × CH), 129.9 (CH), 132.1 (CH), 132.4 (Cquat), 134.5 
(Cquat), 144.9 (Cquat). 
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2-Hex-1-ynyl-1-(toluene-4-sulfonyl)-3-p-tolylaziridine (190) 
 
Following GP3 using imine 166 and sulfonium salt 180 for 4 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] gave aziridine 190 as a white solid (290 mg, 
79%, 7:1 cis:trans); νmax (neat)/cm-1 3052, 2958, 2928, 2860, 2246, 1917, 1595, 1517, 1492, 
1321, 1162, 1089, 1018, 899, 853, 809, 768, 706; HRMS m/z (TOF ES+) 390.1492. 
C22H25NO2NaS requires 390.1504; aziridine cis-190: δH (300 MHz; CDCl3) 0.76 (3H, t, J 7.2, 
CH3), 1.06-1.31 (4H, m, 2 × CH2), 2.02 (2H, td, J 6.9 and 1.8, CH2), 2.32 (3H, s, CH3), 2.42 
(3H, s, CH3), 3.60 (1H, dt, J 6.9 and 1.8, CH), 3.89 (1H, d, J 6.9, CH), 7.09 (2H, d, J 8.1 and 
2 × CH), 7.21 (2H, d, J 8.1, 2 × CH), 7.33 (2H, d, J 8.4, 2 × CH), 7.87 (2H, d, J 8.4, 2 × CH); 
δC (75 MHz; CDCl3) 13.4 (CH3), 18.3 (CH2), 21.2 (CH2), 21.5 (CH3), 30.0 (CH2), 36.1 (CH), 
46.2 (CH), 72.3 (Cquat), 86.6 (Cquat), 127.6 (2C, 2 × CH), 127.9 (2C, 2 × CH), 128.6 (2C, 2 × 
CH), 129.7 (2C, 2 × CH), 131.3 (Cquat), 134.8 (Cquat), 138.0 (Cquat), 144.7 (Cquat). 
 
2-cyclohexyl-3-(hex-1-ynyl)-1-(toluene-4-sulfonyl)aziridine (191) 
N
SO O
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Following GP3 using imine 145 and sulfonium salt 180 for 3 h. Purification by flash 
chromatography [hexane:ethylacetate (4:1)] gave aziridine 191 as a white solid (180 mg, 
50%, 7:1 cis:trans); νmax (neat)/cm-1 2926, 2854, 2248, 1598, 1449, 1367, 1314, 1304, 1154, 
1121, 1088, 1021, 962, 905, 882, 813, 789, 727, 672; HRMS m/z (TOF ES+) 382.1821. 
C21H29NO2NaS requires 382.1817; aziridine cis-191: δH (300 MHz; CDCl3) 0.87 (3H, t, J 7.2, 
CH3), 0.90-1.16 (5H, m, 2 × CH2 and CH), 1.25-1.48 (6H, m, 3 × CH2), 1.53-1.78 (4H, m, 2 × 
CH2), 2.17 (2H, dt, J 6.8 and 1.8, CH2), 2.44 (3H, s, CH3), 2.54 (1H, dd, J 9.7 and 6.9, CH), 
3.35 (1H, dt, J 6.9 and 1.8, CH), 7.32 (2H, d, J 8.3, 2 × CH), 7.82 (2H, d, J 8.3, 2 × CH); δC 
(75 MHz; CDCl3) 18.4 (CH2), 21.6 (CH3), 21.7 (CH2), 25.3 (2C, 2 × CH2), 25.4 (2C, 2 × 
CH2), 26.0 (CH2), 29.0 (CH2), 30.3 (CH2), 33.9 (CH3), 37.1 (CH), 49.5 (CH), 72.8 (Cquat), 
85.2 (Cquat), 128.0 (2C, 2 × CH), 129.6 (2C, 2 × CH), 134.7 (Cquat), 144.5 (Cquat). 
 
2-Phenyl-3-phenylethynyl-1-(toluene-4-sulfonyl)aziridine (192) 
N
S OO
 
Following GP3 using imine 141 and sulfonium salt 177 for 1.5 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] gave aziridine 192 as a white solid (317 mg, 
85%, 7:1 cis:trans); νmax (neat)/cm-1 3032, 2950, 2926, 2230, 1597, 1490, 1457, 1441, 1319, 
1157, 1087, 1071, 873, 854, 784, 757, 708; HRMS m/z (TOF ES+) 396.1041. C23H19NO2NaS 
requires 396.1034; aziridine cis-192: δH (300 MHz; CDCl3) 2.42 (3H, s, CH3), 3.85 (1H, d, J 
6.9, CH), 4.07 (1H, d, J 6.9, CH), 7.14-7.38 (12H, m, 12 × CH), 7.90 (2H, d, J 8.3, 2 × CH); 
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δC (75 MHz; CDCl3) 21.7 (CH3), 36.3 (CH), 46.5 (CH), 81.6 (Cquat), 85.1 (Cquat), 121.8 
(Cquart), 127.8 (2C, 2 × CH), 128.0 (4C, 4 × CH), 128.1 (2C, 2 × CH), 128.5 (CH), 128.8 
(CH), 129.9 (2C, 2 × CH), 131.8 (2C, 2 × CH), 132.1 (Cquat), 134.6 (Cquat), 144.9 (Cquat). 
 
2-Phenylethynyl-1-(toluene-4-sulfonyl)-3-p-tolylaziridine(193) 
N
S OO
 
Following GP3 using imine 166 and sulfonium salt 177 for 8 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] aziridine 193 as a white solid (252 mg, 65%, 
50:1 cis:trans); νmax (neat)/cm-1 3053, 2957, 2926, 2228, 1597, 1519, 1491, 1317, 1155, 1089, 
1021, 877, 824, 806, 757; HRMS m/z (TOF ES+) 410.1199. C24H21NO2NaS requires 
410.1191; aziridine cis-193: δH (300 MHz; CDCl3) 2.30 (3H, s, CH3), 2.41 (3H, s, CH3), 3.82 
(1H, d, J 6.9, CH), 4.01 (1H, d, J 6.9, CH), 7.10 (2H, d, J 8.0, 2 × CH), 7.18-7.27 (7H, m, 7 × 
CH), 7.31 (2H, d, J 8.5, 2 × CH), 7.88 (2H, d, J 8.5, 2 × CH); δC (75 MHz; CDCl3) 21.2 
(CH3), 21.7 (CH3), 36.3 (CH), 46.5 (CH), 81.8 (Cquat), 85.2 (Cquat), 121.9 (Cquart), 127.7 (2C, 2 
× CH), 128.0 (2C, 2 × CH), 128.1 (2C, 2 × CH), 128.7 (3C, 3 × CH), 129.0 (CH), 129.8 (2C, 
2 × CH), 131.9 (2C, 2 × CH), 134.7 (Cquat), 138.3 (Cquat), 144.9 (Cquat). 
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2-Butyl-3-(phenylethynyl)-1-(toluene-4-sulfonyl)aziridine (194) 
N
SO O
 
Following GP3 using imine 168 and sulfonium salt 177 for 12 h. Purification by flash 
chromatography [hexane:ethylacetate (60:1)] aziridine 194 as a light yellow solid (141 mg, 
40%, 50:1 cis:trans)); νmax (neat)/cm-1 2965, 2930, 2860, 2249, 1601, 1491, 1316, 1304, 1292, 
1152, 1087, 934, 842, 809, 753, 730, 715, 688, 672; HRMS m/z (TOF ES+) 376.1340. 
C21H23NO2NaS requires 376.1347; aziridine cis-194: δH (300 MHz; CDCl3) 0.84 (3H, t, J 7.0, 
CH3), 1.26-1.32 (4H, m, 2 × CH2), 1.55-1.75 (2H, m, CH2), 2.45 (3H, s, CH3), 2.63 (1H, q, J 
13.0 and 6.9, CH), 3.59 (1H, d, J 6.9, CH), 7.28-7.41 (7H, m, 7 × CH), 7.87 (2H, d, J 8.3, 2 × 
CH); δC (75 MHz; CDCl3) 13.8 (CH3), 21.6 (CH3), 22.1 (CH2), 27.9 (CH2), 28.7 (CH2), 34.4 
(CH), 45.3 (CH), 82.0 (Cquat), 84.2 (Cquat), 121.9 (Cquat), 128.0 (2C, 2 × CH), 128.2 (CH), 
128.8 (CH), 129.7 (2C, 2 × CH), 131.9 (2C, 2 × CH), 134.7 (Cquat), 144.7 (Cquat). 
 
2-isopropyl-3-(phenylethynyl)-1-(toluene-4-sulfonyl)aziridine (195) 
N
SO O
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Following GP3 using imine 144 and sulfonium salt 177 for 4 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] gave aziridine 195 as a yellow solid (203 mg, 
60%, 25:1 cis:trans); νmax (neat)/cm-1 2965, 2923, 2881, 1601, 1493, 1441, 1406, 1362, 1316, 
1304, 1186, 1151, 1087, 1059, 980, 945, 873, 820, 768, 750, 711, 687, 670; HRMS m/z (TOF 
ES+) 362.1189. C20H21NO2NaS requires 362.1191; aziridine cis-195: δH (300 MHz; CDCl3) 
0.80 (3H, d, J 6.7, CH3), 1.00 (3H, d, J 6.7, CH3), 1.60-1.72 (1H, m, CH), 2.41 (3H, s, CH3), 
2.59 (1H, dd, J 9.7 and 6.9, CH), 3.56 (1H, d, J 6.9, CH), 7.22-7.37 (7H, m, 7 × CH), 7.83 
(2H, d, J 8.3, 2 × CH); δC (75 MHz; CDCl3) 18.6 (CH3), 20.1 (CH3), 21.6 (CH3), 28.5 (CH), 
34.2 (CH), 51.3 (CH), 82.0 (Cquat), 83.9 (Cquat), 122.0 (Cquat), 128.1 (2C, 2 × CH), 128.2 (2C, 
2 × CH), 128.8 (CH), 129.7 (2C, 2 × CH), 131.9 (2C, 2 ×CH), 134.7 (Cquat), 144.7 (Cquat). 
 
2-cyclohexyl-3-(phenylethynyl)-1-(toluene-4-sulfonyl)aziridine (196) 
N
SO O
 
Following GP3 using imine 145 and sulfonium salt 177 for 6 h. Purification by flash 
chromatography [hexane:ethylacetate (4:1)] gave aziridine 196 as a white solid (303 mg, 
80%, 50:1 cis:trans); νmax (neat)/cm-1 2925, 2853, 2250, 1601, 1491, 1448, 1326, 1155, 1090, 
981, 951, 911, 860, 826, 755, 715, 690, 667; HRMS m/z (TOF ES+) 402.1510. 
C23H25NO2NaS requires 402.1504; aziridine cis-196: δH (300 MHz; CDCl3) 0.80-1.24 (6H, m, 
3 × CH2), 1.32-1.82 (5H, m, 2 × CH2 and CH), 2.40 (3H, s, CH3), 2.63 (1H, dd, J 9.6 and 6.9, 
CH), 3.54 (1H, d, J 6.9, CH), 7.21-7.36 (7H, m, 7 × CH), 7.82 (2H, d, J 8.3, 2 × CH); δC (75 
175 
MHz; CDCl3) 21.6 (CH3), 25.3 (CH2), 25.5 (CH2), 26.0 (CH2), 29.1 (CH2), 30.5 (CH2), 33.9 
(CH), 37.4 (CH), 49.8 (CH), 82.3 (Cquat), 83.8 (Cquat), 122.0 (Cquat), 128.1 (3C, 3 × CH), 128.8 
(2C, 2 × CH), 129.7 (2C, 2 × CH), 131.9 (2C, 2 × CH), 134.6 (Cquat), 144.6 (Cquat). 
 
2-Isopropyl-3-(pent-4-en-1-ynyl)-1-(toluene-4-sulfonyl)aziridine (197) 
N
SO O
 
Following GP3 using imine 144 and sulfonium salt 183 for 4 h. Purification by flash 
chromatography [hexane:ethylacetate (12:1)] aziridine 197 as a yellow oil (121 mg, 40%, 
25:1 cis:trans); νmax (neat)/cm-1 3089, 3047, 2958, 2875, 2230, 1830, 1630, 1323, 1160, 1093, 
980, 940, 876, 725; HRMS m/z (TOF ES+) 326.1182. C17H21NO2NaS requires 326.1191; 
aziridine cis-197: δH (300 MHz; CDCl3) 0.81 (3H, d, J 6.7, CH3), 0.99 (3H, d, J 6.7, CH3), 
1.58-1.69 (1H, m, CH), 2.45 (3H, s, CH3), 2.52 (1H, dd, J 9.8 and 6.9, CH), 2.95 (2H, dd, J 
5.2 and 1.8, CH2), 3.41 (1H, dt, J 6.9 and 1.8, CH), 5.09 (1H, dd, J 10.0 and 1.7, CH), 5.23 
(1H, dd, J 17.0 and 1.7, CH), 5.70-5.79 (1H, m, CH), 7.34 (2H, d, J 8.3, 2 × CH), 7.84 (2H, d, 
J 8.3, 2 × CH); δC (75 MHz; CDCl3) 18.6 (CH3), 20.1 (CH3), 21.6 (CH3), 23.0 (CH2), 28.3 
(CH), 34.0 (CH), 51.0 (CH), 76.4 (Cquat), 81.6 (Cquat), 116.3 (CH2), 128.1 (2C, 2 × CH), 129.6 
(2C, 2 × CH), 131.7 (CH), 134.7 (Cquat), 144.7 (Cquat). 
 
176 
2-(Cyclohexylethynyl)-3-isopropyl-1-(toluene-4-sulfonyl)aziridine (199) 
N
SO O
 
Following GP3 using imine 144 and sulfonium salt 178 for 4 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] gave aziridine 199 as a white solid (196 mg, 
50%, 15:1 cis:trans); νmax (neat)/cm-1 2965, 2927, 2854, 2241, 1598, 1449, 1406, 1314, 1304, 
1151, 1088, 946, 899, 876, 866, 813, 801, 775; HRMS m/z (TOF ES+) 368.1666. 
C20H27NO2NaS requires 368.1660; aziridine cis-199: δH (300 MHz; CDCl3) 0.77 (3H, d, J 
6.7, CH3), 0.96 (3H, d, J 6.7, CH3), 1.24-1.48 (6H, m, 3 × CH2), 1.54-1.80 (4H, m, 2 × CH2), 
2.37-2.44 (4H, m, CH and CH3), 3.37 (1H, J 6.9 and 1.3, CH), 7.31 (2H, d, J 8.2, 2 × CH), 
7.81 (2H, d, J 8.2, 2 × CH); δC (75 MHz; CDCl3) 18.5 (CH3), 20.1 (CH3), 21.6 (CH3), 24.5 
(2C, 2 × CH2), 25.7 (CH2), 28.3 (CH), 32.1 (2C, 2 × CH2), 34.1 (2 × CH2), 50.9 (CH), 72.6 
(Cquat), 89.1 (Cquat), 128.0 (2C, 2 × CH), 129.5 (2C, 2 × CH), 134.7 (Cquat), 144.5 (Cquat). 
 
2-cyclohexyl-3-(cyclohexylethynyl)-1-(toluene-4-sulfonyl)aziridine (198) 
N
SO O
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Following GP3 using imine 145 and sulfonium salt 178 for 2 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] gave aziridine 198 as a white solid (196 mg, 
51%, 25:1 cis:trans); νmax (neat)/cm-1 2967, 2871, 2249, 1598, 1448, 1319, 1153, 1192, 815, 
709, 686; HRMS m/z (TOF ES+) 408.1976. C23H31NO2NaS requires 408.1973; aziridine cis-
198: δH (300 MHz; CDCl3) 0.85-1.15 (5H, m, 2 × CH2 and CH), 1.24-1.43 (9H, m, 4 × CH2 
and CH), 1.59-1.78 (8H, m, 4 × CH2), 2.43 (3H, s, CH3), 2.53 (1H, dd, J 9.6 and 7.0, CH), 
3.35 (1H, dd, J 6.9 and 1.5, CH), 7.31 (2H, d, J 8.3, 2 × CH), 7.81 (2H, d, J 8.3, 2 × CH); δC 
(75 MHz; CDCl3) 21.6 (CH3), 24.4 (2C, 2 × CH2), 25.3 (CH2), 25.4 (CH2), 25.7 (CH2), 26.0 
(2C, 2 × CH2), 28.8 (CH2), 29.0 (CH2), 32.0 (2C, 2 × CH2), 33.8 (CH3), 37.2 (CH), 49.4 (CH), 
72.8 (Cquat), 88.9 (Cquat), 128.0 (2C, 2 × CH), 129.5 (2C, 2 × CH), 134.7 (Cquat), 144.5 (Cquat). 
 
2-phenyl-3-(4-phenylbut-1-yn-1-yl)-1-(toluene-4-sulfonyl)aziridine (200) 
N
S OO
 
Following GP3 using imine 141 and sulfonium salt 179 for 3 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] gave aziridine 200 as a yellow oil (281 mg, 
70%, 11:1 cis:trans); νmax (neat)/cm-1 2987, 2931, 2248, 1597, 1495, 1453, 1384, 1327, 1291, 
1233, 1158, 1090, 1021, 875, 814, 742, 695; HRMS m/z (TOF ES+) 424.1340. 
C25H23NO2NaS requires 424.1347; aziridine cis-200: δH (300 MHz; CDCl3) 2.27-2.34 (2H, m, 
CH2), 2.44 (3H, s, CH3), 2.50-2.66 (2H, m, CH2), 3.63 (1H, dt, J 6.9 and 1.8, CH), 3.95 (1H, 
d, J 6.9, CH), 6.96-7.01 (2H, m, 2 × CH), 7.24-7.27 (3H, m, 3 × CH), 7.30 (5H, s, 5 × CH), 
178 
7.34 (2H, d, J 8.3, 2 × CH), 7.89 (2H, d, J 8.3, 2 × CH); δC (75 MHz; CDCl3) 20.8 (CH3), 
21.7 (CH3), 34.4 (CH2), 36.2 (CH), 46.1 (CH), 73.0 (Cquat), 85.9 (Cquat), 126.2 (CH), 127.8 
(2C, 2 × CH), 127.9 (2C, 2 × CH), 128.0 (2C, 2 × CH), 128.3 (5C, 5 × CH), 129.8 (2C, 2 × 
CH), 132.2 (Cquat), 134.8 (Cquat), 140.2 (Cquat), 144.8 (Cquat). 
 
2-((4-bromophenyl)ethynyl)-3-phenyl-1-(toluene-4-sulfonyl)aziridine (201) 
 
Following GP3 using imine 141 and sulfonium salt 186 for 8 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] aziridine 201 as a brown solid (339 mg, 75%, 
15:1 cis:trans); νmax (neat)/cm-1 3066, 2233, 1599, 1450, 1334, 1233, 1160, 1087, 1023, 885, 
818, 745, 698; HRMS m/z (TOF ES+) 474.0144. C23H18NO2NaS79Br requires 474.0139; 
aziridine cis-201: δH (300 MHz; CDCl3) 2.43 (3H, s, CH3), 3.85 (1H, d, J 6.9, CH), 4.09 (1H, 
d, J 6.9, CH), 7.02 (2H, d, J 8.6, 2 × CH), 7.31-7.36 (9H, m, 9 × CH), 7.92 (2H, d, J 8.3, 2 × 
CH); δC (75 MHz; CDCl3) 21.7 (CH3), 26.9 (CH), 42.2 (CH), 80.0 (Cquat), 92.3 (Cquat), 121.9 
(Cquart), 123.1 (Cquat), 127.1 (CH), 128.0 (2C, 2 × CH), 128.3 (2C, 2 × CH), 128.6 (2C, 2 × 
CH), 129.4 (2C, 2 × CH), 131.5 (2C, 2 × CH), 134.7 (2C, 2 × CH), 136.9 (Cquat), 137.8 (Cquat), 
138.4 (Cquat). 
 
179 
2-Butyl-5-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (202) 
N
S OO
 
Following GP6 using aziridine 187 or 194 at room temperature for 12 h gave 202 as yellow 
oil (69 mg, 98%); νmax (neat)/cm-1 3060, 2956, 2928, 2861, 1733, 1597, 1528, 1482, 1444, 
1366, 1169, 1116, 1092, 911, 809, 759; δH (300 MHz; CDCl3) 0.97 (3H, t, J 7.3, CH3), 1.37-
1.50 (2H, m, CH2), 1.65-1.75 (2H, m, CH2), 2.37 (3H, s, CH3), 2.92 (2H, t, J 7.7, CH2), 6.04 
(1H, d, J 3.3, CH), 6.07 (1H, d, J 3.3, CH), 7.15 (2H, d, J 8.4, 2 × CH), 7.28 (2H, d, J 8.4, 2 × 
CH), 7.33 (5H, m, 5 × CH); δC (75 MHz; CDCl3) 14.0 (CH3), 21.6 (CH3), 22.5 (CH2), 29.3 
(CH2), 31.6 (CH2), 112.6 (CH), 115.6 (CH), 126.4 (2C, 2 × CH), 127.2 (2C, 2 × CH), 127.7 
(CH), 129.3 (2C, 2 × CH), 130.4 (2C, 2 × CH), 133.3 (Cquat), 136.4 (Cquat), 138.0 (Cquat), 
139.9 (Cquat), 144.2 (Cquat); HRMS m/z (TOF ES+) 376.1350. C21H23NO2NaS requires 
3761347. 
 
2-Butyl-4-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (203) 
N
SO O
 
Following GP7 using aziridine 187 (70 mg) for 2 h. Purification by flash chromatography 
[hexane:ethylacetate (25:1)] gave a mixture of 2,4-substituted pyrrole 203 and 2,5-substituted 
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pyrrole 202 (42 mg, 60%, 1:7.6 202:203); νmax (neat)/cm-1 2958, 2929, 2871, 1723, 1596, 
1526, 1494, 1448, 1401, 1361, 1306, 1292, 1188, 1168, 1120, 1089, 1038, 1009, 920, 812, 
789, 761, 693; HRMS m/z (TOF ES+) 376.1356. C21H23NO2NaS requires 376.1347; 2-Butyl-
4-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole 203: δH (300 MHz; CDCl3) 0.91 (3H, t, J 7.3, 
CH3), 1.31-1.43 (2H, m, CH2), 1.54-1.61 (2H, m, CH2), 2.41 (3H, s, CH3), 2.69 (2H, t, J 7.6, 
CH2), 6.33 (1H, dt, J 1.9 and 1.0, CH), 7.29 (2H, d, J 8.4, 2 × CH), 7.32 (2H, d, J 8.4, 2 × 
CH), 7.37 (1H, d, J 8.2, CH), 7.51 (2H, dd, J 8.4, 8.2, 2 × CH), 7.58 (1H, d, J 1.9, CH), 7.69 
(2H, d, J 8.4, 2 × CH); δC (75 MHz; CDCl3) 13.9 (CH3), 21.6 (CH3), 22.4 (CH2), 26.9 (CH2), 
30.7 (CH2), 110.4 (CH), 117.7 (CH), 125.4 (2C, 2 × CH), 126.7 (3C, 3 × CH),126.8 (Cquat), 
127.8 (2C, 2 × CH), 130.0 (2C, 2 × CH), 133.7 (Cquat), 136.3 (Cquat), 136.9 (Cquat), 144.8 
(Cquat). 
 
2,5-dicyclohexyl-1-(toluene-4-sulfonyl)-1H-pyrrole (204) 
N
S OO
 
Following GP6 using aziridine198 at 70 °C for 3 h gave 204 as a colorless oil (67 mg, 98%); 
νmax (neat)/cm-1 2924, 2853, 1726, 1681, 1601, 1524, 1497, 1443, 1367, 1358, 1309, 1271, 
1195, 1177, 1154, 1120, 1097, 1087, 1069, 1045, 891, 810, 784, 738, 688, 652; δH (300 MHz; 
CDCl3) 1.14-1.40 (8H, m, 4 × CH2), 1.62-1.72 (8H, m, 4 × CH2), 1.90 (4H, m, 2 × CH2), 2.38 
(3H, s, CH3), 3.05 (2H, m, 2 × CH), 5.94 (2H, s, 2 × CH) 7.22 (2H, d, J 8.3, 2 × CH), 7.38 
(2H, d, J 8.3, 2 × CH); δC (75 MHz; CDCl3) 21.5 (CH3), 26.2 (2C, 2 × CH2), 26.8 (4C, 4 × 
CH2), 34.8 (4C, 4 × CH2), 37.3 (2C, 2 × CH), 109.4 (2C, 2 × CH), 125.5 (2C, 2 ×CH), 129.7 
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(2C, 2 ×CH), 138.2 (Cquat), 143.9 (Cquat), 144.0 (2C, 2 × Cquat); HRMS m/z (TOF ES+) 
408.1969. C23H31NO2NaS requires 408.1973. 
 
2-(4-Bromophenyl)-5-butyl-1-(toluene-4-sulfonyl)-1H-pyrrole (206) 
 
Following GP6 using 188 aziridine (86 mg) at 70 °C for 4 h gave 206 as a brown oil (84 mg, 
98%); νmax (neat)/cm-1 3048, 2953, 2929, 2826, 1592, 1368, 1170, 1092, 1023, 810, 750, 732, 
650, 660; δH (300 MHz; CDCl3) 1.03 (3H, t, J 7.3, CH3), 1.43-1.55 (2H, m, CH2), 1.70-1.80 
(2H, m, CH2), 2.43 (3H, s, CH3), 2.97 (2H, t, J 7.7, CH2), 6.10-6.14 (2H, m, 2 × CH), 7.21-
7.27 (4H, m, 4 × CH), 7.34 (2H, d, J 8.4, 2 × CH), 7.52 (2H, d, J 8.4, 2 × CH); δC (75 MHz; 
CDCl3) 13.9 (CH3), 21.5 (CH3), 22.5 (CH2), 29.2 (CH2), 31.6 (CH2), 112.8 (CH), 116.1 (CH), 
121.9 (Cquat), 126.3 (2C, 2 × CH), 129.4 (2C, 2 × CH), 130.4 (2C, 2 × CH), 131.9 (2C, 2 × 
CH), 132.3 (Cquat), 136.2 (Cquat), 136.8 (Cquat), 140.4 (Cquat), 144.4 (Cquat); HRMS m/z (TOF 
ES+) 454.0437. C21H22NO2NaS79Br requires 454.0452. 
 
182 
4-(4-Bromophenyl)-2-butyl-1-(toluene-4-sulfonyl)-1H-pyrrole (207) 
N
SO O
Br
 
Following GP7 using aziridine 188 (86 mg) for 2 h. Purification by flash chromatography 
[hexane:ethylacetate (25:1)] gave a mixture of 2,4-substituted pyrrole 207 and 2,5-substituted 
pyrrole 206 (63 mg, 74%, 1:1.1 206:207); νmax (neat)/cm-1 2957, 2928, 2870, 1728, 1596, 
1524, 1476, 1465, 1397, 1364, 1302, 1259, 1188, 1168, 1119, 1090, 1071, 1009, 919, 810, 
728, 703; HRMS m/z (TOF ES+) 454.0446. C21H22NO2NaS79Br requires 454.0452. 4-(4-
Bromophenyl)-2-butyl-1-(toluene-4-sulfonyl)-1H-pyrrole 207: δH (300 MHz; CDCl3) 0.97 
(3H, t, J 7.3, CH3), 1.39-1.50 (2H, m, CH2), 1.59-1.69 (2H, m, CH2), 2.48 (3H, s, CH3), 2.75 
(2H, t, J 7.7, CH2), 6.34 (1H, dt, J 1.9 and 1.0, CH), 7.37 (2H, d, J 8.4, 2 × CH), 7.43 (2H, d, 
J 8.6, 2 × CH), 7.54 (2H, d, J 8.6, 2 × CH), 7.63 (1H, d, J 1.9, CH), 7.76 (2H, d, J 8.4, 2 × 
CH); δC (75 MHz; CDCl3) 13.9 (CH3), 21.6 (CH3), 22.4 (CH2), 26.9 (CH2), 30.7 (CH2), 110.0 
(CH), 117.7 (CH), 120.4 (Cquat), 126.9 (2C, 2 × CH),126.8 (2C, 2 × CH), 130.0 (2C, 2 × CH), 
131.8 (2C, 2 × CH), 132.7 (Cquat), 136.2 (Cquat), 137.2 (Cquat), 140.4 (Cquat), 144.9 (Cquat). 
 
183 
2-(2-Bromophenyl)-5-butyl-1-(toluene-4-sulfonyl)-1H-pyrrole (208) 
N
S OO
Br
 
Following GP6 using aziridine 189 (86 mg) at 70 °C for 4 h gave 208 as a brown oil (84 mg, 
98%); νmax (neat)/cm-1 3049, 2956, 2928, 2861, 1736, 1597, 1459, 1365, 1170, 1091, 1025, 
1095, 810, 755; δH (300 MHz; CDCl3) 0.94 (3H, t, J 7.3, CH3), 1.38-1.45 (2H, m, CH2), 1.62-
1.70 (2H, m, CH2), 2.39 (3H, s, CH3), 2.80-2.89 (2H, m, CH2), 6.07 (1H, dt, J 3.4 and 1.0, 
CH), 6.15 (1H, d, J 3.4, CH), 7.19-7.30 (4H, m, 4 × CH), 7.42 (2H, d, J 8.4, 2 × CH), 7.59 
(2H, d, J 7.7, 2 × CH); δC (75 MHz; CDCl3) 13.9 (CH3), 21.6 (CH3), 22.5 (CH2), 28.6 (CH2), 
31.3 (CH2), 111.4 (CH), 115.7 (CH), 126.0 (Cquat), 126.1 (CH), 126.6 (2C, 2 × CH), 129.5 
(CH), 129.6 (2C, 2 × CH), 132.2 (CH), 133.1 (CH), 134.6 (2C, 2 × Cquat), 136.9 (Cquat), 138.7 
(Cquat), 144.4 (Cquat); HRMS m/z (TOF ES+) 454.0460. C21H22NO2NaS79Br requires 
454.0452. 
 
4-(2-Bromophenyl)-2-butyl-1-(toluene-4-sulfonyl)-1H-pyrrole (209) 
N
SO O
Br
 
Following GP7 using aziridine 189 (86 mg) for 3 h. Purification by flash chromatography 
[hexane:ethylacetate (25:1)] gave a mixture of 2,4-substituted pyrrole 209 and 2,5-substituted 
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pyrrole 208 (77 mg, 90%, 3:1 208:209); νmax (neat)/cm-1 3051, 2957, 2928, 2861, 1597, 1527, 
1460, 1364, 1170, 1125, 1096, 1025, 908, 810, 755, 729; HRMS m/z (TOF ES+) 454.0460. 
C21H22NO2NaS79Br requires 454.0452. 4-(2-Bromophenyl)-2-butyl-1-(toluene-4-sulfonyl)-
1H-pyrrole 209: δH (300 MHz; CDCl3) 0.90 (3H, t, J 7.2, CH3), 1.33-1.45 (2H, m, CH2), 
1.53-1.63 (2H, m, CH2), 2.42 (3H, s, CH3), 2.63-2.78 (2H, m, CH2), 6.28 (1H, m, CH), 7.12 
(1H, ddd, J 7.9, 1.7, 1.2, CH), 7.19-7.43 (4H, m, 4 × CH, underneath major isomer), 7.60-7.64 
(2H, m, 2 × CH), 7.72 (2H, d, J 8.4, 2 × CH). 
 
2-Butyl-1-(toluene-4-sulfonyl)-5-p-tolyl-1H-pyrrole (210) 
 
Following GP6 using aziridine 190 (73 mg) at 70 °C for 5 h gave pyrrole 210 as brown oil (71 
mg, 98%); νmax (neat)/cm-1 3052, 2958, 2930, 2870, 1738, 1590, 1462, 1369, 1178, 1090, 
1028, 1093, 815, 757; δH (300 MHz; CDCl3) 0.97 (3H, t, J 7.3, CH3), 1.37-1.49 (2H, m, CH2), 
1.64-1.75 (2H, m, CH2), 2.44 (3H, s, CH3), 2.47 (3H, s, CH3), 2.91 (2H, t, J 7.6, CH2), 6.03 
(1H, dt, J 3.3 and 1.0, CH), 6.04 (1H, d, J 3.3, CH), 7.14-7.16 (4H, m, 4 × CH), 7.23 (2H, d, J 
8.0, 2 × CH), 7.29 (2H, d, J 8.4, 2 × CH); δC (75 MHz; CDCl3) 13.9 (CH3), 21.3 (CH3), 21.5 
(CH3), 22.5 (CH2), 29.3 (CH2), 31.6 (CH2), 112.6 (CH), 115.3 (CH), 126.3 (2C, 2 × CH), 
127.9 (2C, 2 × CH), 129.3 (2C, 2 × CH), 130.3 (2C, 2 × CH), 130.5 (Cquat), 136.4 (Cquat), 
137.5 (Cquat), 138.2 (Cquat), 139.6 (Cquat), 144.1 (Cquat); HRMS m/z (TOF ES+) 390.1502. 
C22H25NO2NaS requires 390.1504. 
 
185 
2-Butyl-1-(toluene-4-sulfonyl)-4-p-tolyl-1H-pyrrole (211) 
N
SO O
 
Following GP7 using aziridine 190 (74 mg) for 1.5 h. Purification by flash chromatography 
[hexane:ethylacetate (25:1)] gave a mixture of 2,4-substituted pyrrole 211 and 2,5-substituted 
pyrrole 210 (23 mg, 32%, 1:50 210:211); νmax (neat)/cm-1 3058, 2954, 2921, 1724, 1596, 
1490, 1445, 1365, 1161, 1093, 912, 814, 755; HRMS m/z (TOF ES+) 368.1691. 
C22H26NO2NaS requires 368.1684. 2-Butyl-1-(toluene-4-sulfonyl)-4-p-tolyl-1H-pyrrole 
211: δH (300 MHz; CDCl3) 0.90 (3H, t, J 7.3, CH3), 1.30-1.43 (2H, m, CH2), 1.53-1.63 (2H, 
m, CH2), 2.35 (3H, s, CH3), 2.40 (3H, s, CH3), 2.68 (2H, t, J 7.4, CH2), 6.30 (1H, dt, J 1.9, 
0.9, CH), 7.16 (2H, d, J 8.2, 2 × CH), 7.28 (2H, d, J 8.4, 2 × CH), 7.40 (2H, d, J 8.2, 2 × CH), 
7.54 (1H, d, J 1.9, CH), 7.68 (2H, d, J 8.4, 2 × CH); δC (75 MHz; CDCl3) 13.9 (CH3), 21.1 
(CH3), 21.6 (CH3), 22.4 (CH2), 26.9 (CH2), 30.7 (CH2), 110.5 (CH), 117.3 (CH), 125.3 (2C, 2 
× CH), 126.7 (2C, 2 × CH),129.4 (2C, 2 × CH), 129.9 (2C, 2 × CH), 130.8 (Cquat), 136.4 
(Cquat), 136.5 (2C, 2 × Cquat), 136.9 (Cquat), 144.7 (Cquat). 
 
 
186 
2,5-Diphenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (212) 
N
S OO
 
Following GP6 using aziridine 192 (75 mg) at 70 °C for 3 h gave 212 as a yellow oil (74 mg, 
98%); νmax (neat)/cm-1 3048, 2949, 2925, 1717, 1592, 1491, 1437, 1367, 1167, 1088, 914, 
812, 754; δH (300 MHz; CDCl3) 2.34 (3H, s, CH3), 6.24 (2H, s, 2 × CH), 7.05 (4H, m, 4 × 
CH), 7.37-7.44 (6H, m, 6 × CH), 7.50-7.53 (4H, m, 4 × CH); δC (75 MHz; CDCl3) 21.5 
(CH3), 117.3 (2C, 2 × CH), 127.0 (4C, 4 × CH), 127.5 (2C, 2 × CH), 127.9 (2C, 2 × CH), 
128.7 (4C, 4 × CH), 129.6 (2C, 2 × CH), 133.3 (2C, 2 × Cquat), 134.6 (Cquat), 141.2 (2C, 2 × 
Cquat), 144.3 (Cquat); HRMS m/z (TOF ES+) 396.1039. C23H19NO2NaS requires 396.1034. 
 
Data were in agreement with those reported in the literature.69 
 
2,4-Diphenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (213) 
N
SO O
 
Following GP7 using aziridine 192 (75 mg) for 1.5 h. Purification by flash chromatography 
[hexane:ethylacetate (25:1)] gave a mixture of 2,4-substituted pyrrole 213 and 2,5-substituted 
pyrrole 212 (74 mg, 98%, 1:6 212:213); νmax (neat)/cm-1 3061, 3048, 2923, 1725, 1596, 1492, 
187 
1449, 1363, 1307, 1188, 1168, 1091, 1069, 1046, 1028, 1004, 911, 812, 759; HRMS m/z 
(TOF ES+) 396.1047. C23H19NO2NaS requires 396.1034. 2,4-Diphenyl-1-(toluene-4-
sulfonyl)-1H-pyrrole 213: δH (300 MHz; CDCl3) 2.34 (3H, s, CH3), 6.49 (1H, d, J 1.6, CH), 
7.08 (2H, d, J 8.1, 2 × CH), 7.24-7.37 (10H, m, 10 × CH), 7.53 (2H, d, J 7.3, 2 × CH), 7.73 
(1H, d, J 1.6, CH); δC (75 MHz; CDCl3) 21.6 (CH3), 114.3 (CH), 119.5 (CH), 125.5 (2C, 2 × 
CH), 127.0 (CH), 127.1 (2C, 2 × CH),127.4 (2C, 2 × CH), 127.5 (Cquat), 128.4 (CH), 128.8 
(2C, 2 × CH), 129.4 (2C, 2 × CH), 130.8 (2C, 2 × CH), 130.9 (Cquat), 132.8 (Cquat), 134.9 
(Cquat), 136.5 (Cquat), 144.7 (Cquat). 
 
2-Phenyl-1-(toluene-4-sulfonyl)-5-p-tolyl-1H-pyrrole (214) 
 
Following GP6 using aziridine 193 (77 mg) at 70 °C for 3.5 h gave 214 as a colourless oil (75 
mg, 98%); νmax (neat)/cm-1 3056, 2960, 2937, 1730, 1580, 1491, 1438, 1360, 1167, 1091, 910, 
813, 759; δH (300 MHz; CDCl3) 2.38 (3H, s, CH3), 2.41 (3H, s, CH3), 6.22 (1H, d, J 3.9, CH), 
6.23 (1H, J 3.9, CH), 7.09 (5H, m, 5 × CH), 7.21 (2H, d, J 7.8, 2 × CH), 7.23-7.35 (6H, m, 6 
× CH); δC (75 MHz; CDCl3) 21.4 (CH3), 21.6 (CH3), 117.0 (CH), 117.4 (CH), 127.0 (2C, 2 × 
CH), 127.5 (2C, 2 × CH), 127.8 (CH), 128.3 (2C, 2 × CH), 128.7 (2C, 2 × CH), 129.5 (2C, 2 
× CH), 129.6 (2C, 2 × CH), 130.5 (Cquat), 133.4 (Cquat), 134.6 (Cquat), 137.8 (Cquat), 140.9 
(Cquat), 141.4 (Cquat), 144.3 (Cquat); HRMS m/z (TOF ES+) 410.1188. C24H21NO2NaS requires 
410.1191. 
 
188 
2-Phenyl-1-(toluene-4-sulfonyl)-4-p-tolyl-1H-pyrrole (215) 
N
SO O
 
Following GP7 using aziridine 193 (77 mg) for 30 min. Purification by flash chromatography 
[hexane:ethylacetate (25:1)] gave 2,4-substituted pyrrole 215 as a light brown oil (50 mg, 
65%); νmax (neat)/cm-1 3051, 2950, 2930, 1720, 1590, 1492, 1440, 1360, 1165, 1091, 911, 
811, 756; δH (300 MHz; CDCl3) 2.33 (3H, s, CH3), 2.34 (3H, s, CH3), 6.45 (1H, d, J 1.9, CH), 
7.07 (2H, d, J 8.0, 2 × CH), 7.17 (2H, d, J 8.0, 2 × CH), 7.23-7.43 (9H, m, 9 × CH), 7.67 (1H, 
d, J 1.9, CH); δC (75 MHz; CDCl3) 21.1 (CH3), 21.6 (CH3), 114.4 (CH), 119.2 (CH), 125.4 
(2C, 2 × CH), 127.1 (2C, 2 × CH), 127.4 (2C, 2 × CH),127.6 (Cquat), 128.3 (CH), 129.4 (2C, 2 
× CH), 129.5 (2C, 2 × CH), 130.4 (Cquat), 130.8 (2C, 2 × CH), 131.3 (Cquat), 135.5 (Cquat), 
136.8 (Cquat), 136.9 (Cquat), 144.7 (Cquat); HRMS m/z (TOF ES+) 410.1177. C24H21NO2NaS 
requires 410.1191. 
 
2-Allyl-5-isopropyl-1-(toluene-4-sulfonyl)-1H-pyrrole (216) 
N
S OO
 
Following GP6 using aziridine 197 at 70 °C for 12 h. Purification by flash chromatography 
[hexane:ethylacetate (25:1)] gave 216 as a colourless oil (57 mg, 95%); νmax (neat)/cm-1 3089, 
189 
3010, 2967, 2871, 1831, 1635, 1597, 1366, 1179, 1189, 980, 925, 818, 706, 686; δH (300 
MHz; CDCl3) 1.24 (6H, d, J 6.7, 2 × CH3), 2.44 (3H, s, CH3), 3.50 (1H, sept, J 6.7, CH), 3.60 
(2H, dd, 3.6 and 1.1, CH2), 5.11 (1H, m, CH), 5.16 (1H, m, CH), 5.85-5.99 (2H, m, 2 × CH), 
6.05 (1H, d, J 3.4, CH), 7.31 (2H, d, J 8.2, 2 × CH), 7.50 (2H, d, J 8.2, 2 × CH); δC (75 MHz; 
CDCl3) 21.5 (CH3), 24.0 (2C, 2 × CH3), 27.3 (CH), 33.7 (CH2), 108.9 (CH), 111.9 (CH), 
116.7 (CH2), 125.7 (2C, 2 × CH), 129.8 (2C, 2 × CH), 135.2 (CH), 135.4 (Cquat), 137.7 (Cquat), 
144.2 (Cquat), 145.5 (Cquat); HRMS m/z (TOF ES+) 326.1198. C17H21NO2NaS requires 
326.1191. 
 
2-cyclohexyl-5-isopropyl-1-(toluene-4-sulfonyl)-1H-pyrrole (217) 
N
S OO
 
Following GP6 using aziridine 199 at 70 °C for 3 h gave 217 as a colorless oil (67 mg, 98%); 
νmax (neat)/cm-1 2968, 2926, 2853, 1681, 1598, 1528, 1493, 1447, 1370, 1357, 1304, 1193, 
1180, 1167, 1142, 1111, 1095, 1060, 1016, 810, 783, 747, 703, 682, 665; δH (300 MHz; 
CDCl3) 1.17 (6H, d, J 6.7, 2 × CH3), 1.21-1.49 (4H, m, 2 × CH2), 1.52-1.82 (4H, m, 2 × CH2), 
1.91 (2H, d, J 12.1, CH2), 2.38 (3H, s, CH3), 3.05 (1H, m, CH), 3.42 (1H, sept, J 6.7, CH), 
5.95 (1H, d, J 3.5, CH), 5.98 (1H, d, J 3.5, CH), 7.22 (2H, d, J 8.4, 2 × CH), 7.28 (2H, d, J 
8.4, 2 × CH); δC (75 MHz; CDCl3) 21.5 (CH3), 24.0 (2C, 2 × CH3), 26.2 (CH2), 26.7 (2C, 2 × 
CH2), 27.5 (CH), 34.8 (2C, 2 × CH2), 37.4 (CH), 109.2 (CH), 109.4 (CH), 125.4 (2C, 2 × 
CH), 129.7 (2C, 2 × CH), 138.0 (Cquat), 144.0 (Cquat), 144.5 (Cquat), 145.0 (Cquat); HRMS m/z 
(TOF ES+) 368.1676. C20H27NO2NaS requires 368.1660. 
190 
 
2-isopropyl-5-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (218) 
N
S OO
 
Following GP6 using aziridine 195 at room temperature for 12 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] gave 218 as a yellow oil (64 mg, 95%); νmax 
(neat)/cm-1 3062, 2953, 2931, 2859, 1731, 1595, 1531, 1481, 1445, 1370, 1168, 1116, 1090, 
912, 807, 757; δH (300 MHz; CDCl3) 1.29 (6H, d, J 6.7, 2 × CH3), 2.36 (3H, s, CH3), 3.62 
(1H, sept, J 6.7, CH), 6.07 (2H, m, 2 × CH), 7.13 (2H, d, J 8.4, 2 × CH), 7.25 (2H, d, J 8.8, 2 
× CH), 7.32 (5H, s, 5 × CH); δC (75 MHz; CDCl3) 21.5 (CH3), 23.8 (2C, 2 × CH3), 28.1 (CH), 
111.0 (CH), 115.9 (CH), 126.2 (2C, 2 × CH), 127.2 (2C, 2 × CH), 127.6 (CH), 129.2 (2C, 2 × 
CH), 130.2 (2C, 2 × CH), 133.5 (Cquat), 136.3 (Cquat), 138.8 (Cquat), 144.1 (Cquat), 147.2 (Cquat); 
HRMS m/z (TOF ES+) 362.1186. C20H21NO2NaS requires 362.1191. 
 
Data were in agreement with those reported in the literature.69 
 
 
 
191 
2-Cyclohexyl-5-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (219) 
N
S OO
 
Following GP6 using aziridine 196 at room temperature for 12 h gave 219 as a brown solid 
(74 mg, 98%); mp 143-145 °C; νmax (neat)/cm-1 2929, 2854, 1716, 1598, 1531, 1445, 1363, 
1309, 1215, 1196, 1179, 1167, 1091, 1079, 1062, 1049, 1018, 895, 811, 798, 756, 747; δH 
(300 MHz; CDCl3) 1.38-1.68 (4H, m, 2 × CH2), 1.90-2.01 (4H, m, 2 × CH2), 2.24-2.30 (2H, 
m, CH2), 2.52 (3H, s, CH3), 3.42 (1H, t, J 11.2, CH), 6.20 (1H, dd, J 3.3 and 0.8, CH), 6.24 
(1H, d, J 3.3, CH), 7.29 (2H, d, J 8.1, 2 × CH), 7.41 (2H, d, J 8.1, 2 × CH), 7.48 (5H, s, 5 × 
CH); δC (75 MHz; CDCl3) 21.5 (CH3), 26.5 (CH2), 26.7 (2C, 2 × CH), 34.6 (2C, 2 × CH2), 
37.9 (CH), 111.0 (CH), 115.9 (CH), 126.2 (2C, 2 × CH), 127.2 (2C, 2 × CH), 127.6 (CH), 
129.2 (2C, 2 ×CH), 130.2 (2C, 2 × CH), 133.5 (Cquat), 136.4 (Cquat), 138.4 (Cquat), 144.1 
(Cquat), 146.2 (Cquat); HRMS m/z (TOF ES+) 376.1350. C23H25NO2NaS requires 376.1347. 
 
Data were in agreement with those reported in the literature.69 
 
 
 
 
192 
2-Butyl-5-cyclohexyl-1-(toluene-4-sulfonyl)-1H-pyrrole (220) 
N
S OO
 
Following GP6 using aziridine 191 at 70 °C for 4 h gave 220 as a brown oil (70 mg, 98%); 
νmax (neat)/cm-1 2925, 2855, 1740, 1681, 1601, 1528, 1493, 1448, 1369, 1359, 1340, 1192, 
1174, 1152, 1117, 1093, 892, 810, 770, 751, 722, 665; δH (300 MHz; CDCl3) 0.99 (3H, t, J 
7.3, CH3), 1.15-1.38 (4H, m, 4 × CH2), 1.61-1.70 (6H, m, 3 × CH2), 1.85 (2H, m, CH2), 2.02 
(2H, d, J 12.3, CH2), 2.48 (3H, s, CH3), 2.83 (2H, t, J 12.3, CH2), 3.18 (1H, m, CH), 6.02 (1H, 
d, J 3.5, CH), 6.04 (1H, d, J 3.5, CH), 7.34 (2H, d, J 8.4, 2 × CH), 7.52 (2H, d, J 8.4, 2 × CH); 
δC (75 MHz; CDCl3) 13.9 (CH3), 21.6 (CH3), 22.4 (CH2), 26.2 (CH2), 26.7 (2C, 2 × CH2), 
28.8 (CH2), 31.1 (CH2), 34.8 (2C, 2 × CH2), 37.2 (CH), 109.0 (CH), 111.0 (CH), 125.6 (2C, 2 
× CH), 129.7 (2C, 2 × CH), 137.7 (Cquat), 138.0 (Cquat), 144.0 (Cquat), 144.2 (Cquat); HRMS m/z 
(TOF ES+) 382.1828. C21H29NO2NaS requires 382.1817. 
 
Data were in agreement with those reported in the literature.69 
 
2-phenethyl-5-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (221) 
N
S OO
 
Following GP6 using aziridine 200 at 70 °C for 4 h. Purification by flash chromatography 
[hexane:ethylacetate (20:1)] gave 221 as a yellow oil (76 mg, 95%); νmax (neat)/cm-1 3027, 
193 
2920, 2851, 1596, 1494, 1452, 1363, 1295, 1170, 1098, 1071, 1028, 908, 809, 759, 729, 694; 
δH (300 MHz; CDCl3) 2.38 (3H, s, CH3), 3.05-3.10 (2H, m, CH2), 3.23-3.28 (2H, m, CH2), 
6.06 (1H, d, J 3.3, CH), 6.09 (1H, d, J 3.3, CH), 7.15 (2H, d, J 8.3, 2 × CH), 7.21-7.33 (7H, 
m, 7 × CH), 7.35 (5H, m, 5 × CH); δC (75 MHz; CDCl3) 21.6 (CH3), 31.8 (CH2), 36.3 (CH2), 
113.5 (CH), 115.6 (CH), 126.0 (CH), 126.4 (2C, 2 × CH), 127.2 (2C, 2 × CH), 127.8 (CH), 
128.3 (2C, 2 × CH), 128.5 (2C, 2 × CH), 129.3 (2C, 2 × CH), 130.5 (2C, 2 × CH), 133.2 
(Cquat), 136.2 (Cquat), 138.4 (Cquat), 138.8 (Cquat), 141.5 (Cquat), 144.3 (Cquat); HRMS m/z (TOF 
ES+) 424.1340. C25H23NO2NaS requires 424.1347. 
 
2-(4-bromophenyl)-5-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (222) 
 
N
S OO Br
 
Following GP6 using aziridine 201 at 70 °C for 3 h gave pyrrole 222 as a brown oil (88 mg, 
98%); νmax (neat)/cm-1 2233, 1705, 1596, 1439, 1371, 1176, 1092, 920, 810, 729, 703; δH (300 
MHz; CDCl3) 2.38 (3H, s, CH3), 6.26 (2H, d, J 3.5, 2 × CH), 7.05-7.12 (4H, m, 4 × CH), 
7.28-7.55 (9H, m, 9 × CH); δC (75 MHz; CDCl3) 21.6 (CH3), 117.3 (CH), 118.3 (CH), 126.8 
(2C, 2 × CH), 127.6 (2C, 2 × CH), 127.8 (Cquat), 128.7 (2C, 2 × CH), 128.8 (2C, 2 × CH), 
128.9 (2C, 2 × CH), 129.5 (2C, 2 × CH), 133.0 (Cquat), 133.4 (CH), 134.3 (Cquat), 134.8 
(Cquat), 139.2 (Cquat), 141.9 (Cquat), 144.7 (Cquat); HRMS m/z (TOF ES+) 474.0144. 
C23H18NO2NaS79Br requires 474.0139. 
 
194 
(3-phenyl-1,2-propandienyl)triphenylphosphonium bromide (223) 
 
Triphenylphosphine (10.5 mmol, 2.75 g) was added to a solution of bromide 173 (10.5 mmol, 
2.04 g) in toluene (45 mL) and the reaction mixture was heated at 75 °C. After 12 h stirring 
was pursued at room temperature for 1 h. The solid was filtered off, washed with n-pentane (4 
× 15 mL) and dried to give phosphonium bromide 223 as a white solid (3.93 g, 82 %); mp 
180-181 ºC; νmax (neat)/cm-1 2987, 2901, 2803, 1585,1487, 1455, 1440, 1394, 1380, 1108, 
1066, 993, 906; δH (300 MHz; CDCl3) 5.19 (2H, d, J 15.1, CH2), 6.95-7.20 (4H, m, 4 × CH), 
7.45-7.70 (16H, m, 16 × CH); δC (75 MHz; CDCl3) 20.2 (CH2), 80.0 (Cquat), 81.2 (Cquat), 
118.0 (3 × Cquat), 128.4 (2C, 2 × CH), 129.0 (Cquat), 130.3 (6C, 6 × CH), 131.5 (CH), 134.0 
(2C, 2 × CH), 134.1 (6C, 6 × CH), 135.3 (3C, 3 × CH). 
 
Mixture of (E)- and (Z)-But-1-en-3-yne-1,4-dibenzene (224) 
 
n-BuLi (3.28 mmol, 1.32 mL of a 2.5M solution in hexane) was added dropwise to a solution 
of phosphonium bromide 223 (3.28 mmol, 1.51 g) in THF (40 mL) at 0 ºC. The reaction 
mixture was cooled down to -78 ºC and was stirred 30 min. Benzaldehyde (3.28 mmol, 0.35 
mL) was added dropwise and the reaction mixture was stirred at room temperature for 12 h. 
NH4Cl solution (20 mL) was added to quench the reaction and the THF was removed under 
reduced pressure. CH2Cl2 (20 mL) was added and the phases were separated. The aqueous 
195 
phase was washed with CH2Cl2 (3 × 20 mL) and the combined organic extracts were washed 
with brine (20 mL), dried (Na2SO4) and concentrated under reduced pressure. Purification by 
flash chromatography of the residue gave enyne 224 as a yellow solid (422 mg, 63%, 2:1 
E:Z); νmax (neat)/cm-1 3058, 3026, 2190, 1948,1879, 1593, 1487, 1440, 1119, 1069, 1027, 950, 
913, 782, 747, 721, 686; δH (300 MHz; CDCl3) 5.92 (1H, d, J 12.0, CH, from Z isomer), 6.39 
(1H, d, J 16.1, CH, from E isomer), 6.70 (1H, d, J 12.0, CH, from Z isomer), 7.05 (1H, d, J 
16.1, CH, from E isomer), 7.25-7.55 (18H, m, 18 × CH), 7.93 (2H, d, J 7.6, 2 × CH, from Z 
isomer); δC (75 MHz; CDCl3) 141.3 (CH, from E isomer), 138.7 (CH, from Z isomer), 136.6 
(Cquat, CH, from Z isomer), 136.4 (Cquat, from E isomer), 131.5 (2C, 2 × CH, from E isomer), 
131.4 (2C, 2 × CH, from Z isomer), [128.7-128.1] (18C, unidentified), 126.3 (2C, 2 × CH, CH 
from Z isomer and CH, from E isomer), 108.2 (CH, from E isomer), 107.4 (CH, CH, from Z 
isomer), 91.8 (Cquat, from Z isomer), 88.9 (Cquat, from E isomer), 88.3 (Cquat, from E isomer), 
87.7 (Cquat, from Z isomer). 
 
Data were in agreement with those reported in the literature.101 
 
2-Phenyl-3-(phenylethynyl)oxirane (225) 
 
mCPBA (4.1 mmol, 1.09 g of a 77% mixture with water) was added in one portion to a 
solution of enyne 224 (2 mmol, 408 mg) and NaHCO3 (6.2 mmol, 521 mg) in CH2Cl2 (10 
mL). The reaction mixture was stirred 12 h at room temperature. Water was then added and 
the phases were separated. The aqueous phase was washed with CH2Cl2 (3 × 10 mL) and the 
combined organic extracts were washed with brine (10 mL), dried (Na2SO4) and concentrated 
196 
under reduced pressure. Purification of the residue by flash chromatography 
[hexane:ethylacetate (90:1)] gave oxirane 225 as a white solid (220 mg, 50%, cis: trans 
1:1.2); cis-2-Phenyl-3-(phenylethynyl)oxirane: δH (300 MHz; CDCl3) 3.60 (1H, d, J 2.1, 
CH), 4.17 (1H, d, J 2.1, CH), 7.30-7.52 (10H, m, 10 × CH); δC (75 MHz; CDCl3) 49.9 (CH), 
60.4 (CH), 83.9 (Cquat), 85.3 (Cquat), 121.9 (Cquat), 125.6 (2C, 2 × CH), 128.4 (2C, 2 × CH), 
128.6 (2C, 2 × CH), 128.8 (CH), 128.9 (CH), 132.0 (2C, 2 × CH), 135.8 (Cquat). trans-2-
Phenyl-3-(phenylethynyl)oxirane: δH (300 MHz; CDCl3) 3.99 (1H, d, J 4.3, CH), 4.25 (1H, 
d, J 4.3, CH), 7.33-7.54 (10H, m, 10 × CH); δC (75 MHz; CDCl3) 48.7 (CH), 59.3 (CH), 83.7 
(Cquat), 86.1 (Cquat), 122.0 (Cquat), 127.0 (2C, 2 × CH), 127.9 (2C, 2 × CH), 128.3 (2C, 2 × 
CH), 128.5 (CH), 128.8 (CH), 131.9 (2C, 2 × CH), 134.3 (Cquat). 
 
2,5-diphenylfuran (226) 
 
Following GP6 using oxirane 225 (44 mg) at 70 °C for 4 h. Purification by flash 
chromatography [hexane:ethylacetate (4:1)] gave 226 as a colourless oil (12 mg, 27%); νmax 
(neat)/cm-1 3120, 3004, 2960, 1730, 1602, 1532, 1475, 1266, 1080, 980, 932, 852, 796; δH 
(300 MHz; CDCl3) 6.75 (2H, s, 2 × CH), 7.26-7.30 (2H, m, 2 × CH), 7.38-7.44 (4H, m, 4 × 
CH), 7.72-7.79 (4H, m, 4 × CH); δC (75 MHz; CDCl3) 107.2 (2C, 2 × CH), 123.7 (4C, 4 × 
CH), 127.4 (2C, 2 × CH), 128.7 (4C, 4 × CH), 130.8 (2C, 2 × Cquat), 153.4 (2C, 2 × Cquat). 
 
Data was in agreement with the one reported in the literature.102 
 
197 
2,4-diphenyl (227) 
 
Following GP7 using oxirane 225 (44 mg) for 15 min. Purification by flash chromatography 
[hexane:ethylacetate (4:1)] gave a mixture of 2,4-substituted furan 227 and 2,5-substituted 
furan 226 (8 mg, 19%, 1:3 226:227); νmax (neat)/cm-1 3130, 3012, 2933, 2902, 1740, 1609, 
1482, 1230, 1152, 1075, 998, 956, 810, 789; δH (300 MHz; CDCl3) 6.90 (1H, s, CH), 7.18-
7.40 (6H, m, 6 × CH), 7.41-7.73 (5H, m, 5 × CH); δC (75 MHz; CDCl3) 104.0 (CH), 123.9 
(Cquat), 125.8 (2C, 2 × CH), 127.1 (2C, 2 × CH), 127.6 (2C, 2 × CH), 128.4 (2C, 2 × CH), 
128.7 (CH), 128.8 (CH), 130.7 (CH), 132.4 (Cquat), 137.9 (Cquat), 154.9 (Cquat). 
 
Data was in agreement with the one reported in the literature.103 
 
tert-butyldimethyl(pent-4-ynyloxy)silane (230) 
 
TBDMSCl (11 mmol, 1.66 g) was added to a solution of pent-4-yn-1-ol (10 mmol, mL), 
DMAP (0.1 mmol, 12 mg) and triethylamine (22 mmol, 3.0 mL) in CH2Cl2 (50 mL). The 
reaction mixture was stirred at room temperature for 48 h. A NH4Cl solution (20 mL) was 
added to quench the reaction and the two phases were separated. The aqueous phase was 
washed with CH2Cl2 (3 × 15 mL) and the combined organic extracts were washed with brine 
(15 mL), dried (Na2SO4) and concentrated under reduced pressure. The residue was purified 
by flash chromatography [hexane:ethylacetate (4:1)] to give silyl ether 230 as a colourless oil 
198 
(1.95 g, 99%); νmax (neat)/cm-1 3315, 2958, 2935, 2870, 1530, 1479, 1430, 1356, 1280, 1262, 
1104, 979, 844, 802, 795; δH (300 MHz; CDCl3) 0.04 (6H, s, 2 × CH3), 0.89 (9H, s, 3 × CH3), 
1.71 (2H, tt, J 7.1 and 6.1, CH2),1.91 (1H, t, J 2.8, CH), 2.26 (2H, td, J 7.1 and 2.8, CH2), 
3.68 (2H, t, J 6.1, CH2); δC (75 MHz; CDCl3) -5.4 (2C, 2 × CH3), 14.8 (CH2), 18.3 (Cquat), 
25.9 (3C, 3 × CH3), 31.5 (CH2), 61.5 (CH2), 68.2 (Cquat), 84.2 (CH). 
 
Data were in agreement with those reported in the literature.104 
 
6-(tert-butyldimethylsilyloxy)hex-2-yn-1-ol (231) 
 
n-BuLi (10 mmol, 4.0 mL of a 2.5M solution in hexane) was added dropwise to a solution of 
silylether 230 (10 mmol) in THF (40 mL) at -78 ºC. The reaction mixture was stirred 30 min 
at -78 ºC before paraformaldehyde (10 mmol, 300 mg) was added. The temperature was 
raised to room temperature and the reaction mixture stirred for 12 h. NH4Cl solution (20 mL) 
was added to quench the reaction and the THF was removed under reduced pressure. Et2O (20 
mL) was added and the phases were separated. The aqueous phase was washed with Et2O (3 × 
20 mL) and the combined organic extracts were washed with brine (20 mL), dried (Na2SO4) 
and concentrated under reduced pressure. Purification of the residue by flash chromatography 
[hexane:ethylacetate (2:1)] gave alcohol 231 as a colourless oil (1.82 g, 80%); νmax (neat)/cm-1 
3345, 2956, 2935, 2853, 1478, 1389, 1364, 1307, 1260, 1108, 983, 850, 812; δH (300 MHz; 
CDCl3) 0.04 (6H, s, 2 × CH3), 0.88 (9H, s, 3 × CH3), 1.70 (2H, tt, J 7.0 and 6.1, CH2), 2.16 
(1H, s, OH), 2.28 (2H, tt, J 7.1 and 2.1, CH2), 3.67 (2H, t, J 6.1, CH2), 4.21 (2H, t, J 2.1, 
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CH2); δC (75 MHz; CDCl3) -5.4 (2C, 2 × CH3), 15.1 (CH2), 18.3 (Cquat), 25.9 (3C, 3 × CH3), 
31.5 (CH2), 51.1 (CH2), 61.5 (CH2), 78.4 (Cquat), 85.9 (Cquat). 
 
Data were in agreement with those reported in the literature.104 
 
(6-bromohex-4-ynyloxy)tert-butyldimethylsilane (232) 
 
To a solution of PPh3 (8.7 mmol, 2.28 g) in CH2Cl2 (25 mL) at 0 °C was added Br2 (8.6 
mmol, 0.43 mL) dropwise. The reaction mixture was stirred for 30 min at 0 °C before a 
solution of alcohol 231 (7.9 mmol, 1.82 g) in CH2Cl2 (10 mL) was added dropwise. The 
reaction mixture was warmed to room temperature and stirred for 1h. Water (25 mL) was 
added to quench the reaction and the two phases were separated. The aqueous phase was 
washed with CH2Cl2 (3 × 20 mL) and the combined organic extracts were washed with brine 
(20 mL), dried (Na2SO4) and concentrated under reduced pressure. Purification of the residue 
by flash chromatography [hexane:ethylacetate (15:1)] gave bromide 232 as a yellow oil ( 
2.07g, 90%); νmax (neat)/cm-1 3009, 2966, 2856, 2241, 1532, 1480, 1359, 1258, 1208, 1116, 
1106, 932, 875, 810; δH (300 MHz; CDCl3) 0.05 (6H, s, 2 × CH3), 0.89 (9H, s, 3 × CH3), 1.70 
(2H, tt, J 7.0 and 6.1, CH2), 2.32 (2H, tt, J 7.0 and 2.2, CH2), 3.68 (2H, t, J 6.1, CH2), 3.91 
(2H, t, J 2.2, CH2); δC (75 MHz; CDCl3) -5.4 (2C, 2 × CH3), 15.3 (CH2), 15.6 (CH2), 18.3 
(Cquat), 25.9 (3C, 3 × CH3), 31.3 (CH2), 61.4 (CH2), 75.4 (Cquat), 87.8 (Cquat). 
 
Data were in agreement with those reported in the literature.104 
 
200 
3-(tert-butyldimethylsilyloxy)propan-1-ol (228) 
OH O
Si
 
TBDPSCl (7.6 mmol, 1.15 g) was added to a solution of 1,3-propandiol (30 mmol, 2.75 mL), 
DMAP (0.38 mmol, 46 mg) and triethylamine (15.2 mmol, 2.1 mL) in CH2Cl2 (100 mL). The 
reaction mixture was stirred at room temperature for 48 h. A NH4Cl solution (40 mL) was 
added to quench the reaction and the two phases were separated. The aqueous phase was 
washed with CH2Cl2 (3 × 20 mL) and the combined organic extracts were washed with brine 
(20 mL), dried (Na2SO4) and concentrated under reduced pressure. The residue was purified 
by flash chromatography [hexane:ethylacetate (4:1)] to give alcohol 228 as a colourless oil 
(1.15 g, 80%); νmax (neat)/cm-1 2990, 2982, 1474, 1366, 1216, 1105, 1092, 762, 705; δH (300 
MHz; CDCl3) 0.08 (6H, s, 2 × CH3), 0.90 (9H, s, 3 × CH3), 1.77 (2H, quint, J 5.8, CH2), 3.81-
3.84 (4H, m, 2 × CH2); δC (75 MHz; CDCl3) -5.4 (2C, 2 × CH3), 18.3 (Cquat), 25.9 (3C, 3 × 
CH3), 34.1 (CH2), 62.5 (CH2), 63.0 (CH2). 
 
Data were in agreement with those reported in the literature.105 
 
3-(tert-butyldimethylsilyloxy)propanal (229) 
 
A solution of DMP (7.3 mmol, 3.10 g) in CH2Cl2 (10 mL) was added to a solution of alcohol 
228 (6.08 mmol, 1.15 g) in CH2Cl2 (50 mL) at room temperature. After stirring 2 h, Na2S2O3 
solution (15 mL) was added to quench the reaction. The two phases were separated and the 
aqueous phase was washed with CH2Cl2 (3 × 15 mL). The combined organic extracts were 
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washed with brine (15 mL), dried (Na2SO4) and concentrated under reduced pressure. The 
residue was purified by flash chromatography [hexane:ethylacetate (20:1)] to give alcohol 229 
as a colourless oil (973 mg, 85%); νmax (neat)/cm-1 2960, 2941, 2875, 2735, 1727, 1530, 1478, 
1390, 1260, 1163, 1105, 978, 826, 803, 770; δH (300 MHz; CDCl3) 0.02 (6H, s, 2 × CH3), 
0.85 (9H, s, 3 × CH3), 2.55 (2H, td, J 6.0 and 2.1, CH2), 3.95 (2H, t, J 6.0, 2 × CH), 9.76 (1H, 
t, J 2.1, CH); δC (75 MHz; CDCl3) -5.5 (2C, 2 × CH3), 18.1 (Cquat), 25.7 (3C, 3 × CH3), 46.5 
(CH2), 57.3 (CH2), 201.8 (Cquat). 
 
Data were in agreement with those reported in the literature106 
 
trans-2-Phenyl-3-(phenylethynyl)aziridin-1-yl)isoindoline-1,3-dione (233) 
 
A solution of (PbOAc)4 (4 mmol, 1.77 g) in CH2Cl2 (10 mL) was added over 20 min to a 
mixture of enyne 224 (2 mmol, 408 mg), N-aminophthalimide (4 mmol, 648 mg) and K2CO3 
(20 mmol, 2.76 g) in CH2Cl2 (50 mL) at 0 °C. The reaction mixture was then stirred 12 h at 
room temperature. Water (15 mL) was added to quench the reaction and the phases were 
separated. The aqueous phase was washed with CH2Cl2 (3 × 20 mL) and the combined 
organic extracts were washed with brine (30 mL), dried (Na2SO4) and concentrated under 
reduced pressure. Purification of the residue by flash chromatography [hexane:ethylacetate 
(5:1)] gave trans-aziridine 233 as a yellow solid (480 mg, 60%); mp 112-114 °C; νmax 
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(neat)/cm-1 3063, 2250, 1735, 1605, 1532, 1376, 1136, 1055, 963, 870, 865, 732; δH (300 
MHz; CDCl3) 3.56 (1H, d, J 5.1, CH), 4.48 (1H, d, J 5.1, CH), 7.20-7.30 (5H, m, 5 × CH), 
7.36-7.43 (3H, m, 3 × CH), 7.47-7.50 (2H, m, 2 × CH), 7.69-7.72 (2H, m, 2 × CH), 7.82-7.84 
(2H, m, 2 × CH); δC (75 MHz; CDCl3) 40.6 (CH), 50.9 (CH), 82.8 (Cquat), 85.7 (Cquat), 121.8 
(2C, 2 × Cquat), 123.1 (2C, 2 × CH), 127.0 (2C, 2 × CH), 128.2 (2C, 2 × CH), 128.4 (CH), 
128.6 (2C, 2 × CH), 130.2 (2C, 2 × CH), 131.6 (2C, 2 × CH2), 134.1 (2C, 2 × Cquat), 135.0 
(CH), 165.3 (2C, 2 × Cquat). 
 
Data were in agreement with those reported in the literature.107 
 
2-(2,5-diphenyl-1H-pyrrol-1-yl)isoindoline-1,3-dione (234) 
 
Following GP7 using alkynyl aziridine 233 at 70 °C for 12 h. Purification by flash 
chromatography [hexane:ethylacetate (4:1)] gave 234 as a yellow solid (3 mg, 5%); mp 170-
172 °C; δH (300 MHz; CDCl3) 6.51 (2H, s, 2 × CH), 7.20-7.23 (2H, m, 2 × CH), 7.25-7.30 
(4H, m, 4 × CH), 7.42-7.46 (4H, m, 4 × CH), 7.65-7.70 (2H, m, 2 × CH), 7.76-7.80 (2H, m, 2 
× CH); δC (75 MHz; CDCl3) 109.3 (2C, 2 × CH), 124.1 (2C, 2 × CH), 127.8 (2C, 2 × CH), 
127.9 (4C, 4 × CH), 128.6 (4C, 4 × CH), 129.1 (2C, 2 × Cquat), 131.0 (2C, 2 × Cquat), 134.7 
(2C, 2 × CH), 137.6 (2C, 2 × Cquat), 165.1 (2C, 2 × Cquat). 
 
Data was in agreement with the one reported in the literature.107 
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4-methylbenzaldehyde-α-d (235) 
 
Ethyl 4-methylbenzoate (2.5 mmol, 0.39 mL) was added to a suspension of LiAlD4 (3.5 
mmol, 147 mg) in Et2O (5 mL) at 0 °C.The reaction mixture was stirred at room temperature 
for 1 h. After cooling down to 0 °C water (2.5 mL) was added to quench the reaction. A 
solution of HCl (10%, 2.5 mL) was added to solubilise the suspension and the two phases 
were separated. The aqueous phase was washed with Et2O (3 × 10 mL). The combined 
organic abstracts were wased with brine (10 mL), dried (Na2SO4), and concentrated under 
reduced pressure to give 4-methylbenzyl alcohol-α,α-d.  
A solution of the crude deuterated alcohol in CH2Cl2 (2 mL) was added to a solution of DMP 
(3 mmol, 1.26 g) in CH2Cl2 (5 mL). The reaction mixture was stirred at room temperature for 
2 h and a solution of Na2S2O3 (5 mL) was added to quench the reaction. The two phases were 
separated and the aqueous phase was washed with CH2Cl2 (3 × 10 mL). The combined 
organic extracts were washed with brine (10 mL), dried (Na2SO4) and concentrated under 
reduced pressure. The residue was purified by distillation under reduced pressure (78 °C at 10 
mmHg) to give aldehyde 235 as a colourless liquid (455 mg, 85%); δH (300 MHz; CDCl3) 
2.43 (3H, s, CH3), 7.30 (2H, d, J 7.9, 2 × CH), 7.75 (2H, d, J 7.9, 2 × CH); δC (75 MHz; 
CDCl3) 21.9 (CH3), 129.7 (2C, 2 × CH), 129.9 (2C, 2 × CH), 134.2 (Cquat), 145.5 (Cquat). 
 
N-(Deuteriophenylmethylene)-4-methylbenzenesulfonamide (236) 
 
A mixture of 4-methylbenzaldehyde-α-d (2 mmol, 428 mg), p-toluenesulfonamide (1.9 mmol, 
325 mg), amberlyst (150 mg) and 4Å molecular sieve (150 mg) in toluene was stirred at 130 
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°C in a Dean-stark apparatus. After 12h, the reaction mixture was cooled down to room 
temperature and filtered. The filtrate was concentrated under reduced pressure and the residue 
was recristalised (ethyl acetate/n-pentane) to give imine 236 as a white solid (383 mg, 70%); 
99-100 °C; νmax (neat)/cm-1 3356, 3260, 1582, 1552, 1508, 1494, 1445, 1409, 1387, 1318, 
1303, 1288, 1155, 1089, 1033, 1018, 905, 858, 821, 809, 785, 753, 705; δH (300 MHz; 
CDCl3) 2.43 (6H, s, 2 × CH3), 7.28 (2H, d, J 7.9, 2 × CH), 7.34 (2H, d, J 7.9, 2 × CH), 7.81 
(2H, d, J 8.2, 2 × CH), 7.88 (2H, d, J 8.2, 2 × CH); δC (75 MHz; CDCl3) 21.6 (CH3), 22.0 
(CH3), 128.0 (2C, 2 × CH), 129.8 (2C, 2 × CH), 129.9 (2C, 2 × CH), 131.4 (2C, 2 × CH), 
135.5 (Cquat), 144.4 (2C, 2 × Cquat), 146.4 (2C, 2 × Cquat); HRMS m/z (TOF ES+) 297.0791. 
C15H14DNO2NaS requires 297.0784. 
 
2-Deuterio-3-Hex-1-ynyl-1-(toluene-4-sulfonyl)-2-p-tolylaziridine (237) 
 
Following GP 3 using imine 236 and sulfonium salt 180 for 3 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] gave aziridine 237 as a beige solid (143 mg, 
77%, 12:1 cis:trans); νmax (neat)/cm-1 2961, 2926, 2874, 2248, 1921, 1598, 1518, 1458, 1410, 
1363, 1323, 1301, 1181, 1161, 1133, 1090, 1019, 914, 894, 838, 805, 757, 704; δH (300 MHz; 
CDCl3) 0.76 (3H, t, J 7.2, CH3), 1.05-1.18 (2H, m, CH2), 1.22-1.31 (2H, m, CH2), 2.02 (2H, 
td, J 6.9 and 1.8, CH2), 2.32 (3H, s, CH3), 2.43 (3H, s, CH3), 3.60 (1H, t, J 1.8, CH), 7.09 (2H, 
d, J 8.1, 2 × CH), 7.21 (2H, d, J 8.1, 2 × CH), 7.33 (2H, d, J 8.4, 2 × CH), 7.87 (2H, d, J 8.4, 
2 × CH); δC (75 MHz; CDCl3) 13.4 (CH3), 18.3 (CH2), 21.2 (CH3), 21.5 (CH2), 21.6 (CH3), 
205 
30.0 (CH2), 36.1 (CH), 72.3 (Cquat), 86.6 (Cquat), 127.6 (2C, 2 × CH), 127.9 (2C, 2 × CH), 
128.6 (2C, 2 × CH), 129.1 (Cquat), 129.7 (2C, 2 × CH), 134.8 (Cquat), 138.0 (Cquat), 144.7 
(Cquat); HRMS m/z (TOF ES+) 391.1563. C22H24DNO2NaS requires 391.1566. 
 
Mixture of 2-butyl-3-deuterio-1-(toluene-4-sulfonyl)-5-p-tolyl-1H-pyrrole (205) and 2-
Butyl-1-(toluene-4-sulfonyl)-5-p-tolyl-1H-pyrrole (210) 
N
S OO
D
 
Following GP 6 using aziridine 237 (0.2 mmol, 70 mg) for 2.5 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] gave a mixture of deuterated pyrrole 205, 
pyrrole 210 and deuterated pyrrole 238 as a colourless oil (69 mg, 84%, 205:210:238 
49:38:1); νmax (neat)/cm-1 2956, 2927, 2862, 1597, 1529, 1494, 1455, 1405, 1367, 1291, 1187, 
1172, 1092, 1017, 810, 703, 660; HRMS m/z (TOF ES+) 391.1572. C22H24DNO2NaS requires 
391.1566. 
2-butyl-3-deuterio-1-(toluene-4-sulfonyl)-5-p-tolyl-1H-pyrrole 205: δH (300 MHz; CDCl3) 
0.96 (3H, t, J 7.3, CH3), 1.36-1.49 (2H, m, CH2), 1.64-1.74 (2H, m, CH2), 2.37 (3H, s, CH3), 
2.39 (3H, s, CH3), 2.90 (2H, t, J 7.7, CH2), 6.04 (1H, s, CH), 7.12-7.16 (4H, m, 4 × CH), 7.23 
(2H, d, J 8.0, 2 × CH), 7.29 (2H, d, J 8.4, 2 × CH); δC (75 MHz; CDCl3) 13.9 (CH3), 21.3 
(CH3), 21.5 (CH3), 22.5 (CH2), 29.3 (CH2), 31.6 (CH2), 115.2 (CH), 126.3 (2C, 2 × CH), 
127.9 (2C, 2 × CH), 129.3 (2C, 2 × CH), 130.3 (2C, 2 × CH), 130.5 (Cquat), 136.4 (Cquat), 
137.5 (Cquat), 138.2 (Cquat), 139.6 (Cquat), 144.1 (Cquat). 
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2-butyl-3-deuterio-1-(toluene-4-sulfonyl)-4-p-tolyl-1H-pyrrole (239) 
N
S OO
D
 
Following GP7 using aziridine 237 (74 mg) for 1 h. Purification by flash chromatography 
[hexane:ethylacetate (25:1)] gave a mixture of 2,4-substituted pyrrole 239, 2,4-substituted 
pyrrole 211 and 2,5-substituted pyrrole 210 (13 mg, 18%, 10.5:3.1:1 239:211:210); δH (300 
MHz; CDCl3) 0.90 (3H, t, J 7.3, CH3), 1.30-1.43 (2H, m, CH2), 1.53-1.64 (2H, m, CH2), 2.35 
(3H, s, CH3), 2.40 (3H, s, CH3), 2.68 (2H, t, J 7.4, CH2), 7.16 (2H, d, J 8.2, 2 × CH), 7.28 
(2H, d, J 8.4, 2 × CH), 7.40 (2H, d, J 8.2, 2 × CH), 7.54 (1H, s, CH), 7.68 (2H, d, J 8.4, 2 × 
CH); δC (75 MHz; CDCl3) 13.9 (CH3), 21.1 (CH3), 21.6 (CH3), 22.4 (CH2), 26.9 (CH2), 30.7 
(CH2), 117.3 (CH), 125.3 (2C, 2 × CH), 126.7 (2C, 2 × CH),129.4 (2C, 2 × CH), 129.9 (2C, 2 
× CH), 130.8 (Cquat), 136.4 (Cquat), 136.5 (Cquat), 136.6 (Cquat), 136.9 (Cquat), 144.7 (Cquat); 
HRMS m/z (TOF ES+) 391.1559. C22H24DNO2NaS requires 391.1566. 
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13C-enriched benzaldehyde (241) 
 
A solution of 13C-enriched benzoic acid (5 mmol, 610 mg, 13C:12C 1:5) in Et2O (5 mL), was 
added dropwise to a suspension of LiAlH4 (12 mmol, 504 mg) in Et2O (25 mL) at 0 °C. After 
20 min stirring the reaction mixture was heated at 50 °C for 2 h. After cooling down to 0 °C 
water (15 mL) was added to quench the reaction. A solution of HCl (10%, 5 mL) was added 
to solubilise the suspension and the two phases were separated. The aqueous phase was 
washed with Et2O (3 × 15 mL). The combined organic abstracts were wased with brine (15 
mL), dried (Na2SO4), and concentrated under reduced pressure to give 13C-enriched benzyl 
alcohol.  
A solution of the crude 13C-enriched benzyl alcohol in CH2Cl2 (5 mL) was added to a solution 
of DMP (7.5 mmol, 3.16 g) in CH2Cl2 (30 mL). The reaction mixture was stirred at room 
temperature for 4 h and a solution of Na2S2O3 (15 mL) was added to quench the reaction. The 
two phases were separated and the aqueous phase was washed with CH2Cl2 (3 × 15 mL). The 
combined organic extracts were washed with brine (15 mL), dried (Na2SO4) and concentrated 
under reduced pressure. The residue was purified by distillation under reduced pressure (75 
°C at 10 mmHg) to give 13C-enriched benzaldehyde 241 as a colourless liquid (425 mg, 80%); 
δH (300 MHz; CDCl3) 7.50-7.73 (3H, m, 3 × CH), 7.75-7.92 (2H, m, 2 × CH), 10.07 (1H, s, 
CH); δC (75 MHz; CDCl3) 129.2 (2C, 2 × CH), 130.0 (2C, 2 × CH), 134.7 (CH), 136.7 (Cquat), 
192.6 (13C-enriched signal, CH). 
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13C enriched N-Benzylidene-4-methylbenzenesulfonamide (242) 
 
A 1:5 mixture of benzaldehyde-α-13C and benzaldehyde (5.5 mmol, 589 mg), p-
toluenesulfonamide (5.0 mmol, 856 mg), amberlyst 15 (380 mg) and 4Å molecular sieve (380 
mg) in toluene (30 mL) was stirred at 130 °C in a Dean-Stark apparatus. After 12h, the 
reaction mixture was cooled down to room temperature and filtered. The filtrate was 
concentrated under reduced pressure and the residue was recristalised (ethyl acetate/n-
pentane) to give 13C-enriched imine 242 as a white solid (907 mg, 70%); mp 102-103 °C; νmax 
(neat)/cm-1 2922, 2853, 2179, 1598, 1449, 1413, 1364, 1326, 1291, 1245, 1158, 1135, 1090, 
1061, 994, 959, 859, 838, 824, 815, 749, 701; δH (300 MHz; CDCl3) 2.41 (3H, s, CH3), 7.35 
(2H, d, J 8.0, 2 × CH), 7.49 (2H, d, J 8.0, 2 × CH), 7.59-7.64 (1H, m, CH), 7.88-7.94 (4H, m, 
4 × CH), 9.03 (1H, s, CH); δC (75 MHz; CDCl3) 21.6 (CH3), 128.0 (2C, 2 × CH), 129.1 (2C, 2 
× CH), 129.8 (2C, 2 × CH), 131.3 (2C, 2 × CH), 132.4 (Cquat), 134.9 (CH), 135.1 (Cquat), 
144.6 (Cquat), 170.1 (13CH, enriched signal); HRMS m/z (TOF ES+) 283.0592. 
C1313CH13NO2NaS requires 283.0598. 
 
13C enriched 2-(Hex-1-ynyl)-3-phenyl-1-(toluene-4-sulfonyl)aziridine (243) 
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Following GP3 using 13C enriched imine 242 and sulfonium salt 180 for 3 h. Purification by 
flash chromatography [hexane:ethylacetate (12:1)] gave 13C-enriched aziridine 243 as a white 
solid (212 mg, 60%, 8:1 cis:trans); νmax (neat)/cm-1 2960, 2934, 2252, 1601, 1497, 1455, 
1381, 1319, 1305, 1292, 1230, 1187, 1158, 1088, 1038, 1025, 871, 811, 784, 754, 738, 
717,695, 672; δH (300 MHz; CDCl3) 0.75 (3H, t, J 7.2, CH3), 1.01-1.32 (4H, m, 2 × CH2), 
1.98 (2H, td, J 6.8 and 1.7, CH2), 2.42 (3H, s, CH3), 3.63 (1H, dt, J 6.9 and 1.7, CH), 3.94 
(1H, d, J 6.9, CH), 7.21-7.39 (7H, m, 7 × CH), 7.88 (2H, d, J 8.3, 2 × CH); δC (75 MHz; 
CDCl3) 13.4 (CH3), 18.2 (CH2), 21.4 (CH2), 21.6 (CH3), 30.0 (CH2), 36.2 (CH), 46.1 (13CH, 
enriched signal, CH), 72.1 (Cquat), 86.7 (Cquat), 127.7 (2C, 2 × CH) 127.9 (4C, 4 × CH), 128.2 
(CH), 129.8 (2C, 2 × CH), 132.2 (Cquat), 134.7 (Cquat), 144.6 (Cquat); HRMS m/z (TOF ES+) 
377.1376. C2013CH23NO2NaS requires 377.1381. 
 
13C-enriched 2-Butyl-5-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (244) 
 
Following GP6 using 13C enriched aziridine 243 (71 mg) at 70 °C for 4 h gave pyrrole 244 
(69 mg, 98%); νmax (neat)/cm-1 3060, 2956, 2928, 2861, 1737, 1596, 1527, 1482, 1444, 1366, 
1169, 1116, 1092, 911, 809, 759; δH (300 MHz; CDCl3) 0.97 (3H, t, J 7.3, CH3), 1.38-1.50 
(2H, m, CH2), 1.66-1.76 (2H, m, CH2), 2.36 (3H, s, CH3), 2.92 (2H, t, J 7.7, CH2), 6.04 (1H, 
d, J 3.3, CH), 6.08 (1H, d, J 3.3, CH),7.14 (2H, d, J 8.4, 2 × CH), 7.28 (2H, d, J 8.4, 2 × CH), 
7.32 (5H, s, 5 × CH); δC (75 MHz; CDCl3) 14.0 (CH3), 21.6 (CH3), 22.5 (CH2), 29.3 (CH2), 
31.6 (CH2), 112.6 (CH), 115.6 (CH), 126.4 (2C, 2 × CH), 127.2 (2C, 2 × CH), 127.7 (CH), 
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129.3 (2C, 2 × CH), 130.4 (2C, 2 × CH), 133.3 (Cquat), 136.4 (Cquat), 138.0 (13C, enriched 
signal, Cquat), 139.9 (Cquat), 144.2 (Cquat); HRMS m/z (TOF ES+) 377.1373. 
C2013CH23NO2NaS requires 377.1381. 
 
Mixture of 13C enriched 2-butyl-4phenyl-1-(toluene-4-sulfonyl)-1H-pyrroles with 2-
butyl-5phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (244). 
 
Following GP7 using 13C enriched aziridine 243 (71 mg) at room temperature for 2 h. 
Purification by flash chromatography [hexane:ethylacetate (25:1)] gave a mixture of 2,4-
substituted pyrroles 245, 246 and 2,5-substituted pyrroles 244 (50 mg, 71%, 244:(245+246) 
1:5); HRMS m/z (TOF ES+) 377.1378. C2013CH23NO2NaS requires 377.1381. 
13C enriched 2-butyl-4phenyl-1-(toluene-4-sulfonyl)-1H-pyrroles (245): 
13C
N
S OO
H
 
δH (300 MHz; CDCl3) 0.91 (3H, t, J 7.3, CH3), 1.31-1.43 (2H, m, CH2), 1.54-1.61 (2H, m, 
CH2), 2.41 (3H, s, CH3), 2.69 (2H, t, J 7.6, CH2), 6.33 (1H, dt, J 1.9 and 1.0, CH), 7.29 (2H, 
d, J 8.4, 2 × CH), 7.32 (2H, d, J 8.4, 2 × CH), 7.37 (1H, d, J 8.2, CH), 7.51 (2H, dd, J 8.4 and 
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8.2, 2 × CH), 7.58 (1H, d, J 1.9, CH), 7.69 (2H, d, J 8.4, 2 × CH); δC (75 MHz; CDCl3) 13.9 
(CH3), 21.6 (CH3), 22.4 (CH2), 26.9 (CH2), 30.7 (CH2), 110.4 (CH), 117.7 (13CH, enriched 
signal, CH), 125.4 (2C, 2 × CH), 126.7 (2C, 2 × CH), 126.8 (CH), 126.9 (Cquat), 128.7 (2C, 2 
× CH), 130.0 (2C, 2 × CH), 133.7 (Cquat), 136.3 (Cquat), 136.9 (Cquat), 144.8 (Cquat). 
13C enriched 2,5- diphenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (246): 
13C
N
S OO
 
δH (300 MHz; CDCl3) 0.91 (3H, t, J 7.3, CH3), 1.31-1.43 (2H, m, CH2), 1.54-1.61 (2H, m, 
CH2), 2.41 (3H, s, CH3), 2.69 (2H, t, J 7.6, CH2), 6.33 (1H, dt, J 1.9 and 1.0, CH), 7.29 (2H, 
d, J 8.4, 2 × CH), 7.32 (2H, d, J 8.4, 2 × CH), 7.37 (1H, d, J 8.2, CH), 7.51 (2H, dd, J 8.4 and 
8.2, 2 × CH), 7.58 (1H, d, J 1.9, CH) 7.69 (2H, d, J 8.4, 2 × CH); δC (75 MHz; CDCl3) 13.9 
(CH3), 21.6 (CH3), 22.4 (CH2), 26.9 (CH2), 30.7 (CH2), 110.4 (CH), 117.7 (CH), 125.4 (2C, 2 
× CH), 126.7 (2C, 2 × CH), 126.8 (CH), 126.9 (13CH, enriched signal, Cquat), 128.7 (2C, 2 × 
CH), 130.0 (2C, 2 × CH), 133.7 (Cquat), 136.3 (Cquat), 136.9 (Cquat), 144.8 (Cquat). 
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13C-enriched 2-phenyl-3-(phenylethynyl)-1-(toluene-4-sulfonyl)aziridine (247) 
13C
N
SO O
 
Following GP1 using 13C enriched imine 242 and sulfonium salt 177 for 1.5 h. Purification by 
flash chromatography [hexane:ethylacetate (25:1)] gave 13C-enriched aziridine 247 (298 mg, 
80%, 12:1 cis:trans); νmax (neat)/cm-1 3032, 2950, 2926, 2240, 1597, 1490, 1457, 1441, 1319, 
1157, 1087, 1071, 873, 854, 784, 757, 708; δH (300 MHz; CDCl3) 2.44 (3H, s, CH3), 3.87 
(1H, d, J 6.9, CH), 4.09 (1H, d, J 6.9, CH), 7.12-7.28 (4H, m, 4 × CH), 7.29-7.45 (8H, m, 8 × 
CH), 7.92 (2H, d, J 8.3, 2 × CH); δC (75 MHz; CDCl3) 21.7 (CH3), 36.3 (CH), 46.5 (13CH, 
enriched signal, CH), 81.6 (Cquat), 85.1 (Cquat), 121.8 (Cquat), 127.8 (2C, 2 × CH), 128.0 (4C, 4 
× CH), 128.1 (2C, 2 × CH), 128.5 (CH), 128.8 (CH), 129.9 (2C, 2 × CH), 131.8 (2C, 2 × CH), 
132.1 (Cquat), 134.6 (Cquat), 144.9 (Cquat); HRMS m/z (TOF ES+) 397.1074. C2213CH18NO2NaS 
requires 397.1068. 
 
Mixture of 13C-enriched 2,4-diphenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (249) and 2,5- 
diphenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (248) 
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Following GP7 using 13C enriched 2-phenyl-3-(phenylethynyl)-1-(toluene-4-
sulfonyl)aziridine (75 mg) at room temperature for 2 h. Purification by flash chromatography 
[hexane:ethylacetate (25:1)] gave a mixture of 2,4-substituted 249 and 2,5-substituted 
pyrroles 248 (49 mg, 65%, 248:249 1:10); HRMS m/z (TOF ES+) 397.1075. 
C2213CH19NO2NaS requires 397.1068. 
13C enriched 2,4-diphenyl-1-(toluene-4-sulfonyl)-1H-pyrrole: 
δH (300 MHz; CDCl3) 2.34 (3H, s, CH3), 6.49 (1H, d, J 2.0, CH), 7.24-7.37 (10H, m, 10 × 
CH), 7.53 (2H, d, J 7.1, 2 × CH), 7.73 (1H, d, J 2.0, CH); δC (75 MHz; CDCl3) 21.6 (CH3), 
114.3 (CH), 119.5 (13C-enriched signal, CH), 125.5 (2C, 2 × CH), 127.0 (CH), 127.1 (2C, 2 × 
CH), 127.4 (2C, 2 × CH), 128.4 (CH), 128.8 (2C, 2 × CH), 129.4 (2C, 2 × CH), 130.8 (2C, 2 
× CH), 131.2 (Cquat), 133.3 (Cquat), 135.4 (Cquat), 136.9 (Cquat), 141.2 (Cquat), 144.7 (Cquat). 
13C enriched 2,5- diphenyl-1-(toluene-4-sulfonyl)-1H-pyrrole: 
δH (300 MHz; CDCl3) 2.34 (3H, s, CH3), 6.24 (2H, m, 2 × CH), 7.06 (4H, m, 4 × CH), 7.35-
7.46 (6H, m, 6 × CH), 7.49-7.53 (4H, m, 4 × CH); δC (75 MHz; CDCl3) 21.6 (CH3), 117.3 
(2C, 2 × CH), 127.0 (4C, 4 × CH), 127.5 (2C, 2 × CH), 127.9 (2C, 2 × CH), 128.8 (4C, 4 × 
CH), 129.6 (2C, 2 × CH), 133.3 (2C, 2 × Cquat), 134.6 (Cquat), 141.3 (2C, 13C-enriched signal, 
2 × Cquat), 144.3 (Cquat). 
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13C-enriched 2-((4-methoxyphenyl)ethynyl)-3-phenyl-1-(toluene-4-sulfonyl)aziridine 
(250) 
13C
N
S OO
O
 
Following GP1 using 13C enriched imine 242 and sulfonium salt 255 for 45 min. Purification 
by flash chromatography [hexane:ethylacetate (20:1)] gave 13C-enriched aziridine 250 (242 
mg, 60 %, 16:1 cis:trans); νmax (neat)/cm-1 3036, 2933, 2838, 2228, 1603, 1509, 1455, 1327, 
1291, 1247, 1156, 1089, 1027, 976, 872, 831, 812, 786, 733, 697; δH (300 MHz; CDCl3) 2.43 
(3H, s, CH3), 3.76 (3H, s, CH3), 3.86 (1H, d, J 6.9, CH), 4.07 (1H, d, J 6.9, CH), 6.73 (2H, d, 
J 8.9, 2 × CH), 7.11 (2H, d, J 8.9, 2 × CH), 7.30-7.41 (7H, m, 7 × CH), 7.91 (2H, d, J 8.3, 2 × 
CH); δC (75 MHz; CDCl3) 21.7 (CH3), 36.5 (CH), 46.5 (13CH, enriched signal, CH), 55.2 
(CH3), 80.2 (Cquat), 85.3 (Cquat), 113.8 (2C, 2 × CH), 127.8 (2C, 2 × CH), 128.0 (5C, 5 × CH, 
Cquat), 128.4 (CH), 129.8 (2C, 2 × CH), 132.2 (Cquat), 133.4 (2C, 2 × CH), 134.7 (Cquat), 144.9 
(Cquat), 159.9 (Cquat); HRMS m/z (TOF ES+) 426.1089. C2313CH21NO3NaS requires 426.1095. 
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13C-enriched 2-phenyl-1-(toluene-4-sulfonyl)-3-((4-
trifluoromethyl)phenyl)ethynyl)aziridine (251) 
 
Following GP1 using 13C enriched imine 242 and sulfonium salt 258 for 30 min. Purification 
by flash chromatography [hexane:ethylacetate (25:1)] gave 13C-enriched aziridine 251 (287 
mg, 65%%, 15:1 cis:trans); νmax (neat)/cm-1 3065, 3012, 1617, 1596, 1496, 1456, 1405, 1378, 
1320, 1157, 1127, 1106, 1088, 1059, 1016, 973, 870, 838, 812, 785, 737, 696; δH (300 MHz; 
CDCl3) 2.44 (3H, s, CH3), 3.90 (1H, d, J 6.8, CH), 4.13 (1H, d, J 6.8, CH), 7.27 (2H, d, J 8.1, 
2 × CH), 7.31-7.42 (7H, m, 7 × CH), 7.48 (2H, d, J 8.1, 2 × CH), 7.94 (2H, d, J 8.3, 2 × CH); 
δC (75 MHz; CDCl3) 21.6 (CH3), 35.8 (CH), 46.5 (13CH, enriched signal, CH), 83.5 (Cquat), 
84.3 (Cquat), 125.0 (CH), 125.1 (CH), 125.5 (Cquat), 127.7 (2C, 2 × CH), 128.0 (2C, 2 × CH), 
128.1 (2C, 2 × CH), 128.6 (CH), 129.9 (2C, 2 × CH), 130.2 (Cquat), 130.6 (Cquat), 131.9 
(Cquat), 132.1 (2C, 2 × CH), 134.4 (Cquat), 145.1 (Cquat); HRMS m/z (TOF ES+) 465.0934. 
C2313CH18NO2F3NaS requires 465.0942. 
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13C-enriched 2-phenyl-3-(4-phenylbut-1-yn-1-yl)-1-(toluene-4-sulfonyl)aziridine (252) 
13C
N
S OO
 
Following GP1 using 13C enriched imine 242 and sulfonium salt 179 for 4h. Purification by 
flash chromatography [hexane:ethylacetate (20:1)] gave 13C-enriched aziridine 252 (269 mg, 
67%, 14:1 cis:trans). νmax (neat)/cm-1 3029, 2925, 2248, 1597, 1495, 1454, 1384, 1327, 1291, 
1235, 1158, 1090, 1021, 875, 814, 783, 742, 695; δH (300 MHz; CDCl3) 2.27-2.33 (2H, m, 
CH2), 2.44 (3H, s, CH3), 2.50-2.65 (2H, m, CH2), 3.62 (1H, dt, J 6.9 and 1.8, CH), 3.94 (1H, 
d, J 6.9, CH), 6.95-7.01 (2H, m, 2 × CH), 7.14-7.24 (3H, m, 3 × CH), 7.29 (5H, s,5 × CH), 
7.34 (2H, d, J 8.3, 2 × CH), 7.88 (2H, d, J 8.3, 2 × CH); δC (75 MHz; CDCl3) 20.8 (CH2), 
21.7 (CH3), 34.1 (CH2), 36.1 (CH), 46.1 (13CH, enriched signal, CH), 73.0 (Cquat), 85.8 (Cquat), 
126.2 (2C, 2 × CH), 127.8 (2C, 2 × CH), 127.9 (2C, 2 × CH), 128.0 (2C, 2 × CH), 128.3 (5C, 
5 × CH), 129.8 (2C, 2 × CH), 132.2 (Cquat), 134.7 (Cquat), 140.2 (Cquat), 144.8 (Cquat); HRMS 
m/z (TOF ES+) 425.1373. C2413CH23NO2NaS requires 425.1381. 
 
3-(4-Methoxyphenyl)prop-2-yn-1-ol (253) 
 
Following GP5 using 4-iodoanisole (5.85 g). Purification by flash chromatography 
[hexane:ethylacetate (2:1)] gave alcohol 253 as a brown solid (2.64 g, 65%);δH (300 MHz; 
CDCl3) 1.83 (1H, s, OH), 3.81 (3H, s, CH3), 4.49 (2H, s, CH2), 6.85 (2H, d, J 6.5, 2 × CH), 
7.40 (2H, d, J 6.5, 2 × CH); δC (75 MHz; CDCl3) 51.7 (CH2), 55.3 (CH3), 85.7 (Cquat), 85.9 
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(Cquat), 114.0 (2C, 2 × CH), 114.6 (Cquat), 133.2 (2C, 2 × CH), 159.8 (Cquat); HRMS m/z (TOF 
EI+) 162.0683. C10H10O2 requires 162.0681. 
 
Data were in agreement with those reported in the literature.108 
 
1-(3-Bromoprop-1-ynyl)-4-methoxybenzene (254) 
 
Following GP8 using PPh3 (11 mmol, 2.88 g), Br2 (10.9 mmol, 0.55 mL) and alcohol 253 
(1.62 g) in CH2Cl2 (30 mL). Purification by flash chromatography (hexane) gave bromine 254 
as a colourless oil (2.02 g, 90%); νmax (neat)/cm-1 2228, 1609, 1602, 1518, 1471, 1102, 1001, 
960, 820; δH (300 MHz; CDCl3) 3.79 (3H, s, CH3), 4.17 (2H, s, CH2), 6.84 (2H, d, J 9.0, 2 × 
CH), 7.39 (2H, d, J 9.0, 2 × CH); δC (75 MHz; CDCl3) 16.0 (CH2), 55.3 (CH3), 83.0 (Cquat), 
86.9 (Cquat), 114.0 (2C, 2 × CH), 114.1 (Cquat), 133.5 (2C, 2 × CH), 160.0 (Cquat). 
 
Data were in agreement with those reported in the literature.95 
 
(3-(4-methoxyphenyl)prop-2-yn-1-yl)dimethylsulfonium bromide (255) 
 
Following GP9 using bromide 254 (1.125 g) gave sulfonium salt 255 (1.335 g, 93%); mp 124-
125 °C;νmax (neat)/cm-1 2969, 2907, 2864, 2216, 1605, 1565, 1509, 1459, 1421, 1325, 1296, 
1276, 1246, 1180, 1169, 1105, 1046, 1021, 1009, 828, 800, 703; δH (300 MHz; CDCl3) 3.31 
(6H, s, 2 × CH3), 3.81 (3H, s, CH3), 5.31 (2H, s, CH2), 6.85 (2H, d, J 8.8, 2 × CH), 7.40 (2H, 
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d, J 8.8, 2 × CH); δC (75 MHz; CDCl3) 24.6 (2C, 2 × CH3), 34.2 (CH2), 55.3 (CH3), 73.0 
(Cquat), 91.2 (Cquat), 112.5 (Cquat), 114.2 (2C, 2 × CH), 133.7 (2C, 2 × CH), 160.6 (Cquat); 
HRMS m/z (TOF ES+) 207.0844. C12H15OS requires 207.0840. 
 
3-(4-Trifluoromethylphenyl)prop-2-yn-1-ol (256) 
 
Following GP5 using 1-iodo-4-(trifluoromethyl)benzene (6.80 g, 3.67 mL). Purification by 
flash chromatography [hexane:ethylacetate (4:1)] gave alcohol 256 as a brown solid (2.75 g, 
90%); νmax (neat)/cm-1 3350, 3080, 2890, 2275, 1622, 1532, 1405, 1328, 1186, 1129, 953, 
786, 732, 689; δH (300 MHz; CDCl3) 1.91 (1H, t, J 5.5, OH), 4.54 (2H, d, J 5.5, CH2), 7.50 
(2H, d, J 8.5, 2 × CH), 7.54 (2H, d, J 8.5, 2 × CH); δC (75 MHz; CDCl3) 51.5 (CH2), 84.3 
(Cquat), 89.6 (Cquat), 122.5 (Cquat), 125.2 (2C, 2 × CH), 126.4 (Cquat), 130.2 (Cquat), 131.9 (2C, 2 
× CH). 
 
Data were in agreement with those reported in the literature.93 
 
1-(3-Bromoprop-1-ynyl)-4-(trifluoromethyl)benzene (257) 
 
Following GP8 using PPh3 (11 mmol, 2.88 g), Br2 (10.9 mmol, 0.55 mL) and alcohol 256 
(2.00 g) in CH2Cl2 (30 mL). Purification by flash chromatography (n-pentane) gave bromine 
257 as a yellow oil (2.36 g, 90%); νmax (neat)/cm-1 3012, 2232, 2199, 1930, 1725, 1669, 1516, 
1407, 1423, 1329, 1129, 1073, 1052, 1022, 850, 769; δH (300 MHz; CDCl3) 4.16 (2H, s, 
CH2), 7.54 (2H, d, J 8.4, 2 × CH), 7.57 (2H, d, J 8.4, 2 × CH); δC (75 MHz; CDCl3) 14.4 
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(CH2), 85.1 (Cquat), 86.6 (Cquat), 125.3 (2C, 2 × CH), 125.9 (Cquat), 130.6 (Cquat), 132.1 (2C, 2 
× CH); HRMS m/z (TOF EI+) 261.9590. C10H679BrF3 requires 261.9605. 
 
Data were in agreement with those reported in the literature.109 
 
Dimethyl(3-(4-(trifluoromethyl)phenyl)prop-2-yn-1-yl)sulfonium bromide (258) 
 
Following GP9 using bromide 257 (1.315 g) gave sulfonium salt 258 (1.625 g, 50%); mp 139-
140 °C, νmax (neat)/cm-1 3006, 2924, 2891, 2245, 1618,1407, 1319, 1231, 1162, 1126, 1107, 
1067, 1045, 1017, 1001, 982, 840, 712; δH (300 MHz; CDCl3) 3.36 (6H, s, 2 × CH3), 5.43 
(2H, s, CH2), 7.60-7.70 (4H, m, 4 × CH); δC (75 MHz; CDCl3) 24.9 (2C, 2 × CH3), 33.7 
(CH2), 76.9 (Cquat), 89.5 (Cquat), 124.3 (Cquat), 125.7 (2C, 2 × CH), 131.4 (Cquat), 131.8 (Cquat), 
132.5 (2C, 2 × CH); HRMS m/z (TOF ES+) 245.0607. C12H12F3S requires 245.0612. 
 
Mixture of 13C-enriched 2-(4-methoxyphenyl)-5-phenyl-1-(toluene-4-sulfonyl)-1H-
pyrrole (259) and 2-(4-methoxyphenyl)-4-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (260) 
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Following GP7 using 13C enriched aziridine 250 (80 mg) for 45 min. Purification by flash 
chromatography [hexane:ethylacetate (20:1)] gave a mixture of 2,4-substituted 260 and 2,5-
substituted pyrroles 259 (8 mg, <10%, 259:260 2:3). 
Only a complexe and dirty mixture of pyrroles was obtained. Caracteristic pics of 2,4 and 2,5-
substituted expected pyrroles are visible in 1H NMR: 
2-(4-methoxyphenyl)-5-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (259): δH (300 MHz; 
CDCl3) 2.35 (3H, s, CH3), 3.87 (3H, s, CH3), 6.16 (1H, d, J 3.3, CH), 6.23 (1H, d, J 3.3, CH), 
6.85-7.50 (13H, m, 13 × CH). 
13C NMR shows a 13C-enriched signal at 140.7 ppm characteristic of 13C enrichement at C-5 
for a 2,5-pyrrole. The rest of the 13C NMR spectrum could not be interpretate. 
2-(4-methoxyphenyl)-4-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (260): δH (300 MHz; 
CDCl3) 2.35 (3H, s, CH3), 3.88 (3H, s, CH3), 6.43 (1H, d, J 2.0, CH), 6.85-7.50 (13H, m, 13 × 
CH), 7.70 (1H, d, J 2.0, CH). 
13C NMR shows a 13C-enriched signal at 119.2 ppm characteristic of 13C enrichement at C-5 
for a 2,4-pyrrole. The rest of the 13C NMR spectrum could not be interpretate. 
 
13C-enriched 4-Phenyl-1-(toluene-4-sulfonyl)-2-(4-(trifluoromethyl)phenyl)-1H-pyrroles 
(261) and (262) 
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Following GP7 using 13C-enriched 2-phenyl-1-(toluene-4-sulfonyl)-3-((4-
trifluoromethyl)phenyl)ethynyl)aziridine (88 mg) at for 2 h. Purification by flash 
chromatography [hexane:ethylacetate (25:1)] gave a mixture of 2,4-substituted pyrroles 261 
and 262 (39 mg, 45%); HRMS m/z (TOF ES+) 465.0939. C2313CH18NO2F3NaS requires 
465.0942. 
13C-enriched 4-Phenyl-1-(toluene-4-sulfonyl)-2-(4-(trifluoromethyl)phenyl)-1H-pyrrole 
(262): 
13C
N
S OO CF3
 
δH (300 MHz; CDCl3) 2.36 (3H, s, CH3), 6.55 (1H, d, J 1.9, CH), 7.13 (2H, d, J 8.1, 2 × CH), 
7.26-7.31 (3H, m, 3 × CH), 7.37-7.46 (4H, m, 4 × CH), 7.51-7.55 (2H, m, 2 × CH), 7.61 (2H, 
d, J 8.1, 2 × CH), 7.76 (1H, d, J 1.9, CH); δC (75 MHz; CDCl3) 21.6 (CH3),115.4 (CH), 120.4 
(CH), 122.7 (Cquat), 124.4 (CH), 125.5 (2C, 2 × CH), 127.0 (2C, 2 × CH), 127.3 (CH), 128.0 
(13C-enriched signal, Cquat), 128.9 (2C, 2 × CH), 129.6 (2C, 2 × CH), 130.2 (d, JC-F 32.8, 
Cquat), 130.9 (2C, 2 × CH), 132.9 (2C, 2 × CH), 134.9 (Cquat), 135.2 (Cquat), 135.4 (Cquat) 145.1 
(Cquat). 
13C-enriched 4-Phenyl-1-(toluene-4-sulfonyl)-2-(4-(trifluoromethyl)phenyl)-1H-pyrrole 
(261): 
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13C
N
S OO
H
CF3
 
δH (300 MHz; CDCl3) 2.36 (3H, s, CH3), 6.55 (1H, d, J 1.9, CH), 7.13 (2H, d, J 8.1, 2 × CH), 
7.26-7.31 (3H, m, 3 × CH), 7.37-7.46 (4H, m, 4 × CH), 7.51-7.55 (2H, m, 2 × CH), 7.61 (2H, 
d, J 8.1, 2 × CH), 7.76 (1H, d, J 1.9, CH); δC (75 MHz; CDCl3) 21.6 (CH3),115.4 (CH), 120.4 
(CH), 122.7 (Cquat), 124.4 (13C-enriched signal, CH), 125.5 (2C, 2 × CH), 127.0 (2C, 2 × CH), 
127.3 (CH), 128.0 (Cquat), 128.9 (2C, 2 × CH), 129.6 (2C, 2 × CH), 130.2 (d, JC-F 32.8, Cquat), 
130.9 (2C, 2 × CH), 132.9 (2C, 2 × CH), 134.9 (Cquat), 135.2 (Cquat), 135.4 (Cquat) 145.1 
(Cquat). 
 
13C-enriched 2-phenethyl-4-phenyl-1-(toluene-4-sulfonyl)-1H-pyrroles and 2-phenethyl-
5-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (263) 
13C
N
S OO
H
13C
N
S OO
Ph Ph13C
N
S OO
Ph
 
Following GP7 using 13C-enriched aziridine 252 (81 mg) at for 2 h. Purification by flash 
chromatography [hexane:ethylacetate (20:1)] gave a mixture of 2,4-substituted 264, 265 
pyrroles and 2,5-substituted pyrrole 263 (32 mg, 40%, 263:(264+265) 1:2); HRMS m/z (TOF 
ES+) 425.1376. C2413CH23NO2NaS requires 425.1381. 
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13C-enriched 2-phenethyl-4-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (264): 
13C
N
S OO
H
Ph
 
δH (300 MHz; CDCl3) 2.34 (3H, s, CH3), 2.85-2.90 (2H, m, CH2), 2.94-2.99 (2H, m, CH2), 
6.35 (1H, dt, J 2.0 and 0.9, CH), 7.12-7.28 (8H, m, 8 × CH), 7.30-7.33 (2H, m, 2 × CH), 7.42-
7.45 (2H, m, 2 × CH), 7.54 (1H, d, J 2.0, CH), 7.63 (2H, d, J 8.4, 2 × CH); δC (75 MHz; 
CDCl3) 21.6 (CH3), 29.3 (CH2), 35.4 (CH2), 111.2 (CH), 118.0 (13C-enriched signal, CH), 
125.5 (2C, 2 × CH), 126.1 (CH), 126.8 (2C, 2 × CH), 126.9 (CH), 127.0 (Cquat), 127.3 (4C, 4 
× CH), 128.4 (2C, 2 × CH), 130.1 (2C, 2 × CH), 133.6 (Cquat), 136.0 (Cquat), 138.5 (Cquat), 
141.2 (Cquat), 144.9 (Cquat). 
13C-enriched 2-phenethyl-4-phenyl-1-(toluene-4-sulfonyl)-1H-pyrroles (265): 
13C
N
S OO
Ph
 
δH (300 MHz; CDCl3) 2.34 (3H, s, CH3), 2.85-2.90 (2H, m, CH2), 2.94-2.99 (2H, m, CH2), 
6.35 (1H, dt, J 2.0 and 0.9, CH), 7.12-7.28 (8H, m, 8 × CH), 7.30-7.33 (2H, m, 2 × CH), 7.42-
7.45 (2H, m, 2 × CH), 7.54 (1H, d, J 2.0, CH), 7.63 (2H, d, J 8.4, 2 × CH); δC (75 MHz; 
CDCl3) 21.6 (CH3), 29.3 (CH2), 35.4 (CH2), 111.2 (CH), 118.0 (CH), 125.5 (2C, 2 × CH), 
126.1 (CH), 126.8 (2C, 2 × CH), 126.9 (CH), 127.0 (13C-enriched signal, Cquat), 127.3 (4C, 4 
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× CH), 128.4 (2C, 2 × CH), 130.1 (2C, 2 × CH), 133.6 (Cquat), 136.0 (Cquat), 138.5 (Cquat), 
141.2 (Cquat), 144.9 (Cquat). 
13C-enriched 2-phenethyl-5-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole (263): 
13C
N
S OO
Ph
 
δH (300 MHz; CDCl3) 2.36 (3H, s, CH3), 3.05 (2H, m, CH2), 3.24 (2H, m, CH2), 6.02-6.09 
(2H, m, 2 × CH), 7.13 (2H, d, J 8.0, 2 × CH), 7.19-7.31 (7H, m, 7 × CH), 7.34 (5H, 5 × CH); 
δC (75 MHz; CDCl3) 21.6 (CH3), 31.8 (CH2), 36.3 (CH2), 113.5 (CH), 115.7 (CH), 126.0 
(CH), 126.4 (2C, 2 × CH), 127.3 (2C, 2 × CH), 127.8 (CH), 128.4 (2C, 2 × CH), 128.5 (2C, 2 
× CH), 129.4 (2C, 2 × CH), 130.5 (2C, 2 × CH), 133.2 (Cquat), 136.3 (Cquat), 138.5 (13C-
enriched signal, Cquat), 138.8 (Cquat), 141.6 (Cquat), 144.4 (Cquat). 
 
6.4.2  Procedure and characterisation for Chapter 5 
 
Formation of 4-methylbenzenesulfonamides and methanesulfonamides: General 
procedure 10 (GP10):110 
A solution of the corresponding sulfonyl chloride (36 mmol) in CH2Cl2 (20 mL) was added 
dropwise to a mixture of primary amine (30 mmol) and pyridine (15 mL) in CH2Cl2 (80 mL) 
at rt. After stirring one night, a 1M aqueous HCl solution (20 mL) was added to quench the 
reaction. The two phases were separated and the aqueous phase was extracted with CH2Cl2 (2 
× 20 mL). The combined organic extracts were washed with H2O (1 × 20 mL) and brine (1 × 
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20 mL) and dried over Na2SO4. After filtration, concentration under reduced pressure was 
performed and the residue was purified by flash chromatography. 
 
Formation of ynamides: General procedure 11 (GP11)78 
CuCl2 (56 mg, 0.4 mmol), Amide (10 mmol) and Na2CO3 (424 mg, 4 mmol) were added to a 
flame-dried 500 mL three-necked round-bottomed flask under argon. The flask was purged 
with oxygen for 15 min and a solution of pyridine (0.32 mL, 4 mmol) in dry toluene (10mL) 
was added. A balloon filled with oxygen was connected to the flask and the stirred mixture 
was heated a 70 °C. After 15 min, addition of a solution of alkyne (2 mmol) in dry toluene by 
syringe pump (4h) was started. The mixture was allowed to stir at 70 °C for another 4h and 
was then cooled to rt. The reaction mixture was concentrated under reduced pressure and the 
residue was purified by flash chromatography. 
 
α,β-Unsaturated imides preparation: General procedures 12 (GP12): 
System A (GP12A): 
A solution of the corresponding ynamide (0.3 mmol, 1 eq) in ClCH2CH2Cl (1.5 mL) was 
added to a mixture of dichloro(2-pyridinecarboxylato)gold (6 mg, 0.015 mmol, 5 mol %) and 
pyridine-N-oxide (32 mg, 0.33 mmol, 1.1 eq) in a flame-dried Schlenk flask under argon. The 
reaction mixture was stirred at 70 °C until complete consumption of the starting material 
before being filtered through a pad of silica. The filtrate was then concentrated under reduced 
pressure and purification of the residue was performed by flash chromatography.   
 
System B (GP12B): 
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A solution of the corresponding ynamide (0.3 mmol, 1 eq) in THF (1.5 mL) was added to a 
mixture of goldtribromide (7 mg, 0.015 mmol, 5 mol %) and pyridine-N-oxide (32 mg, 0.33 
mmol, 1.1 eq) in a flame-dried Schlenk flask under argon. The reaction mixture was stirred at 
rt until complete consumption of the starting material before being filtered through a pad of 
silica. The filtrate was then concentrated under reduced pressure and purification of the 
residue was performed by flash chromatography. 
 
4-Methyl-N-phenylbenzenesulfonamide (280) 
 
Following GP10 using 4-methylbenzenesulfonyl chloride (6.86 g) and aniline (2.70 mL). 
Purification by flash chromatography [hexanes:EtOAc (10:1)] gave amide 280 as a white 
solid (7.20 g, 97 %); mp: 102-104 °C; νmax (neat)/cm-1 3237, 3061, 2980, 2899, 1597, 1481, 
1414, 1336, 1319, 1291, 1223, 1186, 1153, 1089, 1031, 909, 810, 753, 693; δH (300 MHz; 
CDCl3) 2.37 (3H, s, CH3), 6.94 (1H, br s, NH), 7.06-7.12 (3H, m, 3 × CH), 7.20-7.26 (4H, m, 
4 × CH), 7.67 (2H, d, J 8.3, 2 × CH); δC (400 MHz; CDCl3) 21.5 (CH3), 121.6 (2C, 2 × CH), 
125.3 (CH), 127.3 (2C, 2 × CH), 129.3 (2C, 2 × CH), 129.7 (2C, 2 × CH), 136.1 (Cquat), 136.5 
(Cquat), 143.9 (Cquat); HRMS m/z (TOF ES+) 270.0561. C13H13NO2NaS requires 270.0565. 
 
Data were in agreement with those reported in the literature.111 
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N-Phenylmethanesulfonamide (281) 
 
Following GP10 using methylsulfonyl chloride (2.80 mL) and aniline (2.70 mL). Purification 
by flash chromatography [hexanes:EtOAc (5:1)] gave amide 281 as a white solid (4.74 g, 92 
%); mp (°C) 99-103; νmax (neat)/cm-1 3253, 3019, 2933, 1595, 1494, 1471, 1392, 1319, 1300, 
1275, 1145, 1075, 1028, 975, 959, 918, 894, 751, 692; δH (300 MHz; CDCl3) 3.02 (3H, s, 
CH3), 7.15-7.21 (2H, m, NH, CH), 7.24-7.27 (2H, m, 2 × CH), 7.32-7.39 (2H, m, 2 × CH); δC 
(400 MHz; CDCl3) 39.2 (CH3), 120.8 (2C, 2 × CH), 125.4 (CH), 129.6 (2C, 2 × CH), 136.6 
(Cquat); HRMS m/z (TOF EI+) 171.0356. C7H9NO2S requires 171.0354. 
 
Data were in agreement with those reported in the literature.112 
 
N-(2,6-Diisopropylphenyl)-4-methylbenzenesulfonamide (282) 
N
H
S
O
O
 
Following GP10 using 4-methylbenzenesulfonyl chloride (6.86 g) and 2,6-diisopropylaniline 
(5.70 mL). Purification by flash chromatography [hexanes:EtOAc (15:1)] gave amide 282 as a 
white solid (9.10 g, 91 %); mp (°C) 156-159; νmax (neat)/cm-1 3254, 2970, 2927, 2868, 1596, 
1444, 1398, 1329, 1304, 1156, 1089, 912, 811, 789, 710; δH (300 MHz; CDCl3) 0.97 (12H, d, 
J 6.8, CH3), 2.38 (3H, s, CH3), 3.09 (2H, sept, J 6.8, CH), 5.99 (1H, s, NH), 7.08 (2H, d, J 
7.6, CH), 7.17-7.25 (3H, m, CH), 7.56 (2H, d, J 8.3, CH); δC (400 MHz; CDCl3) 21.5 (CH3), 
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23.8 (4C, CH3), 28.4 (2C, 2 × CH), 123.9 (2C, 2 × CH), 127.4 (2C, 2 × CH), 128.8 (CH), 
129.2 (Cquat), 129.5 (2C, 2 × CH), 137.3 (Cquat), 143.5 (Cquat), 148.3 (Cquat); HRMS m/z (TOF 
ES+) 354.1509. C19H25NO2NaS requires 354.1504. 
 
N-(Hex-1-yn-1yl)-4-methyl-N-phenylbenzenesulfonamide (283) 
N
S
O
O
 
 Following GP11 using amide 280 (2.47 g) and hex-1-yne (0.24 mL). Purification by flash 
chromatography [hexanes:EtOAc (20:1)] gave ynamide 283 as a colorless oil (320 mg, 98%); 
νmax (neat)/cm-1 2957, 2930, 2871, 2254, 1594, 1488, 1455, 1369, 1269, 1173, 1156, 1089, 
923, 892, 812, 755, 704, 690, 678; δH (300 MHz; CDCl3) 0.85 (3H, t, J 7.2, CH3), 1.26-1.50 
(4H, m, 2 × CH2), 2.24 (2H, t, J 6.9, CH2), 2.38 (3H, s, CH3), 7.17-7.29 (7H, m, 7 × CH), 7.49 
(2H, d, J 8.3, 2 × CH); δC (400 MHz; CDCl3) 13.6 (CH3), 18.2 (CH2), 21.7 (CH3), 21.9 (CH2), 
30.9 (CH2), 70.4 (Cquat), 73.8 (Cquat), 126.1 (2C, 2 × CH), 127.8 (CH), 128.3 (2C, 2 × CH), 
128.9 (2C, 2 × CH), 129.3 (2C, 2 × CH), 133.0 (Cquat), 139.4 (Cquat), 144.6 (Cquat); HRMS m/z 
(TOF ES+) 350.1185. C19H21NO2NaS requires 350.1191. 
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N-(6-Chlorohex-1-yn-1yl)-4-methyl-N-phenylbenzenesulfonamide (284) 
 
Following GP11 using amide 280 (2.47 g) and 6-chlorohex-1-yne (0.25 mL). Purification by 
flash chromatography [hexanes:EtOAc (15:1)] gave ynamide 284 as a colorless oil (354 mg, 
98%); νmax (neat)/cm-1 2952, 2869, 2254, 2032, 1594, 1488, 1368, 1266, 1173, 1089, 1027, 
923; δH (300 MHz; CDCl3) 1.66 (2H, m, CH2), 1.87 (2H, m, CH2), 2.36 (2H, t, J 6.8, CH2), 
2.44 (3H, s, CH3), 3.55 (2H, t, J 6.5, CH2), 7.22-7.25 (3H, m, 3 × CH), 7.29-7.33 (4H, m, 4 × 
CH), 7.54 (2H, d, J 8.4, 2 × CH); δC (400 MHz; CDCl3) 17.8 (CH2), 21.7 (CH3), 26.0 (CH2), 
31.5 (CH2), 44.5 (CH2), 69.4 (Cquat),74.5 (Cquat), 126.1 (2C, 2 × CH), 128.0 (CH), 128.2 (2C, 
2 × CH), 129.0 (2C, 2 × CH), 129.4 (2C, 2 × CH), 133.0 (Cquat), 139.2 (Cquat), 144.7 (Cquat); 
HRMS m/z (TOF ES+) 384.0812. C19H20NO2NaS35Cl requires 384.0801. 
 
 
N-(3-methoxyprop-1-yn-1-yl)-4-methyl-N-phenylbenzenesulfonamide (285) 
N
S
O
O
O
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Following GP11 using amide 280 (2.47 g) and 3-methoxyprop-1-yne (0.17 mL). Purification 
by flash chromatography [hexanes:EtOAc (15:1)] gave ynamide 285 as a colourless oil (540 
mg, 86%); νmax (neat)/cm-1 2925, 2860, 2824, 2244, 1595, 1489, 1454, 1370, 1292, 1172, 
1160, 910, 894, 861, 812, 755, 685, 654; δH (300 MHz; CDCl3) 2.40 (3H, s, CH3), 3.30 (3H, 
s, CH3), 4.22 (2H, s, CH2), 7.19-7.30 (7H, m, 7 × CH), 7.54 (2H, d, J 8.4, 2 × CH); δC (400 
MHz; CDCl3) 21.7 (CH3), 57.2 (CH3), 60.0 (CH2), 66.9 (Cquat), 80.3 (Cquat), 126.3 (2C, 2 × 
CH), 128.2 (2C, 2 × CH), 128.3 (CH), 129.5 (2C, 2 × CH), 129.8 (2C, 2 × CH), 133.1 (Cquat), 
138.7 (Cquat), 145.0 (Cquat); HRMS m/z (TOF ES+) 338.0815. C17H17NO3NaS requires 
338.0827. 
 
N-(3-methoxyprop-1-yn-1-yl)-4-methyl-N-phenylbenzenesulfonamide (286) 
N
S
O
O
 
Following GP11 using amide 280 (2.47 g) and phenyacetylene (0.11 mL). Purification by 
flash chromatography [hexanes:EtOAc (20:1)] gave ynamide 286 as a pale yellow solid (639 
mg, 92%); mp 104-105 °C; νmax (neat)/cm-1 3058, 2922, 2240, 1593, 1488, 1442, 1455, 1369, 
1293, 1203, 1164, 1081, 1066, 1023, 924, 893, 813, 783, 758, 690, 680; δH (300 MHz; 
CDCl3) 2.45 (3H, s, CH3), 7.28-7.35 (9H, m, 9 × CH), 7.37-7.41 (3H, m, 3 × CH), 7.63 (2H, 
d, J 8.3, 2 × CH); δC (400 MHz; CDCl3) 21.7 (CH3), 70.5 (Cquat), 83.0 (Cquat), 122.7 (Cquat), 
126.3 (2C, 2 × CH), 128.0 (CH), 128.3 (5C, 5 × CH), 129.1 (2C, 2 × CH), 129.5 (2C, 2 × 
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CH), 131.5 (2C, 2 × CH), 133.0 (Cquat), 139.0 (Cquat), 145.0 (Cquat); HRMS m/z (TOF ES+) 
370.0872. C21H17NO2NaS requires 370.0878. 
 
N-(Cyclohexylethynyl)-4-methyl-N-phenylbenzenesulfonamide (287) 
N
S
O
O
 
Following GP11 using amide 280 (2.47 g) and cyclohex-1-yne (0.26 mL). Purification by 
flash chromatography [hexanes:EtOAc (20:1)] gave ynamide 287 as a colorless oil (343 mg, 
98%); νmax (neat)/cm-1 2932, 2853, 2251, 1738, 1596, 1488, 1447, 1366, 1268, 1174, 1154, 
1088, 1029, 921; δH (300 MHz; CDCl3) 1.30-1.36 (2H, m, CH2), 1.36-1.54 (4H, m, 2 × CH2), 
1.62-1.71 (2H, m, CH2), 1.74-1.81 (2H, m, CH2), 2.43 (3H, s, CH3), 2.47-2.55 (1H, m, CH), 
7.24-7.28 (4H, m, 4 × CH), 7.28-7.33 (3H, m, 3 × CH), 7.55 (2H, d, J 8.3, 2 × CH); δC (400 
MHz; CDCl3) 21.7 (CH3), 24.7 (2C, 2 × CH2), 25.9 (CH2), 28.8 (CH), 32.7 (2C, 2 × CH2), 
74.2 (Cquat), 74.3 (Cquat), 126.0 (2C, 2 × CH), 127.8 (CH), 128.3 (2C, 2 × CH), 128.9 (2C, 2 × 
CH), 129.2 (2C, 2 × CH), 132.9 (Cquat), 139.5 (Cquat), 144.6 (Cquat); HRMS m/z (TOF ES+) 
376.1339. C21H23NO2NaS requires 376.1347. 
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4-Methyl-N-phenyl-N-((trimethylsilyl)ethynyl)benzenesulfonamide (288) 
N
S
O
O
Si
 
Following GP11 using amide 280 (2.75 g) and ethynyltrimethylsilane (0.28 mL). Purification 
by flash chromatography [hexanes:EtOAc (20:1)] gave ynamide 288 as a colourless solid 
(670 mg, 98%); mp 120-122 °C; νmax (neat)/cm-1 2961, 2165, 1591, 1490, 1365, 1248, 1185, 
1160, 1139, 1085, 934, 908, 843, 831, 780, 712, 692; δH (300 MHz; CDCl3) 0.17 (9H, s, 3 × 
CH3), 2.45 (3H, s, CH3), 7.22-7.27 (3H, m, 3 × CH), 7.29-7.34 (4H, m, 4 × CH), 7.57 (2H, d, 
J 8.4, 2 × CH); δC (400 MHz; CDCl3) 0.0 (3C, 3 × CH3), 21.7 (CH3), 73.3 (Cquat), 95.3 (Cquat), 
126.2 (2C, 2 × CH), 128.2 (CH), 128.4 (2C, 2 × CH), 129.0 (2C, 2 × CH), 129.3 (2C, 2 × 
CH), 132.9 (Cquat), 138.6 (Cquat), 144.9 (Cquat); HRMS m/z (TOF ES+) 366.0963. 
C18H21NO2NaSSi requires 366.0960. 
 
N-(Hex-1-yn-1-yl)-N-phenylmethanesulfonamide (289) 
N
S
O
O
 
Following GP11 using amide 281 (1.71 g) and hex-1-yne (0.24 mL). Purification by flash 
chromatography [hexanes:EtOAc (20:1)] gave ynamide 289 as a colorless oil (576 mg, 98%); 
νmax (neat)/cm-1 2957, 2929, 2858, 2256, 1593, 1490, 1456, 1362, 1322, 1270, 1168, 1155, 
1075, 1027, 958, 924, 901, 825, 757, 737, 691; δH (300 MHz; CDCl3) 0.92 (3H, t, J 7.2, CH3), 
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1.37-1.48 (2H, m, CH2), 1.49-1.60 (2H, m, CH2), 2.35 (2H, t, J 7.0, CH2), 3.07 (3H, s, CH3), 
7.30-7.43 (3H, m, 3 × CH), 7.51 (2H, d, J 7.9, 2 × CH); δC (400 MHz; CDCl3) 13.6 (CH2), 
18.2 (CH2), 22.0 (CH2), 30.9 (CH2), 36.1 (CH3), 71.1 (Cquat), 73.1 (Cquat), 125.4 (2C, 2 × CH), 
128.0 (CH), 129.3 (2C, 2 × CH), 139.1 (Cquat); HRMS m/z (TOF EI+) 251.0981. C13H17NO2S 
requires 251.0980. 
 
(E) and (Z),N-Phenyl-N-tosylhex-2-enamides (294) 
 
Following GP12A using ynamide 283 (98 mg) for 10 min. Purification by flash 
chromatography [hexanes:EtOAc (15:1)] gave imide (E)-294 as a colourless oil (50 mg, 49 
%) and imide (Z)-294 as a colourless oil (22 mg, 21 %). Total yield in imide 294: 70 % [E:Z 
(2.3:1)]. 
Following GP12B using ynamide 283 (98 mg) for 18 h. Purification by flash chromatography 
[hexanes:EtOAc (15:1)] gave imide (E)-294 as a colourless oil (57 mg, 56 %) and imide (Z)-
294 as a colourless oil (15 mg, 14 %). Total yield in imide 294: 70 % [E:Z (3.7:1)]; imide (Z)-
294: νmax (neat)/cm-1 2964, 2931, 2877, 1688, 1623, 1597, 1488, 1455, 1420, 1357, 1241, 
1174, 1149, 1120, 1087, 1074, 1002, 877, 819, 793, 733, 696, 685; δH (300 MHz; CDCl3) 
0.87 (3H, t, J 7.4, CH3), 1.31-1.44 (2H, m, CH2), 2.46 (3H, s, CH3), 2.52 (2H, dtd, J 7.5 and 
7.3, 1.8, CH2), 5.41 (1H, dt, J 11.6 and 1.8, CH), 5.98 (1H, dt, J 11.6 and 7.3, CH), 7.22-7.25 
(2H, m, 2 × CH), 7.34 (2H, d, J 8.4, 2 × CH), 7.42-7.50 (2H, m, 2 × CH), 7.93 (2H, d, J 8.4, 2 
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× CH); δC (400 MHz; CDCl3) 13.7 (CH3), 21.7 (CH3), 22.2 (CH2), 31.1 (CH2), 120.3 (CH), 
129.2 (2C, 2 × CH), 129.3 (2C, 2 × CH), 129.6 (2C, 2 × CH), 129.7 (CH), 130.3 (2C, 2 × 
CH), 136.4 (Cquat), 136.5 (Cquat), 144.6 (Cquat), 151.4 (CH), 165.3 (Cquat); HRMS m/z (TOF 
ES+) 366.1135. C19H21NO3NaS requires 366.1140; imide (E)-294: νmax (neat)/cm-1 2963, 
2929, 2876, 1689, 1635, 1595, 1488, 1455, 1361, 1291, 1255, 1165, 1121, 1088, 975, 904, 
814, 726, 695, 682; δH (300 MHz; CDCl3) 0.78 (3H, t, J 7.4, CH3), 1.23-1.35 (2H, m, CH2), 
1.97 (2H, dtd, J 7.3 and 7.2 and 1.5, CH2), 2.45 (3H, s, CH3), 5.44 (1H, dt, J 15.1 and 1.5, 
CH), 6.95 (1H, dt, J 15.1 and 7.1, CH), 7.23-7.29 (2H, m, 2 × CH), 7.34 (2H, d, J 8.4, 2 × 
CH), 7.45-7.53 (3H, m, 3 × CH), 7.93 (2H, d, J 8.4, 2 × CH) ; δC (400 MHz; CDCl3) 13.5 
(CH3), 21.2 (CH2), 21.7 (CH3), 34.4 (CH2), 121.3 (CH), 129.2 (2C, 2 × CH), 129.3 (2C, 2 × 
CH), 129.7 (2C, 2 × CH), 129.8 (CH), 130.4 (2C, 2 × CH), 136.1 (Cquat), 136.3 (Cquat), 144.7 
(Cquat), 151.0 (CH), 165.3 (Cquat); HRMS m/z (TOF ES+) 366.1141. C18H21NO2NaS requires 
366.1140. 
 
2-Oxo-N,2-diphenyl-N-tosylacetamide (298) 
N
S
O
O
O
O
 
The catalyst system was prepared by addition of CH2Cl2 (1 mL) to AuClPPh3 (5 mg, 0.01 
mmol, 10 mol%) and AgOTs (2.8 mg, 0.01 mmol, 10 mol%) in a flame-dried Schlenk flask 
under argon. After stirring for 10 min at rt, a white precipitate of AgCl was observed and 
ynamide 286 (0.1 mmol, 35 mg) and pyridine-N-oxide (22 mg, 0.22 mmol, 2.2 eq) were 
added. The reaction mixture was stirred at rt for 3 h before being filtered through a pad of 
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silica. The filtrate was then concentrated under reduced pressure and purification of the 
residue by flash chromatography [hexanes:EtOAc (20:1)] gave oxoacetamide 298 as a 
colourless oil (30 mg, 79 %); νmax (neat)/cm-1 2921, 2988, 1685, 1672, 1595, 1487, 1449, 
1374, 1325, 1306, 1229, 1191, 1173, 1148, 1086, 1073, 1034, 955, 912, 812, 758, 737, 710, 
694, 662; δH (300 MHz; CDCl3) 2.48 (3H, s, CH3), 7.13 (2H, d, J 6.9, 2 × CH), 7.33-7.44 
(5H, m, 5 × CH), 7.50-7.55 (2H, m, 2 × CH), 7.60-7.70 (1H, m, CH), 7.75 (2H, d, J 8.4, 2 × 
CH), 7.88-7.90 (2H, m, 2 × CH); δC (400 MHz; CDCl3) 21.8 (CH3), 128.9 (2C, 2 × CH), 
129.1 (2C, 2 × CH), 129.5 (2C, 2 × CH), 129.6 (2C, 2 × CH), 129.8 (2C, 2 × CH), 130.2 
(CH), 130.6 (2C, 2 × CH), 132.7 (Cquat), 133.5 (Cquat), 134.1 (Cquat), 134.6 (CH), 145.9 (Cquat), 
166.7 (Cquat), 187.6 (Cquat); HRMS m/z (TOF ES+) 402.0765. C21H17NO4NaS requires 
402.0776. 
 
(E) and (Z)-6-Chloro-N-Phenyl-N-tosylhex-2-enamides (303) 
 
Following GP12A using ynamide 284 (109 mg) for 10 min. Purification by flash 
chromatography [hexanes:EtOAc (15:1)] gave imide (E)-303 as a colourless oil (54 mg, 48 
%) and imide (Z)-303 as a colourless oil (29 mg, 25 %). Total yield in enamide 303: 73 % 
[E:Z (1.9:1)]. 
Following GP12B using ynamide 284 (109 mg) for 18 h. Purification by flash 
chromatography [hexanes:EtOAc (15:1)] gave imide (E)-303 as a colourless oil (61 mg, 54 
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%) and imide (Z)-303 as a colourless oil (18 mg, 16 %). Total yield in imide 303: 70 % [E:Z 
(3.5:1)]; imide (E)-303: νmax (neat)/cm-1 2960, 2924, 2853, 1689, 1637, 1594, 1488, 1361, 
1169, 1087, 907, 813, 725, 694, 681; δH (300 MHz; CDCl3) 1.69 (2H, m, CH2), 2.17 (2H, dtd, 
J 7.3 and 7.1 and 1.4, CH2), 2.45 (3H, s, CH3), 3.39 (2H, t, J 6.4, CH2), 5.51 (1H, dt, J 15.0 
and 1.5, CH), 6.90 (1H, dt, J 15.0 and 7.2, CH), 7.23-7.29 (2H, m, 2 × CH), 7.34 (2H, d, J 
8.4, 2 × CH), 7.46-7.55 (3H, m, 3 × CH), 7.92 (2H, d, J 8.4, 2 × CH); δC (400 MHz; CDCl3) 
21.7 (CH3), 29.2 (CH2), 30.4 (CH2), 43.6 (CH2), 122.4 (CH), 129.2 (2C, 2 × CH), 129.3 (2C, 
2 × CH), 129.7 (2C, 2 × CH), 129.9 (CH), 130.2 (2C, 2 × CH), 135.9 (Cquat), 136.2 (Cquat), 
144.8 (Cquat), 148.5 (CH), 164.9 (Cquat); HRMS m/z (TOF ES+) 400.0754. C19H20NO3NaS35Cl 
requires 400.0750; imide (Z)-303: νmax (neat)/cm-1 2924, 2855, 1688, 1627, 1595, 1489, 1454, 
1415, 1359, 1242, 1159, 1088, 907, 881, 812, 726, 694, 684; δH (300 MHz; CDCl3) 1.84 (2H, 
dt, J 14.0 and 6.8, CH2), 2.46 (3H, s, CH3), 2.68 (2H, ddt, J 7.5 and 7.5 and 1.7, CH2), 3.47 
(2H, t, J 6.8, CH2), 5.47 (1H, dt, J 11.5 and 1.7, CH), 5.95 (1H, dt, J 11.5 and 7.5, CH), 7.23-
7.26 (2H, m, 2 × CH), 7.35 (2H, d, J 8.3, 2 × CH), 7.45-7.49 (3H, m, 3 × CH), 7.92 (2H, d, J 
8.3, 2 × CH); δC (400 MHz; CDCl3) 21.7 (CH3), 26.6 (CH2), 31.7 (CH2), 44.2 (CH2), 121.5 
(CH), 129.2 (2C, 2 × CH), 129.4 (2C, 2 × CH), 129.7 (2C, 2 × CH), 129.8 (CH), 130.3 (2C, 2 
× CH), 136.2 (Cquat), 136.3 (Cquat), 144.8 (Cquat), 148.7 (CH), 165.0 (Cquat); HRMS m/z (TOF 
ES+) 400.0751. C19H20NO3NaS35Cl requires 400.0750; 
 
(E)-3-Methoxy-N-phenyl-N-tosylacrylamide (304) 
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Following GP12A using ynamide 285 (95 mg) for 12 h. Purification by flash chromatography 
[hexanes:EtOAc (20:1)] gave imide (E)-304 as a colourless oil (70 mg, 70 %). 
Following GP12B using ynamide 285 (95 mg) for 18 h. Purification by flash chromatography 
[hexanes:EtOAc (20:1)] gave imide (E)-304 as a colourless oil (65 mg, 65 %); νmax (neat)/cm-
1
 2976, 2936, 1682, 1605, 1488, 1453, 1438, 1354, 1331, 1256, 1169, 1113, 1084, 931, 906, 
810, 723, 692, 683; δH (300 MHz; CDCl3) 2.45 (3H, s, CH3), 3.46 (3H, s, CH3), 4.82 (1H, d, J 
12.1, CH), 7.27-7.30 (2H, m, 2 × CH), 7.34 (2H, d, J 8.4, 2 × CH), 7.46-7.56 (4H, m, 4 × 
CH), 7.93 (2H, d, J 8.4, 2 × CH); δC (400 MHz; CDCl3) 21.7 (CH3), 58.1 (CH3), 97.0 (CH), 
129.1 (2C, 2 × CH), 129.3 (2C, 2 × CH), 129.6 (2C, 2 × CH), 129.8 (CH), 130.4 (2C, 2 × 
CH), 136.4 (Cquat), 136.7 (Cquat), 144.6 (Cquat), 164.6 (CH), 166.5 (Cquat); HRMS m/z (TOF 
ES+) 354.0766. C17H17NO4NaS requires 354.0776. 
 
(E) and (Z)-N-(Methylsulfonyl)-N-phenylhex-2-enamides (305). 
 
Following GP12A using ynamide 289 (109 mg) for 10 min. Purification by flash 
chromatography [hexanes:EtOAc (15:1)] gave imide (E)-305 as a colourless oil (45 mg, 56 
238 
%) and imide (Z)-305 as a colourless oil (15 mg, 19 %). Total yield in imide 305: 75 % [E:Z 
(3:1)]. 
Following GP12B using ynamide 289 (109 mg) for 18 h. Purification by flash 
chromatography [hexanes:EtOAc (15:1)] gave imide (E)-305 as a colourless oil (46 mg, 58 
%) and imide (Z)-305 as a colourless oil (11 mg, 13 %). Total yield in imide 305: 71 % [E:Z 
(4:1)]; imide (Z)-305: νmax (neat)/cm-1 2963, 2932, 2876, 1682, 1622, 1594, 1487, 1450, 1345, 
1322, 1253, 1189, 1165, 1120, 840, 760, 736, 696; δH (300 MHz; CDCl3) 0.95 (3H, t, J 7.4, 
CH3), 1.41-1.51 (2H, m, CH2), 2.66 (2H, dtd, J 7.5 and 7.4 and 1.8, CH2), 3.48 (3H, s, CH3), 
5.46 (1H, dt, J 11.5 and 1.8, CH), 6.12 (1H, dt, J 11.5 and 7.4, CH), 7.26-7.30 (2H, m, 2 × 
CH), 7.45-7.50 (3H, m, 3 × CH); δC (400 MHz; CDCl3) 13.8 (CH3), 22.2 (CH2), 31.3 (CH2), 
41.9 (CH3), 119.8 (CH), 129.8 (2C, 2 × CH), 129.9 (CH), 130.0 (2C, 2 × CH), 135.6 (Cquat), 
152.7 (CH), 166.5 (Cquat); HRMS m/z (TOF ES+) 290.0823. C13H17NO3NaS requires 
290.0827; imide (E)-305: νmax (neat)/cm-1 2964, 2937, 2880, 1685, 1634, 1592, 1488, 1455, 
1349, 1320, 1291, 1255, 1182, 1152, 1123, 963, 907, 765, 726, 695; δH (300 MHz; CDCl3) 
0.83 (3H, t, J 7.4, CH3), 1.28-1.44 (2H, m, CH2), 2.05 (2H, dtd, J 7.3 and 7.2 and 1.5, CH2), 
3.48 (3H, s, CH3), 5.51 (1H, dt, J 15.2 and 1.5, CH), 7.10 (1H, dt, J 15.2 and 7.1, CH) 7.26-
7.32 (2H, m, 2 × CH), 7.47-7.52 (3H, m, 3 × CH); δC (400 MHz; CDCl3) 13.5 (CH3), 21.2 
(CH2), 34.4 (CH2), 41.9 (CH3), 121.0 (CH), 129.8 (2C, 2 × CH), 130.0 (CH), 130.1 (2C, 2 × 
CH), 135.3 (Cquat), 151.8 (CH), 166.4 (Cquat); HRMS m/z (TOF ES+) 290.0830. 
C13H17NO3NaS requires 290.0827. 
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2-Cyclohexylidene-N-phenyl-N-tosylacetamide (306). 
N
S
O
O
O
 
Following GP12A using ynamide 287 (109 mg) for 20 min. Purification by flash 
chromatography [hexanes:EtOAc (20:1)] gave imide 306 as a colourless oil (88 mg, 80 %). 
Following GP12B using ynamide 287 (109 mg) for 18 h. Purification by flash 
chromatography [hexanes:EtOAc (20:1)] gave imide 306 as a colourless oil (86 mg, 78 %); 
νmax (neat)/cm-1 2934, 2855, 1681, 1617, 1592, 1485, 1448, 1391, 1361, 1251, 1199, 1185, 
1167, 1143, 1123, 997, 977, 933, 904, 889, 839, 814, 719, 692, 681, 653; δH (300 MHz; 
CDCl3) 1.41-1.64 (6H, m, 3 × CH2), 1.83-1.97 (2H, m, CH2), 2.44 (3H, s, CH3), 2.60-2.75 
(2H, m, CH2), 5.21 (1H, s, CH), 7.22-7.28 (2H, m, 2 × CH), 7.33 (2H, d, J 8.4, 2 × CH), 7.43-
7.49 (3H, m, 3 × CH), 7.92 (2H, d, J 8.4, 2 × CH); δC (400 MHz; CDCl3) 21.7 (CH3), 26.0 
(CH2), 27.7 (CH2), 28.5 (CH2), 30.1 (CH2), 38.2 (CH2), 114.0 (CH), 129.0 (2C, 2 × CH), 
129.2 (2C, 2 × CH), 129.5 (3C, 3 × CH), 130.2 (2C, 2 × CH), 136.5 (Cquat), 136.6 (Cquat), 
144.4 (CH), 164.8 (Cquat), 165.7 (Cquat); HRMS m/z (TOF ES+) 392.1281. C21H23NO3NaS 
requires 392.1296. 
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Appendices 
 
Appendix A) 
Study of the catalyst loading 
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Catalysis followed by GC- MS
(50 °C, 0.5 M, 5 mol% AuCl 3)
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Catalysis followed by GC-MS
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Study of the concentration 
 
 
Catalysis followed by GC-MS
(50 °C, 0.05 M, 10 mol% AuCl 3)
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Catalysis followed by GC-MS
(50 °C, 0.2 M, 10 mol% AuCl 3)
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Catalysis followed by GC-MS
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Catalysis followed by GC-MS
(50 °C, 0.4 M, 10 mol% AuCl 3)
0
10
20
30
40
50
60
70
80
90
100
0 5 15 30 45 75 120
Time (min)
Re
la
tiv
e 
Ar
ea
 
(%
)
Aziridine
Silylated Pyrrole
Desilylated Pyrrole
 
Catalysis followed by GC-MS
(50 °C, 0.6 M, 10 mol% AuCl 3)
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Study of the effect of temperature: 
 
Catalysis followed by GC-MS
(30 °C, 0.5 M, 10 mol% AuCl 3)
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Catalysis followed by GC-MS
(40 °C, 0.5 M, 10 mol% AuCl 3)
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Catalysis followed by GC-MS
(60 °C, 0.5 M, 10 mol% AuCl 3)
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Catalysis followed by GC-MS
(70 °C, 0.5 M, 10 mol% AuCl 3)
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Appendix B) 
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